data_1yqa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yqa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.6 m . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 120.509 0.195 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.512 ' HG2' HD11 ' A' ' 178' ' ' LEU . 67.4 Cg_endo -75.04 -144.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.939 2.426 . . . . 0.0 112.384 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.404 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 27.1 m -151.71 156.2 39.84 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.1 m 60.74 36.57 19.33 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.49 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 175' ' ' PRO . 87.9 mt -91.24 172.89 8.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.581 173.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 182' ' ' GLU . 63.6 p -71.2 154.37 41.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.501 ' CE2' ' HD1' ' A' ' 219' ' ' PHE . 3.0 m-85 -58.42 -32.41 68.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.702 0.286 . . . . 0.0 110.33 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 27.9 ttpp -62.47 -53.63 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.805 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.418 ' HG2' ' OG1' ' A' ' 179' ' ' THR . 70.1 mm-40 -61.77 -34.35 75.71 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.517 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.446 ' HE2' ' O ' ' A' ' 178' ' ' LEU . 62.0 mtt -57.77 -47.37 82.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.581 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.59 HG23 HD12 ' A' ' 236' ' ' LEU . 52.8 mt -69.09 -42.51 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.466 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.3 mt -59.55 -25.6 64.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.438 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.491 ' HG2' ' HD2' ' A' ' 175' ' ' PRO . 55.5 tptt -83.22 -41.21 18.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.916 0.389 . . . . 0.0 110.698 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.2 p -76.42 -34.86 58.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.146 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.433 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 0.0 OUTLIER -52.05 -54.86 36.34 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -176.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 188' ' ' MET . 19.4 Cg_endo -58.85 -22.95 64.88 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.247 1.964 . . . . 0.0 112.473 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -75.54 -44.79 41.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.81 112.39 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.302 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 53.81 38.86 29.52 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 53.32 33.48 15.75 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.012 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 73.73 14.89 79.6 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.282 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -72.56 -38.71 67.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 149.36 146.51 4.34 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.055 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 43.4 p -150.5 145.57 26.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.683 0.277 . . . . 0.0 110.797 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.0 t -57.95 152.13 16.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -56.13 -38.86 71.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.12 -46.21 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.742 0.305 . . . . 0.0 110.747 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.55 -47.04 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.566 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 9.0 tp -64.08 -51.16 65.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.967 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -56.28 -48.26 76.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.033 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -37.19 74.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.224 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -75.75 -45.69 35.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.059 0.457 . . . . 0.0 110.409 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 219' ' ' PHE . 68.6 t -60.73 -47.77 91.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.563 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.623 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 27.4 mtpp -64.76 -33.84 76.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.71 -47.72 37.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.686 0.279 . . . . 0.0 111.408 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 28.5 p -78.34 -30.72 48.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 111.231 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.531 ' O ' HG21 ' A' ' 213' ' ' VAL . 83.0 m-85 -109.53 91.75 10.74 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.08 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.24 -26.61 52.63 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.094 2.53 . . . . 0.0 113.704 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 43.9 pt -69.19 -37.72 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.694 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.623 ' CG2' ' HA ' ' A' ' 207' ' ' LYS . 3.6 m -79.52 -23.16 12.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.369 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.02 62.85 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -69.79 -38.94 76.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 0.0 110.796 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.09 120.92 16.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.6 m -80.67 -34.79 34.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.961 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -67.87 -20.82 65.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.863 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.592 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 10.0 t80 -48.0 -48.23 32.77 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.51 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -54.6 -35.94 63.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.778 -171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.02 -46.93 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 110.312 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.42 -32.2 72.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.566 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 50.0 t80 -57.51 -50.41 73.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.384 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.66 -37.46 87.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.571 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.1 t -66.88 -38.33 86.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.831 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.23 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.711 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.0 mt -63.98 -42.43 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.37 -39.04 75.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 32.0 tptt -73.3 -34.95 66.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.213 0.53 . . . . 0.0 110.324 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.4 -39.58 89.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.167 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.0 m -64.62 -39.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.69 -30.88 64.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.077 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -77.61 -16.92 58.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 76.54 19.39 78.09 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.432 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.85 -51.01 9.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 55.4 mt -120.24 153.16 36.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.413 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.8 m -127.69 132.78 68.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.04 0.448 . . . . 0.0 110.672 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.67 92.76 45.86 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.809 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -65.65 -35.98 35.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.066 2.511 . . . . 0.0 113.166 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.49 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 15.0 mptt -71.39 -51.79 22.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.335 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 140.85 -134.34 6.35 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.03 -53.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.549 2.166 . . . . 0.0 111.259 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.2 m -99.05 125.47 44.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.363 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . 172.45 -114.9 0.54 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.961 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.7 tt -153.23 122.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.164 0.507 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.46 ' O ' ' HA2' ' A' ' 196' ' ' GLY . 4.2 mp -85.46 117.77 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.802 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.432 ' HA ' ' HA2' ' A' ' 196' ' ' GLY . 45.3 mtpt -103.95 136.15 44.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.636 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 248' ' ' LEU . 2.8 tm? -76.02 96.87 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.735 0.303 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.94 33.38 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.272 2.648 . . . . 0.0 113.641 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.0 t 68.45 -64.95 0.29 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.377 0.671 . . . . 0.0 112.048 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.4 t -162.82 142.58 9.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.407 ' O ' ' HE2' ' A' ' 183' ' ' MET . 30.4 mt -157.89 -179.81 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.2 m -70.83 149.3 46.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.74 -40.78 42.05 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.679 0.276 . . . . 0.0 111.221 -176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.476 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 26.0 ttpp -64.06 -45.59 88.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -65.95 -33.95 77.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.352 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.407 ' HE2' ' O ' ' A' ' 178' ' ' LEU . 63.3 mtt -52.36 -53.18 48.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.056 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.415 ' CG2' HD22 ' A' ' 202' ' ' LEU . 55.8 mt -66.35 -43.86 91.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 98.1 mt -54.96 -40.17 69.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -81.46 -28.95 33.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 110.547 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.9 t -71.55 -32.74 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.673 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.456 ' HE1' ' HA ' ' A' ' 188' ' ' MET . 1.5 mmt -52.71 -54.29 44.84 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.5 Cg_endo -58.99 -25.61 78.32 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.873 1.716 . . . . 0.0 112.644 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -73.34 -49.11 29.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.21 132.96 35.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.241 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 53.23 33.49 15.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.572 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 54.02 31.8 14.31 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.773 0.429 . . . . 0.0 112.148 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 65.02 29.64 75.92 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 113.088 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -94.65 -42.01 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.064 0.459 . . . . 0.0 110.55 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 156.08 132.41 1.52 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.1 m -126.07 141.51 51.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.744 0.272 . . . . 0.0 110.618 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.8 p -67.8 147.12 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.18 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -51.02 -39.25 55.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.894 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 74.0 mt -65.34 -43.79 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.443 0.163 . . . . 0.0 111.141 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.74 -46.87 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.145 0.498 . . . . 0.0 110.843 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.454 ' HA ' HD11 ' A' ' 202' ' ' LEU . 27.3 tp -65.44 -45.9 82.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.003 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.56 -45.02 85.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.402 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 205' ' ' TYR . 0.1 OUTLIER -54.98 -44.71 74.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.773 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' ' HG2' ' A' ' 204' ' ' LYS . 44.0 t80 -72.73 -46.81 51.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.92 -44.32 86.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.713 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.579 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 49.5 mtpt -63.92 -41.49 97.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.98 -50.61 47.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.925 0.393 . . . . 0.0 111.238 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -72.17 -43.88 63.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 102.4 35.57 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.74 0.305 . . . . 0.0 110.225 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.74 -14.45 44.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.873 2.382 . . . . 0.0 112.399 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.7 -46.01 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.053 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.609 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 5.5 m -77.14 -30.79 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.91 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -64.19 -40.27 97.86 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.72 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.0 m -74.12 -33.73 63.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.114 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.29 126.05 25.96 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 111.413 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.4 p -75.97 -45.78 33.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.273 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.417 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 59.3 t30 -92.65 39.61 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.694 0.759 . . . . 0.0 110.016 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.609 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 8.3 t80 -65.13 -48.76 72.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.758 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -50.53 -42.53 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.448 -172.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -63.26 -47.84 80.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.725 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 55.6 mt -62.55 -40.5 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.2 0.524 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.435 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 39.8 t80 -56.62 -52.52 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.364 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.82 -31.41 72.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 69.2 m -65.55 -39.94 92.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.854 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.6 94.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.214 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.25 -38.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -57.81 -32.4 67.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.206 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -75.65 -47.73 25.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 109.785 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 97.9 m -55.48 -42.66 74.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.36 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -63.49 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.625 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 231' ' ' VAL . 11.5 pt-20 -75.6 -37.1 60.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.936 0.398 . . . . 0.0 110.434 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -74.42 -9.08 58.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 70.68 33.08 66.93 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.1 -51.14 4.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 66.0 mt -117.18 138.1 51.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.896 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 247' ' ' LYS . 4.8 m -109.25 126.54 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.343 0.592 . . . . 0.0 110.659 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 239' ' ' PRO . 58.9 mt-30 -119.34 99.75 50.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.492 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 9.9 Cg_endo -57.26 -50.48 10.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.204 2.603 . . . . 0.0 113.091 -174.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.33 -56.61 4.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.24 -150.48 18.82 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.489 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.5 -45.85 34.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.971 2.448 . . . . 0.0 112.247 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.9 t -92.07 121.72 33.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.97 -143.04 9.66 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.242 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 21.2 tt -108.03 134.72 49.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.077 0.465 . . . . 0.0 111.019 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.526 HG21 HD13 ' A' ' 236' ' ' LEU . 4.7 mp -98.61 108.25 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.916 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 237' ' ' VAL . 39.5 mtmt -100.67 135.06 42.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.27 113.53 9.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.472 ' HB2' HG13 ' A' ' 237' ' ' VAL . 38.4 t30 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.371 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.455 ' HB2' ' H ' ' A' ' 176' ' ' SER . 72.3 Cg_endo -77.6 -140.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.82 2.346 . . . . 0.0 112.535 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.627 ' HA ' ' CD2' ' A' ' 210' ' ' TYR . 21.7 t -155.65 -163.44 1.51 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.5 p 49.9 37.43 13.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.293 0.637 . . . . 0.0 111.255 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 176' ' ' SER . 88.5 mt -114.37 149.68 35.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.641 ' HB ' ' OE1' ' A' ' 182' ' ' GLU . 12.3 m -64.52 154.89 34.65 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.82 ' HA ' ' HE3' ' A' ' 183' ' ' MET . 23.3 m-85 -45.78 -52.03 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 pttm -67.81 -37.58 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.924 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.641 ' OE1' ' HB ' ' A' ' 179' ' ' THR . 18.3 mp0 -57.65 -38.27 74.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.82 ' HE3' ' HA ' ' A' ' 180' ' ' TYR . 46.5 mtm -58.04 -49.16 77.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.8 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 188' ' ' MET . 37.0 mt -63.45 -45.18 98.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.095 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 95.4 mt -52.58 -43.31 65.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.375 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 3.2 tppp? -78.91 -35.98 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.6 m -68.49 -36.1 78.45 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 84.9 mmm -52.53 -55.64 30.3 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 193' ' ' ASP . 39.2 Cg_exo -56.99 -28.82 80.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.194 1.929 . . . . 0.0 112.478 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 49.3 mm-40 -74.48 -40.85 61.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.682 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 77.0 mt -85.51 114.86 22.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.712 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 68.71 -59.25 0.47 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.833 0.708 . . . . 0.0 111.541 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 189' ' ' PRO . 4.0 t70 175.86 -36.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.783 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 140.21 -19.04 2.87 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.701 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.45 -43.05 67.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.712 -0.744 . . . . 0.0 112.171 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 172.75 137.35 2.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.809 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.0 m -141.6 136.26 30.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 53.5 p -68.15 153.1 44.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.691 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -63.37 -29.77 71.01 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.4 -47.74 89.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.76 -48.36 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.893 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.585 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 25.2 tp -62.27 -48.63 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.847 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.468 ' HA ' ' CG2' ' A' ' 206' ' ' VAL . 38.1 ttpt -66.77 -37.32 84.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -61.26 -35.28 76.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.513 0.673 . . . . 0.0 110.432 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -77.53 -51.34 10.87 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.467 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 203' ' ' LYS . 33.4 m -58.68 -42.52 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.018 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -64.22 -40.26 95.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.69 -41.43 31.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.7 p -83.05 -38.5 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.297 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.627 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 17.0 m-85 -101.56 101.01 15.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.89 -10.74 28.01 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.051 2.501 . . . . 0.0 112.703 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.06 -34.65 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.433 HG13 ' HE2' ' A' ' 183' ' ' MET . 35.0 m -102.36 -24.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.12 62.46 1.72 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.678 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.8 t -171.33 -48.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.682 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.06 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.1 p -77.12 -35.5 56.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.32 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.26 -6.05 36.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.953 0.406 . . . . 0.0 110.751 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -55.0 -36.99 66.02 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.391 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.43 -46.37 69.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -67.63 -47.51 69.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.944 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.12 -40.42 95.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 111.047 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 14.6 t80 -61.31 -50.34 73.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.077 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -58.97 -36.93 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.86 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.2 m -62.52 -40.04 95.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.864 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.17 96.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.852 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.6 mt -64.54 -43.54 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.233 0.539 . . . . 0.0 110.098 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.94 -31.69 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.707 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -71.96 -34.29 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.637 0.732 . . . . 0.0 109.671 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 233' ' ' ASN . 71.8 m -72.52 -33.11 66.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.419 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 26.6 m -63.5 -38.51 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.227 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 231' ' ' VAL . 12.4 pt-20 -73.54 -33.49 64.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.965 0.412 . . . . 0.0 110.159 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 230' ' ' CYS . 7.8 m-80 -62.97 -33.96 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.91 18.72 53.67 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.339 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 235' ' ' GLU . 23.1 mm-40 -95.38 -39.89 9.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 2.8 mm? -119.23 140.45 50.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.417 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.45 136.04 56.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.043 0.449 . . . . 0.0 110.733 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.67 93.85 48.57 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.38 -38.6 25.59 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.11 2.54 . . . . 0.0 112.828 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.57 -42.33 78.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.181 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 150.6 -127.64 2.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.68 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 31.7 Cg_endo -63.83 -29.5 68.0 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.735 2.29 . . . . 0.0 111.9 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.6 m -143.16 -123.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.054 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.51 -63.79 3.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.285 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 245' ' ' ILE . 19.5 tt -168.58 130.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.512 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 196' ' ' GLY . 5.2 mp -92.81 127.1 45.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.237 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -118.65 132.14 56.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.558 0.218 . . . . 0.0 110.575 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.3 tp -75.48 105.96 6.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 t30 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.42 -174.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.776 ' HG2' HD13 ' A' ' 178' ' ' LEU . 7.4 Cg_exo -75.19 -134.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.86 2.374 . . . . 0.0 112.283 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.563 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 13.5 p -152.69 -47.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.3 m -77.21 70.16 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 111.513 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.776 HD13 ' HG2' ' A' ' 175' ' ' PRO . 69.9 mt -142.66 155.12 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.236 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.2 p -64.92 152.06 44.09 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -60.53 -31.54 70.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.783 0.325 . . . . 0.0 110.597 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -61.12 -48.2 82.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.51 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' A' ' 178' ' ' LEU . 20.4 tp10 -63.45 -37.45 87.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.64 176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.491 ' HE3' ' O ' ' A' ' 178' ' ' LEU . 64.2 mtt -57.82 -50.91 71.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.565 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.468 HG21 HD23 ' A' ' 202' ' ' LEU . 60.5 mt -64.75 -45.16 95.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.032 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.6 mt -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.012 0.434 . . . . 0.0 110.794 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -78.14 -38.74 43.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.8 p -78.83 -27.52 44.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.249 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.515 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 2.6 mmt -49.01 -53.86 34.07 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.2 Cg_endo -58.34 -28.79 86.01 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.117 1.878 . . . . 0.0 112.578 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -73.13 -39.8 65.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 109.78 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.01 92.89 9.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.437 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.15 32.75 21.03 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.83 32.78 12.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.992 0.425 . . . . 0.0 111.588 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.84 18.16 68.19 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.273 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.37 -38.45 63.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.267 0.534 . . . . 0.0 109.883 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 167.54 123.68 0.68 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.796 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 50.7 m -140.65 138.27 34.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.618 0.247 . . . . 0.0 110.685 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.544 ' O ' HG12 ' A' ' 201' ' ' VAL . 14.5 p -61.65 148.98 40.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -54.76 -37.38 65.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.402 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -50.29 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.64 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 198' ' ' SER . 8.5 p -69.23 -35.88 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.809 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.468 HD23 HG21 ' A' ' 184' ' ' ILE . 17.3 tp -64.71 -51.13 64.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.338 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -58.85 -40.78 85.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -59.07 -46.23 88.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.935 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -71.04 -43.35 68.04 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.237 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.54 -42.26 80.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.977 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.92 -44.31 89.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.778 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.95 -46.01 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.295 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.6 p -74.66 -43.51 54.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.335 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.563 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 49.2 m-85 -109.82 89.85 8.39 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.14 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.16 -15.83 36.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.891 2.394 . . . . 0.0 112.877 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.89 -32.89 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.877 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.658 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 4.2 m -76.81 -31.25 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.036 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -66.26 -40.43 94.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.631 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.7 t -71.35 -36.22 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.701 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.96 44.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.938 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -75.35 -50.41 16.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 110.976 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 50.2 t30 -90.07 38.52 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.472 0.654 . . . . 0.0 110.603 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.658 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.5 t80 -64.69 -48.52 74.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.562 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.42 -41.48 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.548 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.08 -45.29 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.0 110.549 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 77.8 mt -62.32 -37.77 86.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.192 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 42.8 t80 -59.83 -49.56 77.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.973 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.02 -42.79 81.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.949 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.4 m -65.43 -37.87 88.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.73 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.66 86.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.6 mt -62.23 -45.16 99.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.114 0.483 . . . . 0.0 110.022 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -56.42 -40.99 75.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.791 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -73.81 -43.12 59.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.367 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 73.8 m -59.02 -41.92 88.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.532 0.206 . . . . 0.0 111.428 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 30.0 m -69.18 -43.17 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 231' ' ' VAL . 11.0 pt-20 -69.31 -34.8 75.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.899 0.381 . . . . 0.0 110.447 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -64.79 -24.7 67.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.526 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.44 27.66 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.49 -26.22 10.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.322 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 14.1 tp -141.57 156.37 45.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.452 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 249' ' ' ASN . 2.1 t -133.17 136.14 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.979 0.418 . . . . 0.0 110.351 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.8 OUTLIER -145.67 102.84 4.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 16.6 Cg_endo -61.38 -26.02 80.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.184 2.589 . . . . 0.0 113.0 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -104.82 28.85 6.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 65.2 -122.58 23.94 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.8 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -75.48 -57.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.918 2.412 . . . . 0.0 112.463 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 p -91.94 127.86 37.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.51 -144.55 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.23 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.0 tt -110.35 121.86 63.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.341 0.591 . . . . 0.0 110.521 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.583 HG21 HD23 ' A' ' 236' ' ' LEU . 3.1 mp -85.48 130.0 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.11 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -127.51 132.04 50.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.86 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 248' ' ' LEU . 2.7 tt -70.72 123.53 22.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.473 ' CB ' HG21 ' A' ' 237' ' ' VAL . 6.4 p-10 . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.378 0.609 . . . . 0.0 110.937 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.6 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 9.0 p . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.851 0.358 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.25 138.82 12.83 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.799 2.333 . . . . 0.0 112.254 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.5 t -75.44 -172.2 1.72 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.4 m 59.61 55.04 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.253 0.549 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.407 ' O ' ' HE3' ' A' ' 183' ' ' MET . 40.4 mt -149.63 158.33 44.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.843 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 182' ' ' GLU . 5.6 t -64.76 157.65 26.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.439 ' HA ' ' SD ' ' A' ' 183' ' ' MET . 3.5 m-30 -57.35 -27.75 62.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.673 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 55.9 tttm -65.53 -47.6 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.489 ' H ' HG22 ' A' ' 179' ' ' THR . 65.5 mm-40 -60.87 -38.77 86.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.973 0.416 . . . . 0.0 110.82 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.46 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 58.2 mtt -55.98 -48.31 76.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.7 mt -70.33 -37.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.749 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 86.2 mt -54.75 -45.68 74.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 17.5 tppt? -70.84 -39.53 72.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.405 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 51.0 m -72.57 -32.75 66.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 0.5 OUTLIER -51.79 -51.89 66.13 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 188' ' ' MET . 23.9 Cg_endo -63.44 -30.12 71.95 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.841 1.694 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 66.0 mt-30 -66.7 -36.15 81.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.13 113.85 26.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 54.74 37.7 28.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.78 30.98 9.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.487 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.01 24.08 75.91 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.265 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.82 -41.68 25.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.38 0.609 . . . . 0.0 110.144 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.49 136.34 2.17 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.383 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 41.8 m -139.88 139.79 36.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.989 0.423 . . . . 0.0 110.795 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.1 p -62.26 155.65 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.264 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 243' ' ' SER . 54.2 ttt85 -53.35 -41.52 65.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.55 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.82 -44.56 98.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.646 0.26 . . . . 0.0 111.143 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 76.0 t -63.94 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.369 . . . . 0.0 111.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.523 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 24.2 tp -68.34 -46.81 69.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.06 -43.34 99.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 50.6 pttt -62.43 -32.59 73.47 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.396 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -78.23 -45.5 22.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.145 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 202' ' ' LEU . 40.1 t -59.08 -43.37 89.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.484 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.503 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 46.6 mtpt -67.0 -41.17 87.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.364 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.76 -42.32 81.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.6 ' HB ' ' HG ' ' A' ' 174' ' ' SER . 20.3 p -77.54 -37.17 51.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 183' ' ' MET . 63.7 m-85 -113.79 95.35 37.01 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.52 -17.25 40.3 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.904 2.403 . . . . 0.0 112.519 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.6 pt -71.67 -39.15 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.052 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.645 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 6.1 m -74.36 -29.72 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.02 0.438 . . . . 0.0 110.077 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -63.35 -29.43 74.51 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.745 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.0 m -95.45 48.26 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.47 128.9 13.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.787 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.4 t -78.75 -41.82 29.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.142 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.423 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.0 p-10 -88.76 20.07 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.645 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.2 t80 -59.34 -51.07 71.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -52.54 -40.79 62.9 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.237 0.335 . . . . 0.0 111.207 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -67.01 -48.71 67.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.177 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 63.2 mt -62.39 -36.32 81.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 110.243 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.523 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 21.9 t80 -59.41 -48.88 79.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.723 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.511 ' HB2' HH22 ' A' ' 199' ' ' ARG . 3.0 t-20 -59.47 -41.72 90.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.449 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.5 t -65.24 -37.27 86.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.876 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.36 90.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -39.23 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.417 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -55.12 -42.25 72.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -66.63 -38.56 87.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 110.499 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 78.0 m -64.32 -38.78 92.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.013 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 18.2 m -65.63 -37.65 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.491 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.515 ' N ' HG21 ' A' ' 231' ' ' VAL . 4.9 mt-10 -72.75 -46.03 55.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.468 0.651 . . . . 0.0 109.312 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -60.5 -30.53 69.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.42 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 87.27 31.9 15.47 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -97.02 -49.16 5.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.0 109.025 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 9.8 mp -122.83 142.04 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.882 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.19 134.29 62.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.14 0.495 . . . . 0.0 111.169 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -125.76 79.92 67.52 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.753 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -53.75 -46.13 35.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.397 2.731 . . . . 0.0 112.973 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 63.3 mttm -71.96 -54.65 9.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.95 -162.86 36.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.825 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.88 -41.13 65.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.287 2.658 . . . . 0.0 112.615 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 199' ' ' ARG . 2.7 p -90.96 6.64 43.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.176 0.512 . . . . 0.0 110.628 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . -84.29 164.96 40.64 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.35 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.4 tt -59.26 128.77 20.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 4.6 mp -86.59 119.83 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -114.46 136.51 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.77 117.11 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 52.4 t30 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -176.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.632 ' HB2' HG21 ' A' ' 209' ' ' THR . 27.7 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.17 -136.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.076 2.518 . . . . 0.0 112.285 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.677 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 44.7 m -155.35 -46.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.248 -0.283 . . . . 0.0 111.281 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.3 m -76.43 63.06 1.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 91.2 mt -132.04 156.27 46.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.0 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -63.65 145.64 55.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.74 -36.92 38.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.659 ' O ' HD13 ' A' ' 185' ' ' LEU . 24.3 ttpp -63.18 -53.18 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.545 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -57.91 -37.13 73.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.963 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.556 ' HE2' HG11 ' A' ' 213' ' ' VAL . 48.5 mtp -57.59 -53.19 60.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.424 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 184' ' ' ILE . 57.5 mt -62.59 -53.44 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.932 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 181' ' ' LYS . 10.7 mp -52.29 -32.13 36.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.855 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -74.36 -42.17 59.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.909 0.385 . . . . 0.0 111.217 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.1 p -78.33 -28.01 47.21 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 60.7 mmm -52.24 -50.77 77.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -60.68 -18.15 53.62 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.034 1.823 . . . . 0.0 112.95 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -77.13 -48.56 17.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.337 0.589 . . . . 0.0 109.957 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 68.3 mt -71.79 121.4 18.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.331 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 52.02 36.58 19.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 55.1 30.98 15.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.24 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 68.78 25.73 75.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.238 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -84.43 -39.34 19.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 109.993 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 168.85 132.6 1.45 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.0 m -116.66 126.38 53.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.082 0.441 . . . . 0.0 110.892 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.552 ' O ' HG12 ' A' ' 201' ' ' VAL . 2.7 p -65.05 150.73 47.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.577 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -50.22 -42.74 52.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.599 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.86 -49.43 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 198' ' ' SER . 9.6 p -63.63 -35.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.591 0.234 . . . . 0.0 110.869 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.429 ' HA ' HD11 ' A' ' 202' ' ' LEU . 22.7 tp -69.97 -49.09 55.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.863 0.363 . . . . 0.0 110.187 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.4 -43.72 92.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.336 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -66.46 -37.98 86.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.386 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -44.74 65.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 109.719 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 23.0 t -59.55 -44.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.286 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.592 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 43.6 mtpt -62.94 -45.2 93.62 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.36 -47.41 49.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.522 -175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.632 HG21 ' HB2' ' A' ' 174' ' ' SER . 6.6 m -70.91 -45.29 64.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.121 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.677 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 28.1 m-85 -103.67 103.76 38.32 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.75 -15.14 48.66 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.095 2.53 . . . . 0.0 113.127 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.3 mt -67.05 -45.22 87.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.624 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.702 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 23.2 m -72.8 -31.23 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.382 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -62.45 -42.02 99.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.551 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.4 m -71.83 -34.58 69.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.715 -0.242 . . . . 0.0 111.252 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.59 125.42 23.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 0.0 111.433 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.6 m -76.22 -43.18 43.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.991 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 34.1 t30 -95.01 36.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.534 0.683 . . . . 0.0 110.181 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.702 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 3.4 t80 -62.05 -48.9 78.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.518 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.85 -43.05 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.899 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -62.2 -46.72 87.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.258 . . . . 0.0 110.628 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 222' ' ' LEU . 59.3 mt -63.75 -40.22 96.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.535 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 28.2 t80 -61.1 -54.42 44.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.57 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -63.99 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.9 t -61.83 -40.81 96.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.397 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.09 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.666 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.2 mt -67.83 -39.04 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -55.97 -40.25 72.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.32 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.0 -40.02 65.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.174 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 84.8 m -58.29 -45.71 87.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.025 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 34.8 m -64.15 -37.46 79.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -77.15 -37.07 54.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.424 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.5 -30.51 67.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.51 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.35 25.8 20.24 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -85.17 -49.05 8.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.334 0.588 . . . . 0.0 109.434 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.642 HD11 HG23 ' A' ' 246' ' ' ILE . 45.0 mt -127.23 145.09 50.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.843 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 247' ' ' LYS . 6.5 m -114.71 129.15 71.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.044 0.45 . . . . 0.0 110.346 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.86 97.13 50.14 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.687 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.6 -41.21 66.51 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 123.043 2.495 . . . . 0.0 112.272 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 240' ' ' LYS . 3.6 mptp? -80.95 -69.8 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 0.0 110.278 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 167.5 -156.65 28.54 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.11 -48.61 20.65 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.066 2.511 . . . . 0.0 112.671 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 7.9 t -89.49 55.11 3.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.263 0.554 . . . . 0.0 109.833 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -152.87 162.33 29.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.653 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.3 tt -57.04 125.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.526 0.679 . . . . 0.0 111.971 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.642 HG23 HD11 ' A' ' 236' ' ' LEU . 4.8 mp -87.9 123.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.309 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.47 ' HB2' HG22 ' A' ' 237' ' ' VAL . 58.1 mtpt -112.28 137.12 50.86 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.98 113.51 9.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.458 ' HB2' HG12 ' A' ' 237' ' ' VAL . 46.5 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 120.864 0.364 . . . . 0.0 110.269 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.571 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 18.9 m . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.451 ' HD2' ' HG2' ' A' ' 186' ' ' LYS . 43.5 Cg_endo -70.25 -143.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.031 2.488 . . . . 0.0 113.172 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 50.8 m -153.08 161.87 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.09 -0.381 . . . . 0.0 110.722 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.6 m 62.14 49.99 4.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.55 0.69 . . . . 0.0 111.214 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.418 ' O ' ' HE3' ' A' ' 183' ' ' MET . 51.6 mt -129.35 163.09 26.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.349 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.475 ' HB ' ' HG2' ' A' ' 182' ' ' GLU . 1.9 m -63.0 150.5 42.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -54.57 -37.28 65.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 39.1 ttpt -60.42 -46.45 89.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.033 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.475 ' HG2' ' HB ' ' A' ' 179' ' ' THR . 55.6 mm-40 -61.45 -33.67 74.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.418 ' HE3' ' O ' ' A' ' 178' ' ' LEU . 60.6 mtt -58.15 -49.52 76.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 236' ' ' LEU . 58.8 mt -68.94 -43.35 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 87.6 mt -53.33 -39.52 64.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 47.6 tptt -73.74 -42.06 61.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 m -69.21 -30.04 68.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.33 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.525 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 5.1 mmt -51.63 -57.7 13.58 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 32.1 Cg_exo -59.1 -28.33 87.5 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.12 1.88 . . . . 0.0 112.127 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -71.06 -39.6 72.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.15 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.446 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 51.89 35.34 15.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.057 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 54.78 34.92 22.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.588 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.73 19.22 69.12 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.759 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -75.96 -41.72 50.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.3 0.55 . . . . 0.0 110.251 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 247' ' ' LYS . . . 167.82 145.9 4.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 m -143.69 133.42 23.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.879 0.34 . . . . 0.0 110.793 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.2 t -61.19 144.82 53.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.204 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.551 HH12 ' HB2' ' A' ' 224' ' ' ASN . 46.3 ttm-85 -53.89 -38.71 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 110.419 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.14 -49.67 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.0 -34.44 45.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.714 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 202' ' ' LEU . 28.8 tp -66.17 -49.91 65.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.67 -36.47 76.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -57.34 -45.87 83.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.15 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.27 -44.47 65.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.478 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -45.86 82.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.626 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.43 -43.44 85.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.52 -41.56 96.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.496 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.484 ' CB ' ' HB2' ' A' ' 174' ' ' SER . 18.7 p -79.67 -42.89 23.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.585 ' O ' HG13 ' A' ' 213' ' ' VAL . 16.4 m-85 -106.88 102.58 43.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.92 -31.94 84.74 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.546 2.164 . . . . 0.0 111.509 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.12 -37.04 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.774 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 210' ' ' TYR . 4.1 p -82.25 -36.32 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -82.03 41.1 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.507 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.9 t -160.23 51.89 0.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.323 0.583 . . . . 0.0 109.448 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.94 29.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.592 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.3 m -74.9 -53.07 9.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.456 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 18.1 t-20 -84.82 55.23 3.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 0.0 109.391 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -88.98 -60.13 2.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.312 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -59.94 -36.98 78.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.5 -48.56 81.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.824 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 20.1 mt -68.27 -39.67 82.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.476 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -54.85 -49.72 70.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.709 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.551 ' HB2' HH12 ' A' ' 199' ' ' ARG . 20.4 t30 -62.78 -42.31 99.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.716 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 57.8 m -68.38 -30.67 69.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.94 99.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.75 HG22 HD12 ' A' ' 236' ' ' LEU . 2.0 mt -67.04 -38.76 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 231' ' ' VAL . 25.1 tptp -57.29 -39.94 76.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.38 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.39 -40.34 74.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 87.7 m -61.54 -38.66 88.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.266 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 228' ' ' LYS . 22.4 m -65.36 -34.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.88 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.14 -44.82 59.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 109.224 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -63.51 -22.43 66.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.684 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.75 29.1 55.74 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.164 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -96.18 -52.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 110.279 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.75 HD12 HG22 ' A' ' 227' ' ' ILE . 40.6 mt -110.58 134.7 52.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 247' ' ' LYS . 4.1 m -110.98 135.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.15 0.5 . . . . 0.0 110.699 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -125.87 82.87 63.69 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.166 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.65 -41.71 23.83 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.903 2.402 . . . . 0.0 113.078 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.59 -62.55 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.793 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 169.41 -134.21 3.11 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.711 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.08 -59.71 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.905 2.403 . . . . 0.0 113.202 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.6 m -80.62 -63.2 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 42.82 -123.86 3.91 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.571 -0.741 . . . . 0.0 114.169 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.5 tt -160.74 114.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.413 HG12 HD11 ' A' ' 227' ' ' ILE . 4.1 mp -75.2 114.95 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.71 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 237' ' ' VAL . 56.0 mtpt -112.39 131.87 55.32 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.104 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.4 tp -70.06 106.83 3.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 44.7 t30 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.826 -175.565 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.624 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.3 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.424 ' HD2' HD13 ' A' ' 178' ' ' LEU . 13.0 Cg_exo -71.01 -148.8 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.847 2.364 . . . . 0.0 112.36 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -109.66 -38.28 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.733 0.301 . . . . 0.0 111.279 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.9 t -134.13 131.04 38.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 0.0 110.879 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' HE1' ' A' ' 183' ' ' MET . 33.6 mt -161.61 169.47 21.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.805 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 p -66.37 143.24 57.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -56.42 -32.95 65.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.577 ' O ' HD12 ' A' ' 185' ' ' LEU . 73.5 tttt -62.82 -47.5 83.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.042 173.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.66 -36.73 83.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.865 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.528 ' HE1' ' O ' ' A' ' 178' ' ' LEU . 60.9 mtt -50.73 -50.24 55.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.722 HG23 HD12 ' A' ' 236' ' ' LEU . 79.7 mt -64.83 -54.54 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.208 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 181' ' ' LYS . 7.9 mp -56.37 -24.97 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.69 -36.12 23.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.292 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.416 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 12.9 p -78.39 -26.7 46.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 73.9 mmm -55.89 -50.17 88.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 188' ' ' MET . 13.4 Cg_endo -60.07 -38.36 78.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 112.806 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 11.0 pt20 -75.83 -39.24 57.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.72 114.53 4.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.717 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 53.32 35.58 20.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.311 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 38.5 t0 56.78 34.08 24.08 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.517 0.675 . . . . 0.0 110.954 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 188' ' ' MET . . . 73.56 27.92 66.53 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.637 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.86 -41.4 26.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.472 . . . . 0.0 110.61 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 143.06 157.41 7.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.4 p -151.94 136.24 16.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.955 0.377 . . . . 0.0 110.572 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 2.1 p -68.1 153.43 43.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -51.74 -42.17 62.11 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.43 -41.44 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.4 -48.08 84.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.18 0.514 . . . . 0.0 110.675 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.457 HD21 HG22 ' A' ' 184' ' ' ILE . 20.0 tp -61.81 -41.8 98.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.699 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.25 -44.85 84.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.964 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -39.29 86.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.424 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -50.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.485 HG13 ' CZ ' ' A' ' 219' ' ' PHE . 77.5 t -58.56 -41.81 82.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.716 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.432 ' HA ' HG13 ' A' ' 213' ' ' VAL . 27.2 mtpp -64.38 -45.3 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.27 -46.79 26.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.021 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 33.4 p -67.15 -48.95 66.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.244 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -94.35 106.9 25.82 Favored Pre-proline 0 N--CA 1.453 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.69 -36.32 92.3 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.901 2.401 . . . . 0.0 112.548 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.38 -38.1 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.494 HG12 ' CE1' ' A' ' 219' ' ' PHE . 54.8 t -66.35 -47.98 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.413 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.4 92.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.276 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.5 t -79.97 -26.6 39.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.508 0.194 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.59 136.13 57.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.957 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -78.73 -62.44 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.749 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.469 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.6 p-10 -87.04 35.58 0.7 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.494 ' CE1' HG12 ' A' ' 213' ' ' VAL . 4.7 t80 -63.13 -50.93 68.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.548 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.29 -44.36 53.91 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -62.69 -46.64 87.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.416 . . . . 0.0 110.799 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 53.8 mt -65.2 -35.2 80.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.323 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.403 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 18.6 t80 -58.09 -51.04 71.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.623 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -60.83 -38.68 86.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.179 0.514 . . . . 0.0 110.864 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.3 t -65.08 -38.45 90.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.385 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.93 94.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.641 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.4 mt -62.11 -46.58 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.122 0.487 . . . . 0.0 110.141 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.413 ' O ' HG21 ' A' ' 231' ' ' VAL . 49.1 tttp -61.12 -37.94 84.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.849 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.73 -34.56 78.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.083 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 94.3 m -71.18 -41.96 69.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.565 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 28.2 m -67.96 -39.6 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.617 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.54 -36.45 81.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.391 0.615 . . . . 0.0 109.775 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -68.7 -25.97 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.327 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.55 76.73 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.151 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.85 -32.85 65.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.606 0.717 . . . . 0.0 110.194 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.722 HD12 HG23 ' A' ' 184' ' ' ILE . 7.2 tt -131.49 140.06 49.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.191 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.6 m -116.05 137.88 48.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.031 0.443 . . . . 0.0 110.888 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 242' ' ' PRO . 8.7 mm-40 -127.88 79.07 74.29 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.62 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.26 -39.03 2.31 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.841 2.361 . . . . 0.0 112.264 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.692 ' HD2' HG22 ' A' ' 245' ' ' ILE . 63.6 mttp -90.28 24.72 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.176 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 74.36 173.05 29.01 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.387 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.484 ' HA ' ' NE2' ' A' ' 238' ' ' GLN . 52.0 Cg_exo -55.23 -40.6 84.87 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.015 2.477 . . . . 0.0 113.218 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -81.68 -2.26 49.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.768 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -82.56 -136.22 2.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.883 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.692 HG22 ' HD2' ' A' ' 240' ' ' LYS . 16.1 tt -105.38 121.79 57.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.23 0.538 . . . . 0.0 111.558 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.455 ' O ' ' HE1' ' A' ' 188' ' ' MET . 3.3 mp -79.77 116.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.469 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -116.29 138.65 51.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 0.0 110.471 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 53.2 tp -81.58 113.95 19.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 54.4 t30 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.875 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.437 ' HB2' ' H ' ' A' ' 176' ' ' SER . 60.5 Cg_endo -75.84 -144.25 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.946 2.43 . . . . 0.0 112.625 -176.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.437 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 7.9 t -140.28 -39.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 178' ' ' LEU . 8.1 m -114.4 123.78 50.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.66 0.267 . . . . 0.0 110.75 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 177' ' ' SER . 17.0 mt -166.23 -179.41 5.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.741 0.816 . . . . 0.0 109.121 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -82.35 148.01 28.52 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.59 -42.85 62.22 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.876 0.369 . . . . 0.0 110.933 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.572 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -62.49 -41.16 98.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.031 178.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -67.35 -34.63 77.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.502 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.574 ' HE1' HD12 ' A' ' 212' ' ' ILE . 63.3 mtt -58.65 -49.71 76.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.59 -39.97 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.977 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.5 mt -55.98 -36.94 68.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.506 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 1.9 tppp? -86.28 -32.75 20.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.3 m -70.73 -36.62 73.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.639 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.535 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 4.1 mmt -52.68 -52.11 67.32 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 35.3 Cg_exo -54.31 -33.66 76.94 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.287 1.991 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -67.91 -43.68 78.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.291 0.567 . . . . 0.0 110.394 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.01 107.17 8.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.642 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.79 34.32 23.2 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 59.29 35.15 23.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.955 0.407 . . . . 0.0 110.806 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.72 32.51 70.69 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.395 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -85.8 -41.63 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.231 0.516 . . . . 0.0 110.681 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 247' ' ' LYS . . . 156.27 150.31 5.6 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.848 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 74.7 m -153.64 142.68 21.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.715 0.293 . . . . 0.0 110.872 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.512 ' OG ' HG21 ' A' ' 201' ' ' VAL . 9.1 p -62.7 149.51 43.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.631 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.468 ' HA ' ' CD1' ' A' ' 246' ' ' ILE . 54.8 ttp85 -52.41 -43.03 64.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.049 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.471 HD13 HG23 ' A' ' 200' ' ' ILE . 48.3 mt -64.57 -40.35 88.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.512 HG21 ' OG ' ' A' ' 198' ' ' SER . 51.5 t -63.22 -46.22 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.975 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.528 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 10.8 tp -62.56 -48.66 78.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.338 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -58.75 -41.72 87.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.914 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -58.5 -41.23 84.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.527 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -72.09 -43.05 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 202' ' ' LEU . 99.2 t -60.39 -44.14 95.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.941 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.45 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 60.6 mtpt -67.57 -38.99 84.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.419 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.59 -50.27 70.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.809 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.1 p -79.59 -44.93 20.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.096 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -103.62 97.68 11.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.628 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.79 -15.23 45.58 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.887 2.391 . . . . 0.0 112.942 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.574 HD12 ' HE1' ' A' ' 183' ' ' MET . 14.6 pt -71.81 -35.59 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 0.0 111.285 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.648 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 11.6 m -74.28 -32.71 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 213' ' ' VAL . . . -62.99 -38.86 97.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.734 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -72.59 -33.79 66.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.819 0.342 . . . . 0.0 111.234 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.58 130.52 43.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.98 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.2 m -80.19 -43.87 20.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.159 0.504 . . . . 0.0 110.652 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.5 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 15.2 p-10 -86.66 21.29 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.648 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.0 t80 -61.56 -52.85 62.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -51.24 -40.54 59.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.41 . . . . 0.0 111.42 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -65.3 -52.77 51.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.874 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 57.5 mt -61.22 -37.18 82.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 110.517 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.528 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 58.4 t80 -54.09 -54.66 36.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.927 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -72.04 -32.15 66.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.9 t -64.08 -41.33 97.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.48 92.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.42 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 mt -66.24 -36.26 76.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.689 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -58.49 -34.48 70.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.398 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.46 -38.27 49.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.354 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 181' ' ' LYS . 73.4 m -59.29 -41.64 89.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.782 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -64.0 -42.75 96.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.8 -35.53 67.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.99 0.424 . . . . 0.0 110.203 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.365 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.16 29.22 41.97 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.848 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -95.71 -47.85 6.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 57.3 mt -118.51 144.83 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.972 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 247' ' ' LYS . 10.5 m -115.2 134.8 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 120.984 0.421 . . . . 0.0 110.105 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.11 81.34 28.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.231 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.19 -39.31 79.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.668 2.245 . . . . 0.0 111.804 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -93.68 29.53 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.691 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 63.17 -164.12 29.24 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.174 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.77 -41.35 8.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.936 2.424 . . . . 0.0 112.706 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.2 p -88.2 58.9 4.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.49 . . . . 0.0 111.263 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -161.66 -134.55 1.66 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.653 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.3 tt -98.17 133.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 111.392 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 199' ' ' ARG . 4.9 mp -97.15 129.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.519 ' HB2' HG22 ' A' ' 237' ' ' VAL . 52.8 mtpt -126.41 138.15 53.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.9 tp -71.41 124.76 25.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.425 -176.169 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.651 ' H ' HG21 ' A' ' 209' ' ' THR . 14.3 m . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 120.45 0.167 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.508 ' HB2' ' H ' ' A' ' 176' ' ' SER . 46.5 Cg_endo -69.34 -140.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.463 2.775 . . . . 0.0 113.55 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.625 ' HA ' ' CE2' ' A' ' 210' ' ' TYR . 73.3 m -155.54 177.82 10.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.059 -0.401 . . . . 0.0 110.508 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.6 m 60.77 47.53 7.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 111.076 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' A' ' 175' ' ' PRO . 93.7 mt -135.78 159.92 40.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -66.02 150.98 47.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.737 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -51.91 -42.95 63.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.603 0.239 . . . . 0.0 111.457 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.585 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 ttpt -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.54 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.32 -32.95 74.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.245 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.518 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 61.2 mtt -57.91 -45.89 85.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 109.583 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.45 HG21 HD12 ' A' ' 184' ' ' ILE . 69.6 mt -68.25 -41.16 83.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.235 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 79.8 mt -53.24 -37.65 62.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.61 -33.84 27.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -73.24 -35.62 66.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.829 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.494 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 1.6 mmt -53.36 -54.41 45.56 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.0 Cg_endo -58.82 -29.23 89.39 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.013 1.809 . . . . 0.0 112.205 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.54 -42.07 71.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.647 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.425 ' HA ' HD21 ' A' ' 191' ' ' LEU . 98.6 mt -74.78 115.05 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.189 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 51.44 42.39 29.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.992 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 56.59 30.82 18.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.9 28.17 67.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.847 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -91.92 -36.24 13.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.851 -0.205 . . . . 0.0 110.987 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 150.23 147.48 4.55 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.963 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 72.6 m -154.6 144.71 21.88 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 64.4 p -62.43 154.4 28.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.421 ' HA ' HD11 ' A' ' 246' ' ' ILE . 38.4 ttp85 -57.38 -32.25 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.982 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 55.8 mt -68.6 -41.15 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.08 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 42.6 t -64.35 -43.72 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 43.1 tp -62.85 -39.07 93.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.254 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.562 ' HB2' ' HZ2' ' A' ' 203' ' ' LYS . 3.1 ttmp? -56.66 -43.24 80.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 10.4 pttp -63.45 -34.28 77.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.566 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.38 -47.45 27.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.206 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.452 HG21 ' CE1' ' A' ' 223' ' ' PHE . 48.6 t -56.53 -48.06 80.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -62.6 -44.17 96.98 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.04 -42.42 69.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.81 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.651 HG21 ' H ' ' A' ' 174' ' ' SER . 39.5 p -73.89 -41.39 62.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.906 0.384 . . . . 0.0 111.099 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.633 ' O ' HG11 ' A' ' 213' ' ' VAL . 19.8 m-85 -110.75 98.87 39.61 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.139 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.71 -32.88 85.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.736 2.291 . . . . 0.0 111.975 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.3 pt -64.74 -39.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.18 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.633 HG11 ' O ' ' A' ' 210' ' ' TYR . 5.4 p -77.35 -28.97 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 110.687 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.94 95.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.948 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.0 p -97.82 33.95 1.99 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.894 0.378 . . . . 0.0 111.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.92 142.98 31.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.601 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.1 m -65.8 -60.53 2.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.888 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.492 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 79.2 m-20 -92.99 48.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -53.6 -63.17 1.23 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.243 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -64.94 -33.58 76.38 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.37 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -61.4 -54.66 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.789 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 75.2 mt -66.95 -35.55 80.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.503 ' O ' HG12 ' A' ' 227' ' ' ILE . 17.1 t80 -62.91 -48.19 80.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.012 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.45 -34.18 77.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.561 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.2 t -62.34 -39.45 93.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.092 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.28 96.4 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.6 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 223' ' ' PHE . 6.9 mm -59.95 -46.31 94.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.319 0.58 . . . . 0.0 111.034 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.72 -36.2 78.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.356 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -73.31 -42.35 62.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.892 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 236' ' ' LEU . 16.7 p -60.43 -39.24 86.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.224 -0.297 . . . . 0.0 111.211 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.44 -42.28 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.28 -36.21 74.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.986 0.422 . . . . 0.0 110.792 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -68.35 -27.54 66.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.989 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.65 29.37 29.7 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.805 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.79 -48.28 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 230' ' ' CYS . 19.0 mt -125.55 154.82 41.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.806 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 m -115.09 132.46 64.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.544 ' NE2' HG12 ' A' ' 246' ' ' ILE . 47.1 mt-30 -121.57 93.58 48.68 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.985 0.422 . . . . 0.0 110.859 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.21 -38.17 37.18 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.918 2.412 . . . . 0.0 112.712 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.41 ' HE2' HG22 ' A' ' 245' ' ' ILE . 52.6 mtmt -100.82 32.51 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.079 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 70.5 -175.3 37.16 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.301 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.24 -42.96 45.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.201 2.601 . . . . 0.0 112.708 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 m -84.18 42.67 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -145.76 -148.04 4.72 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.474 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 245' ' ' ILE . 18.1 tt -82.38 123.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.507 0.67 . . . . 0.0 111.258 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.544 HG12 ' NE2' ' A' ' 238' ' ' GLN . 9.4 mt -94.2 116.52 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.812 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.52 133.69 52.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.594 0.235 . . . . 0.0 110.483 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.59 114.57 7.1 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 32.3 t30 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.426 -179.807 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.99 125.51 26.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p -69.62 145.72 52.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.39 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.6 m -85.7 131.92 45.91 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.894 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.512 ' HG2' HD11 ' A' ' 178' ' ' LEU . 67.4 Cg_endo -75.04 -144.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.939 2.426 . . . . 0.0 112.384 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.404 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 27.1 m -151.71 156.2 39.84 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.1 m 60.74 36.57 19.33 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.49 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 175' ' ' PRO . 87.9 mt -91.24 172.89 8.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.581 173.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 182' ' ' GLU . 63.6 p -71.2 154.37 41.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.501 ' CE2' ' HD1' ' A' ' 219' ' ' PHE . 3.0 m-85 -58.42 -32.41 68.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.702 0.286 . . . . 0.0 110.33 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 27.9 ttpp -62.47 -53.63 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.805 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.418 ' HG2' ' OG1' ' A' ' 179' ' ' THR . 70.1 mm-40 -61.77 -34.35 75.71 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.517 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.446 ' HE2' ' O ' ' A' ' 178' ' ' LEU . 62.0 mtt -57.77 -47.37 82.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.581 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.59 HG23 HD12 ' A' ' 236' ' ' LEU . 52.8 mt -69.09 -42.51 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.466 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.3 mt -59.55 -25.6 64.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.438 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.491 ' HG2' ' HD2' ' A' ' 175' ' ' PRO . 55.5 tptt -83.22 -41.21 18.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.916 0.389 . . . . 0.0 110.698 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.2 p -76.42 -34.86 58.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.146 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.433 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 0.0 OUTLIER -52.05 -54.86 36.34 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -176.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 188' ' ' MET . 19.4 Cg_endo -58.85 -22.95 64.88 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.247 1.964 . . . . 0.0 112.473 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -75.54 -44.79 41.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.81 112.39 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.302 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 53.81 38.86 29.52 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 53.32 33.48 15.75 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.012 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 73.73 14.89 79.6 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.282 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -72.56 -38.71 67.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 149.36 146.51 4.34 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.055 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 43.4 p -150.5 145.57 26.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.683 0.277 . . . . 0.0 110.797 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 29.0 t -57.95 152.13 16.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -56.13 -38.86 71.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.12 -46.21 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.742 0.305 . . . . 0.0 110.747 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.55 -47.04 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.566 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 9.0 tp -64.08 -51.16 65.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.967 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -56.28 -48.26 76.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.033 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -37.19 74.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.224 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -75.75 -45.69 35.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.059 0.457 . . . . 0.0 110.409 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 219' ' ' PHE . 68.6 t -60.73 -47.77 91.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.563 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.623 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 27.4 mtpp -64.76 -33.84 76.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.71 -47.72 37.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.686 0.279 . . . . 0.0 111.408 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 28.5 p -78.34 -30.72 48.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 111.231 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.531 ' O ' HG21 ' A' ' 213' ' ' VAL . 83.0 m-85 -109.53 91.75 10.74 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.08 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.24 -26.61 52.63 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.094 2.53 . . . . 0.0 113.704 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 43.9 pt -69.19 -37.72 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.694 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.623 ' CG2' ' HA ' ' A' ' 207' ' ' LYS . 3.6 m -79.52 -23.16 12.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.369 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.02 62.85 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -69.79 -38.94 76.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 0.0 110.796 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.09 120.92 16.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.6 m -80.67 -34.79 34.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.961 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -67.87 -20.82 65.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.863 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.592 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 10.0 t80 -48.0 -48.23 32.77 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.51 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -54.6 -35.94 63.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.778 -171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.02 -46.93 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 110.312 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.42 -32.2 72.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.566 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 50.0 t80 -57.51 -50.41 73.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.384 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.66 -37.46 87.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.571 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.1 t -66.88 -38.33 86.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.831 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.23 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.711 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.0 mt -63.98 -42.43 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.37 -39.04 75.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.501 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 32.0 tptt -73.3 -34.95 66.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.213 0.53 . . . . 0.0 110.324 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.4 -39.58 89.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.167 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.0 m -64.62 -39.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.69 -30.88 64.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.077 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -77.61 -16.92 58.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 76.54 19.39 78.09 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.432 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.85 -51.01 9.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 55.4 mt -120.24 153.16 36.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.413 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.8 m -127.69 132.78 68.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.04 0.448 . . . . 0.0 110.672 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.67 92.76 45.86 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.809 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -65.65 -35.98 35.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.066 2.511 . . . . 0.0 113.166 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.49 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 15.0 mptt -71.39 -51.79 22.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.335 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 140.85 -134.34 6.35 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.03 -53.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.549 2.166 . . . . 0.0 111.259 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.2 m -99.05 125.47 44.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.363 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . 172.45 -114.9 0.54 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.961 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.7 tt -153.23 122.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.164 0.507 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.46 ' O ' ' HA2' ' A' ' 196' ' ' GLY . 4.2 mp -85.46 117.77 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.802 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.432 ' HA ' ' HA2' ' A' ' 196' ' ' GLY . 45.3 mtpt -103.95 136.15 44.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.636 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 248' ' ' LEU . 2.8 tm? -76.02 96.87 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -70.32 0.4 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.403 ' HB2' HD22 ' A' ' 248' ' ' LEU . 55.7 tttp 44.35 45.83 7.52 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.177 173.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 253' ' ' VAL . 18.4 tptm -110.03 -32.25 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.49 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -79.77 31.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.452 . . . . 0.0 111.371 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 253' ' ' VAL . 5.2 p -164.69 106.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.624 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -164.12 32.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.145 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 54.36 48.03 21.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.154 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.11 52.02 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.835 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.496 179.146 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.13 135.72 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.3 m -108.3 143.45 37.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.123 -174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -117.42 135.79 23.31 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.94 33.38 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.272 2.648 . . . . 0.0 113.641 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.0 t 68.45 -64.95 0.29 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.377 0.671 . . . . 0.0 112.048 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.4 t -162.82 142.58 9.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.407 ' O ' ' HE2' ' A' ' 183' ' ' MET . 30.4 mt -157.89 -179.81 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.2 m -70.83 149.3 46.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.74 -40.78 42.05 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.679 0.276 . . . . 0.0 111.221 -176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.476 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 26.0 ttpp -64.06 -45.59 88.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -65.95 -33.95 77.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.352 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.407 ' HE2' ' O ' ' A' ' 178' ' ' LEU . 63.3 mtt -52.36 -53.18 48.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.056 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.415 ' CG2' HD22 ' A' ' 202' ' ' LEU . 55.8 mt -66.35 -43.86 91.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 98.1 mt -54.96 -40.17 69.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -81.46 -28.95 33.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 110.547 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.9 t -71.55 -32.74 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.673 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.456 ' HE1' ' HA ' ' A' ' 188' ' ' MET . 1.5 mmt -52.71 -54.29 44.84 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.5 Cg_endo -58.99 -25.61 78.32 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.873 1.716 . . . . 0.0 112.644 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -73.34 -49.11 29.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.21 132.96 35.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.241 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 53.23 33.49 15.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.572 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 54.02 31.8 14.31 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.773 0.429 . . . . 0.0 112.148 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 65.02 29.64 75.92 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 113.088 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -94.65 -42.01 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.064 0.459 . . . . 0.0 110.55 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 156.08 132.41 1.52 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.1 m -126.07 141.51 51.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.744 0.272 . . . . 0.0 110.618 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.8 p -67.8 147.12 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.18 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -51.02 -39.25 55.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.894 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 74.0 mt -65.34 -43.79 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.443 0.163 . . . . 0.0 111.141 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.74 -46.87 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.145 0.498 . . . . 0.0 110.843 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.454 ' HA ' HD11 ' A' ' 202' ' ' LEU . 27.3 tp -65.44 -45.9 82.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.003 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.56 -45.02 85.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.402 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 205' ' ' TYR . 0.1 OUTLIER -54.98 -44.71 74.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.773 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' ' HG2' ' A' ' 204' ' ' LYS . 44.0 t80 -72.73 -46.81 51.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.92 -44.32 86.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.713 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.579 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 49.5 mtpt -63.92 -41.49 97.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.98 -50.61 47.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.925 0.393 . . . . 0.0 111.238 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 23.2 p -72.17 -43.88 63.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 102.4 35.57 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.74 0.305 . . . . 0.0 110.225 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.74 -14.45 44.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.873 2.382 . . . . 0.0 112.399 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.7 -46.01 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.053 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.609 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 5.5 m -77.14 -30.79 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.91 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -64.19 -40.27 97.86 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.72 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.0 m -74.12 -33.73 63.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.114 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.29 126.05 25.96 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 111.413 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.4 p -75.97 -45.78 33.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.273 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.417 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 59.3 t30 -92.65 39.61 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.694 0.759 . . . . 0.0 110.016 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.609 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 8.3 t80 -65.13 -48.76 72.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.758 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -50.53 -42.53 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.448 -172.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -63.26 -47.84 80.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.725 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 55.6 mt -62.55 -40.5 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.2 0.524 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.435 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 39.8 t80 -56.62 -52.52 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.364 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.82 -31.41 72.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 69.2 m -65.55 -39.94 92.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.854 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.6 94.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.214 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.25 -38.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -57.81 -32.4 67.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.206 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -75.65 -47.73 25.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 109.785 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 97.9 m -55.48 -42.66 74.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.36 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -63.49 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.625 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 231' ' ' VAL . 11.5 pt-20 -75.6 -37.1 60.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.936 0.398 . . . . 0.0 110.434 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.501 ' OD1' ' HE2' ' A' ' 254' ' ' LYS . 51.5 m-20 -74.42 -9.08 58.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.55 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 70.68 33.08 66.93 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.1 -51.14 4.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 66.0 mt -117.18 138.1 51.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.896 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 247' ' ' LYS . 4.8 m -109.25 126.54 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.343 0.592 . . . . 0.0 110.659 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 239' ' ' PRO . 58.9 mt-30 -119.34 99.75 50.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.492 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 9.9 Cg_endo -57.26 -50.48 10.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.204 2.603 . . . . 0.0 113.091 -174.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.33 -56.61 4.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.24 -150.48 18.82 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.489 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.5 -45.85 34.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.971 2.448 . . . . 0.0 112.247 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.9 t -92.07 121.72 33.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.97 -143.04 9.66 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.242 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 21.2 tt -108.03 134.72 49.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.077 0.465 . . . . 0.0 111.019 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.526 HG21 HD13 ' A' ' 236' ' ' LEU . 4.7 mp -98.61 108.25 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.916 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 237' ' ' VAL . 39.5 mtmt -100.67 135.06 42.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.27 113.53 9.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.472 ' HB2' HG13 ' A' ' 237' ' ' VAL . 38.4 t30 -67.68 115.82 7.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.371 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -86.83 89.59 8.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.039 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 251' ' ' LYS . 37.6 tptt -175.19 -44.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.258 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? 59.41 57.75 3.23 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.728 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.75 143.28 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.923 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.501 ' HE2' ' OD1' ' A' ' 233' ' ' ASN . 14.6 ttpp 64.46 76.43 0.35 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.136 0.493 . . . . 0.0 110.341 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.35 137.05 58.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 51.8 p -169.29 -117.55 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.354 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.4 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.522 175.508 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.089 0.471 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.499 ' HB2' ' OH ' ' A' ' 205' ' ' TYR . . . -80.26 62.81 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.579 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.1 m -77.86 59.32 2.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.065 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 p -67.5 129.45 93.56 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.409 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.455 ' HB2' ' H ' ' A' ' 176' ' ' SER . 72.3 Cg_endo -77.6 -140.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.82 2.346 . . . . 0.0 112.535 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.627 ' HA ' ' CD2' ' A' ' 210' ' ' TYR . 21.7 t -155.65 -163.44 1.51 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.5 p 49.9 37.43 13.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.293 0.637 . . . . 0.0 111.255 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 176' ' ' SER . 88.5 mt -114.37 149.68 35.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.641 ' HB ' ' OE1' ' A' ' 182' ' ' GLU . 12.3 m -64.52 154.89 34.65 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.82 ' HA ' ' HE3' ' A' ' 183' ' ' MET . 23.3 m-85 -45.78 -52.03 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 pttm -67.81 -37.58 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.924 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.641 ' OE1' ' HB ' ' A' ' 179' ' ' THR . 18.3 mp0 -57.65 -38.27 74.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.82 ' HE3' ' HA ' ' A' ' 180' ' ' TYR . 46.5 mtm -58.04 -49.16 77.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.8 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 188' ' ' MET . 37.0 mt -63.45 -45.18 98.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.095 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 95.4 mt -52.58 -43.31 65.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.375 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 3.2 tppp? -78.91 -35.98 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.6 m -68.49 -36.1 78.45 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 84.9 mmm -52.53 -55.64 30.3 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 193' ' ' ASP . 39.2 Cg_exo -56.99 -28.82 80.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.194 1.929 . . . . 0.0 112.478 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 49.3 mm-40 -74.48 -40.85 61.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.682 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 77.0 mt -85.51 114.86 22.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.712 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 68.71 -59.25 0.47 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.833 0.708 . . . . 0.0 111.541 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 189' ' ' PRO . 4.0 t70 175.86 -36.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.783 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 140.21 -19.04 2.87 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.701 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.45 -43.05 67.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.712 -0.744 . . . . 0.0 112.171 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 172.75 137.35 2.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.809 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.0 m -141.6 136.26 30.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 53.5 p -68.15 153.1 44.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.691 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -63.37 -29.77 71.01 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.4 -47.74 89.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.76 -48.36 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.893 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.585 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 25.2 tp -62.27 -48.63 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.847 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.468 ' HA ' ' CG2' ' A' ' 206' ' ' VAL . 38.1 ttpt -66.77 -37.32 84.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -61.26 -35.28 76.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.513 0.673 . . . . 0.0 110.432 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 172' ' ' ALA . 66.4 t80 -77.53 -51.34 10.87 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.467 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 203' ' ' LYS . 33.4 m -58.68 -42.52 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.018 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -64.22 -40.26 95.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.69 -41.43 31.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 25.7 p -83.05 -38.5 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.297 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.627 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 17.0 m-85 -101.56 101.01 15.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.89 -10.74 28.01 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.051 2.501 . . . . 0.0 112.703 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.06 -34.65 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.433 HG13 ' HE2' ' A' ' 183' ' ' MET . 35.0 m -102.36 -24.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.12 62.46 1.72 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.678 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.8 t -171.33 -48.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.682 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.06 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.1 p -77.12 -35.5 56.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.32 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.26 -6.05 36.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.953 0.406 . . . . 0.0 110.751 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -55.0 -36.99 66.02 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.391 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.43 -46.37 69.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -67.63 -47.51 69.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.944 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.12 -40.42 95.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 111.047 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 14.6 t80 -61.31 -50.34 73.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.077 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -58.97 -36.93 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.86 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.2 m -62.52 -40.04 95.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.864 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.17 96.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.852 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.6 mt -64.54 -43.54 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.233 0.539 . . . . 0.0 110.098 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.94 -31.69 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.707 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -71.96 -34.29 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.637 0.732 . . . . 0.0 109.671 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 233' ' ' ASN . 71.8 m -72.52 -33.11 66.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.419 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 26.6 m -63.5 -38.51 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.227 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 231' ' ' VAL . 12.4 pt-20 -73.54 -33.49 64.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.965 0.412 . . . . 0.0 110.159 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 230' ' ' CYS . 7.8 m-80 -62.97 -33.96 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.91 18.72 53.67 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.339 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 235' ' ' GLU . 23.1 mm-40 -95.38 -39.89 9.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 2.8 mm? -119.23 140.45 50.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.417 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.45 136.04 56.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.043 0.449 . . . . 0.0 110.733 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.67 93.85 48.57 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.38 -38.6 25.59 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.11 2.54 . . . . 0.0 112.828 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.57 -42.33 78.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.181 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 150.6 -127.64 2.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.68 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.405 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 31.7 Cg_endo -63.83 -29.5 68.0 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.735 2.29 . . . . 0.0 111.9 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.6 m -143.16 -123.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.054 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.51 -63.79 3.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.285 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 245' ' ' ILE . 19.5 tt -168.58 130.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.512 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.408 ' O ' ' HA2' ' A' ' 196' ' ' GLY . 5.2 mp -92.81 127.1 45.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.237 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -118.65 132.14 56.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.558 0.218 . . . . 0.0 110.575 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.3 tp -75.48 105.96 6.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -68.97 117.86 11.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.42 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -63.7 -42.42 97.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.93 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 68.2 -48.79 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.241 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -103.98 35.25 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.934 0.397 . . . . 0.0 111.522 -176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.27 142.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.813 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -156.42 131.43 9.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.895 0.378 . . . . 0.0 111.354 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.6 mp -75.97 133.78 40.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.748 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.4 t -160.72 47.05 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.291 0.567 . . . . 0.0 110.355 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.108 179.71 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.12 91.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.759 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.4 m -156.84 -56.4 0.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.2 m -108.09 121.95 42.18 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.776 ' HG2' HD13 ' A' ' 178' ' ' LEU . 7.4 Cg_exo -75.19 -134.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.86 2.374 . . . . 0.0 112.283 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.563 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 13.5 p -152.69 -47.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.3 m -77.21 70.16 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 111.513 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.776 HD13 ' HG2' ' A' ' 175' ' ' PRO . 69.9 mt -142.66 155.12 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.236 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.2 p -64.92 152.06 44.09 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -60.53 -31.54 70.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.783 0.325 . . . . 0.0 110.597 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -61.12 -48.2 82.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.51 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' A' ' 178' ' ' LEU . 20.4 tp10 -63.45 -37.45 87.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.64 176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.491 ' HE3' ' O ' ' A' ' 178' ' ' LEU . 64.2 mtt -57.82 -50.91 71.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.565 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.468 HG21 HD23 ' A' ' 202' ' ' LEU . 60.5 mt -64.75 -45.16 95.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.032 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.6 mt -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.012 0.434 . . . . 0.0 110.794 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -78.14 -38.74 43.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.8 p -78.83 -27.52 44.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.249 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.515 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 2.6 mmt -49.01 -53.86 34.07 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.2 Cg_endo -58.34 -28.79 86.01 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.117 1.878 . . . . 0.0 112.578 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -73.13 -39.8 65.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 109.78 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.01 92.89 9.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.437 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.15 32.75 21.03 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.83 32.78 12.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.992 0.425 . . . . 0.0 111.588 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.84 18.16 68.19 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.273 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.37 -38.45 63.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.267 0.534 . . . . 0.0 109.883 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 167.54 123.68 0.68 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.796 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 50.7 m -140.65 138.27 34.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.618 0.247 . . . . 0.0 110.685 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.544 ' O ' HG12 ' A' ' 201' ' ' VAL . 14.5 p -61.65 148.98 40.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -54.76 -37.38 65.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.402 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -50.29 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.64 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 198' ' ' SER . 8.5 p -69.23 -35.88 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.809 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.468 HD23 HG21 ' A' ' 184' ' ' ILE . 17.3 tp -64.71 -51.13 64.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.338 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -58.85 -40.78 85.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -59.07 -46.23 88.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.935 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -71.04 -43.35 68.04 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.237 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.54 -42.26 80.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.977 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.92 -44.31 89.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.778 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.95 -46.01 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.295 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.6 p -74.66 -43.51 54.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.335 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.563 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 49.2 m-85 -109.82 89.85 8.39 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.14 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.16 -15.83 36.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.891 2.394 . . . . 0.0 112.877 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.89 -32.89 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.877 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.658 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 4.2 m -76.81 -31.25 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.036 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -66.26 -40.43 94.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.631 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.7 t -71.35 -36.22 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.701 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.96 44.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.938 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -75.35 -50.41 16.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 110.976 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 50.2 t30 -90.07 38.52 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.472 0.654 . . . . 0.0 110.603 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.658 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.5 t80 -64.69 -48.52 74.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.562 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.42 -41.48 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.548 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.08 -45.29 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.0 110.549 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 77.8 mt -62.32 -37.77 86.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.192 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 42.8 t80 -59.83 -49.56 77.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.973 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.02 -42.79 81.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.949 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.4 m -65.43 -37.87 88.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.73 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.66 86.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.6 mt -62.23 -45.16 99.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.114 0.483 . . . . 0.0 110.022 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -56.42 -40.99 75.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.791 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -73.81 -43.12 59.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.367 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 73.8 m -59.02 -41.92 88.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.532 0.206 . . . . 0.0 111.428 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 30.0 m -69.18 -43.17 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 231' ' ' VAL . 11.0 pt-20 -69.31 -34.8 75.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.899 0.381 . . . . 0.0 110.447 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -64.79 -24.7 67.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.526 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.44 27.66 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.49 -26.22 10.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.322 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 14.1 tp -141.57 156.37 45.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.452 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 249' ' ' ASN . 2.1 t -133.17 136.14 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.979 0.418 . . . . 0.0 110.351 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.8 OUTLIER -145.67 102.84 4.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 16.6 Cg_endo -61.38 -26.02 80.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.184 2.589 . . . . 0.0 113.0 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -104.82 28.85 6.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 65.2 -122.58 23.94 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.8 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -75.48 -57.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.918 2.412 . . . . 0.0 112.463 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 p -91.94 127.86 37.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.51 -144.55 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.23 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.0 tt -110.35 121.86 63.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.341 0.591 . . . . 0.0 110.521 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.583 HG21 HD23 ' A' ' 236' ' ' LEU . 3.1 mp -85.48 130.0 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.11 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -127.51 132.04 50.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.86 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 248' ' ' LEU . 2.7 tt -70.72 123.53 22.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.473 ' CB ' HG21 ' A' ' 237' ' ' VAL . 6.4 p-10 -67.71 135.27 52.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.378 0.609 . . . . 0.0 110.937 -173.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -110.87 47.1 1.01 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.954 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -70.93 -28.22 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.412 0.625 . . . . 0.0 109.391 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -168.17 148.42 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.291 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.6 m -73.5 60.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.339 0.59 . . . . 0.0 110.615 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 143.47 57.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.461 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.4 mp -74.32 135.68 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.177 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.5 t -147.0 -48.48 0.18 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--O 1.247 0.963 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.033 175.634 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 60.15 44.37 12.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -78.26 130.93 36.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.6 ' HG ' ' HB ' ' A' ' 209' ' ' THR . 9.0 p -84.82 116.53 65.72 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.884 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.25 138.82 12.83 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.799 2.333 . . . . 0.0 112.254 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.5 t -75.44 -172.2 1.72 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.4 m 59.61 55.04 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.253 0.549 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.407 ' O ' ' HE3' ' A' ' 183' ' ' MET . 40.4 mt -149.63 158.33 44.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.843 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 182' ' ' GLU . 5.6 t -64.76 157.65 26.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.439 ' HA ' ' SD ' ' A' ' 183' ' ' MET . 3.5 m-30 -57.35 -27.75 62.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.673 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 55.9 tttm -65.53 -47.6 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.489 ' H ' HG22 ' A' ' 179' ' ' THR . 65.5 mm-40 -60.87 -38.77 86.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.973 0.416 . . . . 0.0 110.82 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.46 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 58.2 mtt -55.98 -48.31 76.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 23.7 mt -70.33 -37.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.749 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 86.2 mt -54.75 -45.68 74.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 17.5 tppt? -70.84 -39.53 72.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.405 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 51.0 m -72.57 -32.75 66.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.465 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 0.5 OUTLIER -51.79 -51.89 66.13 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 188' ' ' MET . 23.9 Cg_endo -63.44 -30.12 71.95 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.841 1.694 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 66.0 mt-30 -66.7 -36.15 81.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.13 113.85 26.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 54.74 37.7 28.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.78 30.98 9.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.487 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.01 24.08 75.91 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.265 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.82 -41.68 25.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.38 0.609 . . . . 0.0 110.144 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.49 136.34 2.17 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.383 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 41.8 m -139.88 139.79 36.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.989 0.423 . . . . 0.0 110.795 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.1 p -62.26 155.65 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.264 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 243' ' ' SER . 54.2 ttt85 -53.35 -41.52 65.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.55 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.82 -44.56 98.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.646 0.26 . . . . 0.0 111.143 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 76.0 t -63.94 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.369 . . . . 0.0 111.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 24.2 tp -68.34 -46.81 69.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.06 -43.34 99.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 50.6 pttt -62.43 -32.59 73.47 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.396 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -78.23 -45.5 22.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.145 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 202' ' ' LEU . 40.1 t -59.08 -43.37 89.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.484 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.503 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 46.6 mtpt -67.0 -41.17 87.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.364 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.76 -42.32 81.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.6 ' HB ' ' HG ' ' A' ' 174' ' ' SER . 20.3 p -77.54 -37.17 51.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 183' ' ' MET . 63.7 m-85 -113.79 95.35 37.01 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.52 -17.25 40.3 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.904 2.403 . . . . 0.0 112.519 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.6 pt -71.67 -39.15 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.052 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.645 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 6.1 m -74.36 -29.72 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.02 0.438 . . . . 0.0 110.077 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -63.35 -29.43 74.51 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.745 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.0 m -95.45 48.26 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -148.47 128.9 13.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.787 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.4 t -78.75 -41.82 29.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.142 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.423 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.0 p-10 -88.76 20.07 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.645 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.2 t80 -59.34 -51.07 71.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -52.54 -40.79 62.9 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.237 0.335 . . . . 0.0 111.207 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -67.01 -48.71 67.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.177 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 63.2 mt -62.39 -36.32 81.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 110.243 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.523 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 21.9 t80 -59.41 -48.88 79.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.723 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.511 ' HB2' HH22 ' A' ' 199' ' ' ARG . 3.0 t-20 -59.47 -41.72 90.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.449 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.5 t -65.24 -37.27 86.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.876 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.36 90.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -39.23 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.417 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -55.12 -42.25 72.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -66.63 -38.56 87.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 110.499 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 78.0 m -64.32 -38.78 92.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.013 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 18.2 m -65.63 -37.65 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.491 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.515 ' N ' HG21 ' A' ' 231' ' ' VAL . 4.9 mt-10 -72.75 -46.03 55.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.468 0.651 . . . . 0.0 109.312 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -60.5 -30.53 69.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.42 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 87.27 31.9 15.47 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -97.02 -49.16 5.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.0 109.025 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 9.8 mp -122.83 142.04 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.882 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.19 134.29 62.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.14 0.495 . . . . 0.0 111.169 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -125.76 79.92 67.52 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.753 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -53.75 -46.13 35.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.397 2.731 . . . . 0.0 112.973 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 63.3 mttm -71.96 -54.65 9.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.95 -162.86 36.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.825 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.88 -41.13 65.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.287 2.658 . . . . 0.0 112.615 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 199' ' ' ARG . 2.7 p -90.96 6.64 43.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.176 0.512 . . . . 0.0 110.628 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . -84.29 164.96 40.64 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.35 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.4 tt -59.26 128.77 20.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 4.6 mp -86.59 119.83 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.541 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -114.46 136.51 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.77 117.11 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 251' ' ' LYS . 52.4 t30 -74.94 80.31 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -76.61 36.5 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.181 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 249' ' ' ASN . 14.7 mmmm -103.24 -42.62 5.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -90.39 141.77 28.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.019 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 15.7 m -56.44 123.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.299 0.571 . . . . 0.0 111.902 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -72.2 143.89 48.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 83.0 mt -80.57 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 41.5 m 58.45 54.26 5.68 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.113 0.482 . . . . 0.0 110.757 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.869 -179.518 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.715 0.293 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -81.97 43.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.978 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -86.61 132.98 33.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.632 ' HB2' HG21 ' A' ' 209' ' ' THR . 27.7 m -94.21 124.3 56.26 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.17 -136.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.076 2.518 . . . . 0.0 112.285 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.677 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 44.7 m -155.35 -46.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.248 -0.283 . . . . 0.0 111.281 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.3 m -76.43 63.06 1.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 91.2 mt -132.04 156.27 46.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.0 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -63.65 145.64 55.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.74 -36.92 38.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.659 ' O ' HD13 ' A' ' 185' ' ' LEU . 24.3 ttpp -63.18 -53.18 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.545 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -57.91 -37.13 73.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.963 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.556 ' HE2' HG11 ' A' ' 213' ' ' VAL . 48.5 mtp -57.59 -53.19 60.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.424 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 184' ' ' ILE . 57.5 mt -62.59 -53.44 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.932 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 181' ' ' LYS . 10.7 mp -52.29 -32.13 36.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.855 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -74.36 -42.17 59.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.909 0.385 . . . . 0.0 111.217 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.1 p -78.33 -28.01 47.21 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 60.7 mmm -52.24 -50.77 77.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -60.68 -18.15 53.62 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.034 1.823 . . . . 0.0 112.95 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -77.13 -48.56 17.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.337 0.589 . . . . 0.0 109.957 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 68.3 mt -71.79 121.4 18.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.331 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 52.02 36.58 19.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 55.1 30.98 15.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.24 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 68.78 25.73 75.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.238 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -84.43 -39.34 19.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 109.993 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 168.85 132.6 1.45 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.0 m -116.66 126.38 53.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.082 0.441 . . . . 0.0 110.892 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.552 ' O ' HG12 ' A' ' 201' ' ' VAL . 2.7 p -65.05 150.73 47.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.577 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -50.22 -42.74 52.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.599 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.86 -49.43 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 198' ' ' SER . 9.6 p -63.63 -35.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.591 0.234 . . . . 0.0 110.869 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.429 ' HA ' HD11 ' A' ' 202' ' ' LEU . 22.7 tp -69.97 -49.09 55.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.863 0.363 . . . . 0.0 110.187 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.4 -43.72 92.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.336 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -66.46 -37.98 86.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.386 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -70.88 -44.74 65.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 109.719 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 23.0 t -59.55 -44.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.286 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.592 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 43.6 mtpt -62.94 -45.2 93.62 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.36 -47.41 49.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.522 -175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.632 HG21 ' HB2' ' A' ' 174' ' ' SER . 6.6 m -70.91 -45.29 64.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.121 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.677 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 28.1 m-85 -103.67 103.76 38.32 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.75 -15.14 48.66 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.095 2.53 . . . . 0.0 113.127 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.3 mt -67.05 -45.22 87.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.624 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.702 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 23.2 m -72.8 -31.23 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.382 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 213' ' ' VAL . . . -62.45 -42.02 99.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.551 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.4 m -71.83 -34.58 69.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.715 -0.242 . . . . 0.0 111.252 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.59 125.42 23.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 0.0 111.433 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.6 m -76.22 -43.18 43.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.991 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 34.1 t30 -95.01 36.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.534 0.683 . . . . 0.0 110.181 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.702 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 3.4 t80 -62.05 -48.9 78.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.518 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.85 -43.05 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.899 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -62.2 -46.72 87.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.258 . . . . 0.0 110.628 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 222' ' ' LEU . 59.3 mt -63.75 -40.22 96.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.535 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 28.2 t80 -61.1 -54.42 44.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.57 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -63.99 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.9 t -61.83 -40.81 96.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.397 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.09 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.666 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.2 mt -67.83 -39.04 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -55.97 -40.25 72.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.32 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.0 -40.02 65.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.174 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 84.8 m -58.29 -45.71 87.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.025 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 34.8 m -64.15 -37.46 79.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -77.15 -37.07 54.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.424 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.5 -30.51 67.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.51 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.35 25.8 20.24 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -85.17 -49.05 8.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.334 0.588 . . . . 0.0 109.434 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.642 HD11 HG23 ' A' ' 246' ' ' ILE . 45.0 mt -127.23 145.09 50.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.843 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 247' ' ' LYS . 6.5 m -114.71 129.15 71.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.044 0.45 . . . . 0.0 110.346 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.86 97.13 50.14 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.687 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.6 -41.21 66.51 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 123.043 2.495 . . . . 0.0 112.272 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 240' ' ' LYS . 3.6 mptp? -80.95 -69.8 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 0.0 110.278 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 167.5 -156.65 28.54 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.11 -48.61 20.65 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.066 2.511 . . . . 0.0 112.671 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 7.9 t -89.49 55.11 3.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.263 0.554 . . . . 0.0 109.833 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -152.87 162.33 29.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.653 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.3 tt -57.04 125.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.526 0.679 . . . . 0.0 111.971 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.642 HG23 HD11 ' A' ' 236' ' ' LEU . 4.8 mp -87.9 123.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.309 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.47 ' HB2' HG22 ' A' ' 237' ' ' VAL . 58.1 mtpt -112.28 137.12 50.86 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.98 113.51 9.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.458 ' HB2' HG12 ' A' ' 237' ' ' VAL . 46.5 t30 -62.61 119.39 9.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.864 0.364 . . . . 0.0 110.269 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -78.06 58.53 2.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.586 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -77.34 61.48 2.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 69.53 54.29 0.4 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.067 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.21 124.78 40.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.074 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.483 ' HE2' ' OG ' ' A' ' 256' ' ' SER . 8.0 ttpm? -77.82 136.9 38.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 255' ' ' LEU . 7.5 mp -77.61 53.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.695 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.483 ' OG ' ' HE2' ' A' ' 254' ' ' LYS . 1.1 m -64.13 135.52 56.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.971 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.51 0.195 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.45 134.84 49.43 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.4 t -69.23 -47.46 64.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.931 0.396 . . . . 0.0 110.089 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.571 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 18.9 m -73.04 131.3 83.82 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.946 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.451 ' HD2' ' HG2' ' A' ' 186' ' ' LYS . 43.5 Cg_endo -70.25 -143.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.031 2.488 . . . . 0.0 113.172 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 50.8 m -153.08 161.87 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.09 -0.381 . . . . 0.0 110.722 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.6 m 62.14 49.99 4.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.55 0.69 . . . . 0.0 111.214 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.418 ' O ' ' HE3' ' A' ' 183' ' ' MET . 51.6 mt -129.35 163.09 26.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.349 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.475 ' HB ' ' HG2' ' A' ' 182' ' ' GLU . 1.9 m -63.0 150.5 42.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -54.57 -37.28 65.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 39.1 ttpt -60.42 -46.45 89.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.033 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.475 ' HG2' ' HB ' ' A' ' 179' ' ' THR . 55.6 mm-40 -61.45 -33.67 74.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.418 ' HE3' ' O ' ' A' ' 178' ' ' LEU . 60.6 mtt -58.15 -49.52 76.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 236' ' ' LEU . 58.8 mt -68.94 -43.35 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 87.6 mt -53.33 -39.52 64.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 47.6 tptt -73.74 -42.06 61.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 m -69.21 -30.04 68.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.33 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.525 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 5.1 mmt -51.63 -57.7 13.58 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 32.1 Cg_exo -59.1 -28.33 87.5 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.12 1.88 . . . . 0.0 112.127 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -71.06 -39.6 72.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.15 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.446 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 51.89 35.34 15.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.057 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 54.78 34.92 22.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.588 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.73 19.22 69.12 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.759 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -75.96 -41.72 50.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.3 0.55 . . . . 0.0 110.251 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 247' ' ' LYS . . . 167.82 145.9 4.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 m -143.69 133.42 23.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.879 0.34 . . . . 0.0 110.793 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.2 t -61.19 144.82 53.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.204 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.551 HH12 ' HB2' ' A' ' 224' ' ' ASN . 46.3 ttm-85 -53.89 -38.71 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 110.419 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.14 -49.67 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.0 -34.44 45.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.714 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 202' ' ' LEU . 28.8 tp -66.17 -49.91 65.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.67 -36.47 76.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -57.34 -45.87 83.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.15 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.27 -44.47 65.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.478 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.49 -45.86 82.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.626 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.43 -43.44 85.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.52 -41.56 96.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.496 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.484 ' CB ' ' HB2' ' A' ' 174' ' ' SER . 18.7 p -79.67 -42.89 23.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.585 ' O ' HG13 ' A' ' 213' ' ' VAL . 16.4 m-85 -106.88 102.58 43.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.92 -31.94 84.74 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.546 2.164 . . . . 0.0 111.509 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.12 -37.04 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.774 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 210' ' ' TYR . 4.1 p -82.25 -36.32 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -82.03 41.1 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.507 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.9 t -160.23 51.89 0.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.323 0.583 . . . . 0.0 109.448 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.94 29.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.592 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.3 m -74.9 -53.07 9.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.456 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 18.1 t-20 -84.82 55.23 3.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 0.0 109.391 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -88.98 -60.13 2.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.312 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -59.94 -36.98 78.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.5 -48.56 81.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.824 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 20.1 mt -68.27 -39.67 82.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.476 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -54.85 -49.72 70.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.709 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.551 ' HB2' HH12 ' A' ' 199' ' ' ARG . 20.4 t30 -62.78 -42.31 99.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.716 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 57.8 m -68.38 -30.67 69.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.94 99.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.75 HG22 HD12 ' A' ' 236' ' ' LEU . 2.0 mt -67.04 -38.76 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 231' ' ' VAL . 25.1 tptp -57.29 -39.94 76.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.38 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.39 -40.34 74.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 87.7 m -61.54 -38.66 88.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.266 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 228' ' ' LYS . 22.4 m -65.36 -34.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.88 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.14 -44.82 59.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 109.224 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -63.51 -22.43 66.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.684 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.75 29.1 55.74 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.164 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -96.18 -52.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 110.279 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.75 HD12 HG22 ' A' ' 227' ' ' ILE . 40.6 mt -110.58 134.7 52.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 247' ' ' LYS . 4.1 m -110.98 135.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.15 0.5 . . . . 0.0 110.699 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -125.87 82.87 63.69 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.166 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.65 -41.71 23.83 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.903 2.402 . . . . 0.0 113.078 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.59 -62.55 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.793 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 169.41 -134.21 3.11 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.711 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.08 -59.71 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.905 2.403 . . . . 0.0 113.202 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.6 m -80.62 -63.2 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 42.82 -123.86 3.91 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.571 -0.741 . . . . 0.0 114.169 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.5 tt -160.74 114.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.413 HG12 HD11 ' A' ' 227' ' ' ILE . 4.1 mp -75.2 114.95 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.71 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 237' ' ' VAL . 56.0 mtpt -112.39 131.87 55.32 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.104 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.4 tp -70.06 106.83 3.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -73.09 130.49 40.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.826 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 250' ' ' LYS . 16.2 tptm -132.3 36.91 3.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.169 0.509 . . . . 0.0 109.687 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -80.59 59.35 3.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.192 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -52.33 133.18 34.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.643 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.19 137.43 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.21 145.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.543 0.527 . . . . 0.0 110.181 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.423 HD21 ' N ' ' A' ' 255' ' ' LEU . 4.3 mm? -64.15 -38.35 90.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -173.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.2 m -77.53 114.79 16.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.877 0.37 . . . . 0.0 111.126 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 98.4 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.064 176.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.23 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.565 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -159.85 -166.83 1.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.95 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.624 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.3 m -79.19 132.42 63.14 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.424 ' HD2' HD13 ' A' ' 178' ' ' LEU . 13.0 Cg_exo -71.01 -148.8 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.847 2.364 . . . . 0.0 112.36 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -109.66 -38.28 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.733 0.301 . . . . 0.0 111.279 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.9 t -134.13 131.04 38.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 0.0 110.879 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' HE1' ' A' ' 183' ' ' MET . 33.6 mt -161.61 169.47 21.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.805 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 p -66.37 143.24 57.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -56.42 -32.95 65.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.577 ' O ' HD12 ' A' ' 185' ' ' LEU . 73.5 tttt -62.82 -47.5 83.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.042 173.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.66 -36.73 83.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.865 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.528 ' HE1' ' O ' ' A' ' 178' ' ' LEU . 60.9 mtt -50.73 -50.24 55.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.722 HG23 HD12 ' A' ' 236' ' ' LEU . 79.7 mt -64.83 -54.54 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.208 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 181' ' ' LYS . 7.9 mp -56.37 -24.97 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.69 -36.12 23.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.292 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.416 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 12.9 p -78.39 -26.7 46.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 73.9 mmm -55.89 -50.17 88.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 188' ' ' MET . 13.4 Cg_endo -60.07 -38.36 78.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 112.806 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 11.0 pt20 -75.83 -39.24 57.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.72 114.53 4.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.717 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 53.32 35.58 20.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.311 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 38.5 t0 56.78 34.08 24.08 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.517 0.675 . . . . 0.0 110.954 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 188' ' ' MET . . . 73.56 27.92 66.53 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.637 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.86 -41.4 26.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.472 . . . . 0.0 110.61 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 143.06 157.41 7.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.4 p -151.94 136.24 16.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.955 0.377 . . . . 0.0 110.572 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 2.1 p -68.1 153.43 43.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -51.74 -42.17 62.11 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.43 -41.44 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.4 -48.08 84.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.18 0.514 . . . . 0.0 110.675 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.457 HD21 HG22 ' A' ' 184' ' ' ILE . 20.0 tp -61.81 -41.8 98.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.699 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.25 -44.85 84.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.964 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -39.29 86.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.424 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -50.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.485 HG13 ' CZ ' ' A' ' 219' ' ' PHE . 77.5 t -58.56 -41.81 82.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.716 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.432 ' HA ' HG13 ' A' ' 213' ' ' VAL . 27.2 mtpp -64.38 -45.3 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.27 -46.79 26.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.021 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 33.4 p -67.15 -48.95 66.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.244 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -94.35 106.9 25.82 Favored Pre-proline 0 N--CA 1.453 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.69 -36.32 92.3 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.901 2.401 . . . . 0.0 112.548 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.38 -38.1 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.494 HG12 ' CE1' ' A' ' 219' ' ' PHE . 54.8 t -66.35 -47.98 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.413 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.4 92.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.276 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.5 t -79.97 -26.6 39.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.508 0.194 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.59 136.13 57.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.957 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -78.73 -62.44 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.749 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.469 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.6 p-10 -87.04 35.58 0.7 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.494 ' CE1' HG12 ' A' ' 213' ' ' VAL . 4.7 t80 -63.13 -50.93 68.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.548 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.29 -44.36 53.91 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -62.69 -46.64 87.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.416 . . . . 0.0 110.799 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 53.8 mt -65.2 -35.2 80.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.323 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.403 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 18.6 t80 -58.09 -51.04 71.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.623 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -60.83 -38.68 86.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.179 0.514 . . . . 0.0 110.864 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.3 t -65.08 -38.45 90.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.385 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.93 94.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.641 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.4 mt -62.11 -46.58 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.122 0.487 . . . . 0.0 110.141 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.413 ' O ' HG21 ' A' ' 231' ' ' VAL . 49.1 tttp -61.12 -37.94 84.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.849 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.73 -34.56 78.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.083 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 94.3 m -71.18 -41.96 69.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.565 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 28.2 m -67.96 -39.6 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.617 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.54 -36.45 81.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.391 0.615 . . . . 0.0 109.775 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -68.7 -25.97 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.327 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.541 ' HA3' ' HD2' ' A' ' 251' ' ' LYS . . . 89.33 2.55 76.73 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.151 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.85 -32.85 65.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.606 0.717 . . . . 0.0 110.194 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.722 HD12 HG23 ' A' ' 184' ' ' ILE . 7.2 tt -131.49 140.06 49.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.191 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 7.6 m -116.05 137.88 48.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.031 0.443 . . . . 0.0 110.888 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 242' ' ' PRO . 8.7 mm-40 -127.88 79.07 74.29 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.62 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.26 -39.03 2.31 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.841 2.361 . . . . 0.0 112.264 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.692 ' HD2' HG22 ' A' ' 245' ' ' ILE . 63.6 mttp -90.28 24.72 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.176 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 74.36 173.05 29.01 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.387 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.484 ' HA ' ' NE2' ' A' ' 238' ' ' GLN . 52.0 Cg_exo -55.23 -40.6 84.87 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.015 2.477 . . . . 0.0 113.218 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -81.68 -2.26 49.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.768 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -82.56 -136.22 2.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.883 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.692 HG22 ' HD2' ' A' ' 240' ' ' LYS . 16.1 tt -105.38 121.79 57.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.23 0.538 . . . . 0.0 111.558 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.455 ' O ' ' HE1' ' A' ' 188' ' ' MET . 3.3 mp -79.77 116.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.469 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt -116.29 138.65 51.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 0.0 110.471 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 53.2 tp -81.58 113.95 19.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -83.82 -38.24 21.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 58.11 66.49 1.1 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.303 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.541 ' HD2' ' HA3' ' A' ' 234' ' ' GLY . 30.0 tttt -72.05 -24.03 61.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.387 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -73.43 52.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.12 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.2 133.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.039 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -169.82 155.6 5.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.432 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.78 132.5 53.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.447 ' C ' ' HG1' ' A' ' 257' ' ' THR . 8.6 t -172.45 133.69 0.64 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.087 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' THR . . . . . 0.447 ' HG1' ' C ' ' A' ' 256' ' ' SER . 59.2 m . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.57 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.823 0.344 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.08 165.38 25.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.096 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.4 m -62.82 -45.55 92.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.724 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -94.13 124.12 56.98 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.437 ' HB2' ' H ' ' A' ' 176' ' ' SER . 60.5 Cg_endo -75.84 -144.25 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.946 2.43 . . . . 0.0 112.625 -176.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.437 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 7.9 t -140.28 -39.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 178' ' ' LEU . 8.1 m -114.4 123.78 50.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.66 0.267 . . . . 0.0 110.75 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 177' ' ' SER . 17.0 mt -166.23 -179.41 5.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.741 0.816 . . . . 0.0 109.121 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -82.35 148.01 28.52 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.59 -42.85 62.22 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.876 0.369 . . . . 0.0 110.933 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.572 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -62.49 -41.16 98.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.031 178.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -67.35 -34.63 77.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.502 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.574 ' HE1' HD12 ' A' ' 212' ' ' ILE . 63.3 mtt -58.65 -49.71 76.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.59 -39.97 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.977 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.5 mt -55.98 -36.94 68.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.506 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 1.9 tppp? -86.28 -32.75 20.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.3 m -70.73 -36.62 73.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.639 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.535 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 4.1 mmt -52.68 -52.11 67.32 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 35.3 Cg_exo -54.31 -33.66 76.94 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.287 1.991 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -67.91 -43.68 78.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.291 0.567 . . . . 0.0 110.394 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.01 107.17 8.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.642 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.79 34.32 23.2 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 59.29 35.15 23.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.955 0.407 . . . . 0.0 110.806 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.72 32.51 70.69 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.395 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -85.8 -41.63 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.231 0.516 . . . . 0.0 110.681 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 247' ' ' LYS . . . 156.27 150.31 5.6 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.848 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 74.7 m -153.64 142.68 21.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.715 0.293 . . . . 0.0 110.872 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.512 ' OG ' HG21 ' A' ' 201' ' ' VAL . 9.1 p -62.7 149.51 43.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.631 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.468 ' HA ' ' CD1' ' A' ' 246' ' ' ILE . 54.8 ttp85 -52.41 -43.03 64.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.049 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.471 HD13 HG23 ' A' ' 200' ' ' ILE . 48.3 mt -64.57 -40.35 88.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.512 HG21 ' OG ' ' A' ' 198' ' ' SER . 51.5 t -63.22 -46.22 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.975 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.528 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 10.8 tp -62.56 -48.66 78.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.338 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -58.75 -41.72 87.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.914 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -58.5 -41.23 84.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.527 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -72.09 -43.05 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 202' ' ' LEU . 99.2 t -60.39 -44.14 95.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.941 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.45 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 60.6 mtpt -67.57 -38.99 84.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.419 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.59 -50.27 70.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.809 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.1 p -79.59 -44.93 20.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.096 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -103.62 97.68 11.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.628 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.79 -15.23 45.58 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.887 2.391 . . . . 0.0 112.942 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.574 HD12 ' HE1' ' A' ' 183' ' ' MET . 14.6 pt -71.81 -35.59 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 0.0 111.285 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.648 ' HB ' ' CD1' ' A' ' 219' ' ' PHE . 11.6 m -74.28 -32.71 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 213' ' ' VAL . . . -62.99 -38.86 97.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.734 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -72.59 -33.79 66.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.819 0.342 . . . . 0.0 111.234 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.58 130.52 43.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.98 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.2 m -80.19 -43.87 20.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.159 0.504 . . . . 0.0 110.652 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.5 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 15.2 p-10 -86.66 21.29 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.648 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.0 t80 -61.56 -52.85 62.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -51.24 -40.54 59.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.41 . . . . 0.0 111.42 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -65.3 -52.77 51.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.874 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 57.5 mt -61.22 -37.18 82.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 110.517 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.528 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 58.4 t80 -54.09 -54.66 36.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.927 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -72.04 -32.15 66.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.9 t -64.08 -41.33 97.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.48 92.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.42 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 2.3 mt -66.24 -36.26 76.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.689 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -58.49 -34.48 70.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.398 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.46 -38.27 49.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.354 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 181' ' ' LYS . 73.4 m -59.29 -41.64 89.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.782 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -64.0 -42.75 96.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.8 -35.53 67.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.99 0.424 . . . . 0.0 110.203 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.365 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.16 29.22 41.97 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.848 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -95.71 -47.85 6.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 57.3 mt -118.51 144.83 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.972 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 247' ' ' LYS . 10.5 m -115.2 134.8 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 120.984 0.421 . . . . 0.0 110.105 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.11 81.34 28.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.231 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.19 -39.31 79.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.668 2.245 . . . . 0.0 111.804 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -93.68 29.53 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.691 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 63.17 -164.12 29.24 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.174 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.77 -41.35 8.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.936 2.424 . . . . 0.0 112.706 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.2 p -88.2 58.9 4.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.49 . . . . 0.0 111.263 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -161.66 -134.55 1.66 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.653 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.3 tt -98.17 133.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 111.392 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 199' ' ' ARG . 4.9 mp -97.15 129.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.519 ' HB2' HG22 ' A' ' 237' ' ' VAL . 52.8 mtpt -126.41 138.15 53.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.9 tp -71.41 124.76 25.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -60.63 129.59 42.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.425 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.09 53.64 0.07 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.325 0.583 . . . . 0.0 109.686 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -75.04 -39.7 60.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -85.05 117.29 23.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.386 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.14 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -169.69 122.15 0.72 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.852 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.79 55.7 3.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.475 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 27.4 t -66.36 -45.3 80.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.018 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.636 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.889 0.376 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.92 -139.2 0.23 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.7 m -71.66 156.91 38.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.024 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.651 ' H ' HG21 ' A' ' 209' ' ' THR . 14.3 m -54.11 148.79 20.77 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.315 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.508 ' HB2' ' H ' ' A' ' 176' ' ' SER . 46.5 Cg_endo -69.34 -140.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.463 2.775 . . . . 0.0 113.55 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.625 ' HA ' ' CE2' ' A' ' 210' ' ' TYR . 73.3 m -155.54 177.82 10.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.059 -0.401 . . . . 0.0 110.508 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.6 m 60.77 47.53 7.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 111.076 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' A' ' 175' ' ' PRO . 93.7 mt -135.78 159.92 40.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -66.02 150.98 47.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.737 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -51.91 -42.95 63.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.603 0.239 . . . . 0.0 111.457 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.585 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 ttpt -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.54 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.32 -32.95 74.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.245 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.518 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 61.2 mtt -57.91 -45.89 85.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 109.583 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.45 HG21 HD12 ' A' ' 184' ' ' ILE . 69.6 mt -68.25 -41.16 83.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.235 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 79.8 mt -53.24 -37.65 62.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.61 -33.84 27.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -73.24 -35.62 66.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.829 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.494 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 1.6 mmt -53.36 -54.41 45.56 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.0 Cg_endo -58.82 -29.23 89.39 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.013 1.809 . . . . 0.0 112.205 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.54 -42.07 71.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.647 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.425 ' HA ' HD21 ' A' ' 191' ' ' LEU . 98.6 mt -74.78 115.05 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.189 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 51.44 42.39 29.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.992 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 56.59 30.82 18.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.9 28.17 67.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.847 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -91.92 -36.24 13.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.851 -0.205 . . . . 0.0 110.987 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 150.23 147.48 4.55 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.963 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 72.6 m -154.6 144.71 21.88 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 64.4 p -62.43 154.4 28.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.421 ' HA ' HD11 ' A' ' 246' ' ' ILE . 38.4 ttp85 -57.38 -32.25 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.982 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 55.8 mt -68.6 -41.15 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.08 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 42.6 t -64.35 -43.72 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 43.1 tp -62.85 -39.07 93.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.254 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.562 ' HB2' ' HZ2' ' A' ' 203' ' ' LYS . 3.1 ttmp? -56.66 -43.24 80.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 10.4 pttp -63.45 -34.28 77.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.566 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.38 -47.45 27.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.206 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.452 HG21 ' CE1' ' A' ' 223' ' ' PHE . 48.6 t -56.53 -48.06 80.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -62.6 -44.17 96.98 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.04 -42.42 69.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.81 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.651 HG21 ' H ' ' A' ' 174' ' ' SER . 39.5 p -73.89 -41.39 62.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.906 0.384 . . . . 0.0 111.099 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.633 ' O ' HG11 ' A' ' 213' ' ' VAL . 19.8 m-85 -110.75 98.87 39.61 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.139 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.71 -32.88 85.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.736 2.291 . . . . 0.0 111.975 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.3 pt -64.74 -39.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.18 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.633 HG11 ' O ' ' A' ' 210' ' ' TYR . 5.4 p -77.35 -28.97 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 110.687 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.94 95.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.948 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.0 p -97.82 33.95 1.99 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.894 0.378 . . . . 0.0 111.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.92 142.98 31.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.601 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.1 m -65.8 -60.53 2.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.888 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.492 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 79.2 m-20 -92.99 48.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -53.6 -63.17 1.23 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.243 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -64.94 -33.58 76.38 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.37 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -61.4 -54.66 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.789 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 75.2 mt -66.95 -35.55 80.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.503 ' O ' HG12 ' A' ' 227' ' ' ILE . 17.1 t80 -62.91 -48.19 80.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.012 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.45 -34.18 77.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.561 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.2 t -62.34 -39.45 93.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.092 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.28 96.4 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.6 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 223' ' ' PHE . 6.9 mm -59.95 -46.31 94.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.319 0.58 . . . . 0.0 111.034 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.72 -36.2 78.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.356 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -73.31 -42.35 62.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.892 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 236' ' ' LEU . 16.7 p -60.43 -39.24 86.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.224 -0.297 . . . . 0.0 111.211 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.44 -42.28 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.28 -36.21 74.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.986 0.422 . . . . 0.0 110.792 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -68.35 -27.54 66.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.989 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.65 29.37 29.7 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.805 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.79 -48.28 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 230' ' ' CYS . 19.0 mt -125.55 154.82 41.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.806 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.5 m -115.09 132.46 64.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.544 ' NE2' HG12 ' A' ' 246' ' ' ILE . 47.1 mt-30 -121.57 93.58 48.68 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.985 0.422 . . . . 0.0 110.859 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.21 -38.17 37.18 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.918 2.412 . . . . 0.0 112.712 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.41 ' HE2' HG22 ' A' ' 245' ' ' ILE . 52.6 mtmt -100.82 32.51 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.079 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 70.5 -175.3 37.16 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.301 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.24 -42.96 45.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.201 2.601 . . . . 0.0 112.708 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 m -84.18 42.67 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -145.76 -148.04 4.72 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.474 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 245' ' ' ILE . 18.1 tt -82.38 123.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.507 0.67 . . . . 0.0 111.258 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.544 HG12 ' NE2' ' A' ' 238' ' ' GLN . 9.4 mt -94.2 116.52 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.812 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.52 133.69 52.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.594 0.235 . . . . 0.0 110.483 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.59 114.57 7.1 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -69.55 86.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.426 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -87.7 42.01 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.366 0.603 . . . . 0.0 110.278 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -70.52 -23.07 62.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.082 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt 68.77 27.43 5.79 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.24 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.515 ' O ' ' HG2' ' A' ' 254' ' ' LYS . 3.5 t 55.76 36.41 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.33 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER 64.56 146.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.332 1.053 . . . . 0.0 111.604 -177.123 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.437 HD21 ' N ' ' A' ' 255' ' ' LEU . 4.5 mm? -78.35 -143.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.475 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 22.1 m 63.33 35.21 12.51 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.581 0.705 . . . . 0.0 110.12 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.798 -179.354 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.6 m . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 120.509 0.195 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.636 ' HG2' HD11 ' A' ' 178' ' ' LEU . 67.4 Cg_endo -75.04 -144.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.939 2.426 . . . . 0.0 112.384 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 27.1 m -151.71 156.2 39.84 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.1 m 60.74 36.57 19.33 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.49 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.636 HD11 ' HG2' ' A' ' 175' ' ' PRO . 87.9 mt -91.24 172.89 8.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.581 173.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 182' ' ' GLU . 63.6 p -71.2 154.37 41.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.504 ' CE2' ' HD1' ' A' ' 219' ' ' PHE . 3.0 m-85 -58.42 -32.41 68.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.702 0.286 . . . . 0.0 110.33 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 27.9 ttpp -62.47 -53.63 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.805 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 70.1 mm-40 -61.77 -34.35 75.71 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.517 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 212' ' ' ILE . 62.0 mtt -57.77 -47.37 82.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.581 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 202' ' ' LEU . 52.8 mt -69.09 -42.51 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.466 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 235' ' ' GLU . 88.3 mt -59.55 -25.6 64.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.438 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.537 ' HG2' ' HD2' ' A' ' 175' ' ' PRO . 55.5 tptt -83.22 -41.21 18.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.916 0.389 . . . . 0.0 110.698 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.2 p -76.42 -34.86 58.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.146 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 0.0 OUTLIER -52.05 -54.86 36.34 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -176.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 188' ' ' MET . 19.4 Cg_endo -58.85 -22.95 64.88 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.247 1.964 . . . . 0.0 112.473 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -75.54 -44.79 41.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.81 112.39 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.302 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 53.81 38.86 29.52 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 53.32 33.48 15.75 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.012 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 73.73 14.89 79.6 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.282 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -72.56 -38.71 67.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 149.36 146.51 4.34 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.055 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 43.4 p -150.5 145.57 26.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.683 0.277 . . . . 0.0 110.797 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 201' ' ' VAL . 29.0 t -57.95 152.13 16.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.083 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.453 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 50.8 ttp180 -56.13 -38.86 71.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.12 -46.21 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.742 0.305 . . . . 0.0 110.747 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 198' ' ' SER . 42.7 t -60.55 -47.04 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 184' ' ' ILE . 9.0 tp -64.08 -51.16 65.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.967 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -56.28 -48.26 76.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.033 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -37.19 74.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.224 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -75.75 -45.69 35.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.059 0.457 . . . . 0.0 110.409 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.912 HG12 HG21 ' A' ' 213' ' ' VAL . 68.6 t -60.73 -47.77 91.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.563 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.753 ' HA ' HG23 ' A' ' 213' ' ' VAL . 27.4 mtpp -64.76 -33.84 76.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.71 -47.72 37.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.686 0.279 . . . . 0.0 111.408 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 28.5 p -78.34 -30.72 48.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 111.231 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 213' ' ' VAL . 83.0 m-85 -109.53 91.75 10.74 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.08 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 209' ' ' THR . 54.3 Cg_exo -55.24 -26.61 52.63 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.094 2.53 . . . . 0.0 113.704 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 183' ' ' MET . 43.9 pt -69.19 -37.72 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.694 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.912 HG21 HG12 ' A' ' 206' ' ' VAL . 3.6 m -79.52 -23.16 12.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.369 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.537 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -69.27 -45.02 62.85 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -69.79 -38.94 76.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 0.0 110.796 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.09 120.92 16.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.6 m -80.67 -34.79 34.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.961 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -67.87 -20.82 65.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.863 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 10.0 t80 -48.0 -48.23 32.77 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.51 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -54.6 -35.94 63.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.778 -171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.02 -46.93 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 110.312 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.42 -32.2 72.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.607 ' O ' HG13 ' A' ' 227' ' ' ILE . 50.0 t80 -57.51 -50.41 73.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.384 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -63.66 -37.46 87.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.571 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.1 t -66.88 -38.33 86.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.831 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.23 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.711 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -63.98 -42.43 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 231' ' ' VAL . 39.1 ttmt -57.37 -39.04 75.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 229' ' ' LYS . 32.0 tptt -73.3 -34.95 66.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.213 0.53 . . . . 0.0 110.324 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.4 m -66.4 -39.58 89.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.167 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.0 m -64.62 -39.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.69 -30.88 64.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.077 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.464 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 7.0 m-80 -77.61 -16.92 58.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.41 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 76.54 19.39 78.09 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.432 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.683 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.3 mm-40 -79.85 -51.01 9.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 55.4 mt -120.24 153.16 36.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.413 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 247' ' ' LYS . 5.8 m -127.69 132.78 68.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.04 0.448 . . . . 0.0 110.672 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.2 OUTLIER -125.67 92.76 45.86 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.809 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -65.65 -35.98 35.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.066 2.511 . . . . 0.0 113.166 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.523 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 15.0 mptt -71.39 -51.79 22.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.335 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 140.85 -134.34 6.35 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.03 -53.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.549 2.166 . . . . 0.0 111.259 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.2 m -99.05 125.47 44.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.363 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . 172.45 -114.9 0.54 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.961 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.7 tt -153.23 122.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.164 0.507 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 227' ' ' ILE . 4.2 mp -85.46 117.77 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.802 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.73 ' HB2' HG23 ' A' ' 237' ' ' VAL . 45.3 mtpt -103.95 136.15 44.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.636 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 2.8 tm? -76.02 96.87 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.382 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.735 0.303 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.94 33.38 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.272 2.648 . . . . 0.0 113.641 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.0 t 68.45 -64.95 0.29 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.377 0.671 . . . . 0.0 112.048 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.4 t -162.82 142.58 9.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 30.4 mt -157.89 -179.81 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 183' ' ' MET . 3.2 m -70.83 149.3 46.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.42 ' CZ ' HG12 ' A' ' 213' ' ' VAL . 3.0 m-85 -49.74 -40.78 42.05 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.679 0.276 . . . . 0.0 111.221 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.484 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 26.0 ttpp -64.06 -45.59 88.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 79.9 mt-10 -65.95 -33.95 77.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.352 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 179' ' ' THR . 63.3 mtt -52.36 -53.18 48.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.056 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 202' ' ' LEU . 55.8 mt -66.35 -43.86 91.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 98.1 mt -54.96 -40.17 69.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -81.46 -28.95 33.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 110.547 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.9 t -71.55 -32.74 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.673 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.447 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 1.5 mmt -52.71 -54.29 44.84 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.5 Cg_endo -58.99 -25.61 78.32 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.873 1.716 . . . . 0.0 112.644 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -73.34 -49.11 29.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.21 132.96 35.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.241 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 53.23 33.49 15.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.572 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 54.02 31.8 14.31 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.773 0.429 . . . . 0.0 112.148 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 65.02 29.64 75.92 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 113.088 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -94.65 -42.01 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.064 0.459 . . . . 0.0 110.55 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 156.08 132.41 1.52 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.1 m -126.07 141.51 51.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.744 0.272 . . . . 0.0 110.618 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.8 p -67.8 147.12 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.18 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.474 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 72.8 ttt180 -51.02 -39.25 55.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.894 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 74.0 mt -65.34 -43.79 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.443 0.163 . . . . 0.0 111.141 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.74 -46.87 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.145 0.498 . . . . 0.0 110.843 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 184' ' ' ILE . 27.3 tp -65.44 -45.9 82.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.003 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.56 -45.02 85.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.402 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 205' ' ' TYR . 0.1 OUTLIER -54.98 -44.71 74.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.773 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.554 ' N ' ' HG2' ' A' ' 204' ' ' LYS . 44.0 t80 -72.73 -46.81 51.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 1.031 HG12 HG21 ' A' ' 213' ' ' VAL . 53.1 t -57.92 -44.32 86.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 213' ' ' VAL . 49.5 mtpt -63.92 -41.49 97.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.98 -50.61 47.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.925 0.393 . . . . 0.0 111.238 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 23.2 p -72.17 -43.88 63.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.966 -175.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.586 ' O ' HG22 ' A' ' 213' ' ' VAL . 28.1 m-85 -104.98 102.4 35.57 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.74 0.305 . . . . 0.0 110.225 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.1 Cg_exo -64.74 -14.45 44.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.873 2.382 . . . . 0.0 112.399 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.7 -46.01 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.053 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.031 HG21 HG12 ' A' ' 206' ' ' VAL . 5.5 m -77.14 -30.79 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.91 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.27 97.86 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.72 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.0 m -74.12 -33.73 63.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.114 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.29 126.05 25.96 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 111.413 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.4 p -75.97 -45.78 33.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.273 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 59.3 t30 -92.65 39.61 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.694 0.759 . . . . 0.0 110.016 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.62 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 8.3 t80 -65.13 -48.76 72.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.758 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -50.53 -42.53 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.448 -172.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -63.26 -47.84 80.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.725 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 55.6 mt -62.55 -40.5 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.2 0.524 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 227' ' ' ILE . 39.8 t80 -56.62 -52.52 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.364 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.82 -31.41 72.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 69.2 m -65.55 -39.94 92.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.854 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 181' ' ' LYS . . . -61.12 -45.6 94.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.214 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -66.25 -38.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -57.81 -32.4 67.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.206 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -75.65 -47.73 25.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 109.785 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 97.9 m -55.48 -42.66 74.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.36 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -63.49 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.625 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.6 -37.1 60.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.936 0.398 . . . . 0.0 110.434 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -74.42 -9.08 58.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 70.68 33.08 66.93 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.1 -51.14 4.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 66.0 mt -117.18 138.1 51.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.896 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' A' ' 249' ' ' ASN . 4.8 m -109.25 126.54 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.343 0.592 . . . . 0.0 110.659 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 239' ' ' PRO . 58.9 mt-30 -119.34 99.75 50.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.492 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 9.9 Cg_endo -57.26 -50.48 10.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.204 2.603 . . . . 0.0 113.091 -174.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.33 -56.61 4.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.24 -150.48 18.82 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.489 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.5 -45.85 34.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.971 2.448 . . . . 0.0 112.247 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.9 t -92.07 121.72 33.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.97 -143.04 9.66 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.242 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 21.2 tt -108.03 134.72 49.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.077 0.465 . . . . 0.0 111.019 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 236' ' ' LEU . 4.7 mp -98.61 108.25 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.916 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.624 ' HB2' HG23 ' A' ' 237' ' ' VAL . 39.5 mtmt -100.67 135.06 42.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.27 113.53 9.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.646 ' HB2' HG13 ' A' ' 237' ' ' VAL . 38.4 t30 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.371 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 178' ' ' LEU . 72.3 Cg_endo -77.6 -140.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.82 2.346 . . . . 0.0 112.535 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.636 ' HA ' ' CD2' ' A' ' 210' ' ' TYR . 21.7 t -155.65 -163.44 1.51 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.5 p 49.9 37.43 13.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.293 0.637 . . . . 0.0 111.255 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 175' ' ' PRO . 88.5 mt -114.37 149.68 35.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.652 ' HB ' ' OE1' ' A' ' 182' ' ' GLU . 12.3 m -64.52 154.89 34.65 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -45.78 -52.03 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.591 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 pttm -67.81 -37.58 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.924 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.652 ' OE1' ' HB ' ' A' ' 179' ' ' THR . 18.3 mp0 -57.65 -38.27 74.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 179' ' ' THR . 46.5 mtm -58.04 -49.16 77.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.8 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 188' ' ' MET . 37.0 mt -63.45 -45.18 98.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.095 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 95.4 mt -52.58 -43.31 65.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.375 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 3.2 tppp? -78.91 -35.98 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.6 m -68.49 -36.1 78.45 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.655 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 84.9 mmm -52.53 -55.64 30.3 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 39.2 Cg_exo -56.99 -28.82 80.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.194 1.929 . . . . 0.0 112.478 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 49.3 mm-40 -74.48 -40.85 61.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.682 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 77.0 mt -85.51 114.86 22.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.712 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 32.0 m120 68.71 -59.25 0.47 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.833 0.708 . . . . 0.0 111.541 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 189' ' ' PRO . 4.0 t70 175.86 -36.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.783 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 140.21 -19.04 2.87 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.701 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.45 -43.05 67.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.712 -0.744 . . . . 0.0 112.171 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 172.75 137.35 2.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.809 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.0 m -141.6 136.26 30.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 53.5 p -68.15 153.1 44.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.691 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -63.37 -29.77 71.01 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.4 -47.74 89.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.76 -48.36 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.893 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 25.2 tp -62.27 -48.63 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.847 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.653 ' HA ' HG22 ' A' ' 206' ' ' VAL . 38.1 ttpt -66.77 -37.32 84.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -61.26 -35.28 76.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.513 0.673 . . . . 0.0 110.432 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -77.53 -51.34 10.87 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.467 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 203' ' ' LYS . 33.4 m -58.68 -42.52 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.018 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.578 ' HA ' HG23 ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.22 -40.26 95.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.69 -41.43 31.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 25.7 p -83.05 -38.5 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.297 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 17.0 m-85 -101.56 101.01 15.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.6 Cg_exo -65.89 -10.74 28.01 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.051 2.501 . . . . 0.0 112.703 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 213' ' ' VAL . 22.4 pt -69.06 -34.65 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 212' ' ' ILE . 35.0 m -102.36 -24.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.12 62.46 1.72 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.678 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.8 t -171.33 -48.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.682 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.06 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.1 p -77.12 -35.5 56.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.32 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -6.05 36.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.953 0.406 . . . . 0.0 110.751 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -55.0 -36.99 66.02 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.391 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.43 -46.37 69.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -67.63 -47.51 69.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.944 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.12 -40.42 95.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 111.047 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 14.6 t80 -61.31 -50.34 73.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.077 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -58.97 -36.93 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.86 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.2 m -62.52 -40.04 95.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.864 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.17 96.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.852 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -64.54 -43.54 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.233 0.539 . . . . 0.0 110.098 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 231' ' ' VAL . 38.5 ttpt -61.94 -31.69 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.707 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -71.96 -34.29 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.637 0.732 . . . . 0.0 109.671 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 233' ' ' ASN . 71.8 m -72.52 -33.11 66.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.419 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 228' ' ' LYS . 26.6 m -63.5 -38.51 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.227 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.54 -33.49 64.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.965 0.412 . . . . 0.0 110.159 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 230' ' ' CYS . 7.8 m-80 -62.97 -33.96 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.91 18.72 53.67 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.339 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 235' ' ' GLU . 23.1 mm-40 -95.38 -39.89 9.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 2.8 mm? -119.23 140.45 50.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.417 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.7 m -118.45 136.04 56.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.043 0.449 . . . . 0.0 110.733 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.67 93.85 48.57 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.38 -38.6 25.59 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.11 2.54 . . . . 0.0 112.828 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.413 ' HG2' HG22 ' A' ' 245' ' ' ILE . 33.2 mmtp -68.57 -42.33 78.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.181 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 150.6 -127.64 2.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.68 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.415 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 31.7 Cg_endo -63.83 -29.5 68.0 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.735 2.29 . . . . 0.0 111.9 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.6 m -143.16 -123.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.054 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.51 -63.79 3.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.285 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.413 HG22 ' HG2' ' A' ' 240' ' ' LYS . 19.5 tt -168.58 130.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.512 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.438 HG12 HD13 ' A' ' 227' ' ' ILE . 5.2 mp -92.81 127.1 45.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.237 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.75 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.5 mtpp -118.65 132.14 56.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.558 0.218 . . . . 0.0 110.575 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.3 tp -75.48 105.96 6.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 237' ' ' VAL . 58.1 t30 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.42 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 3.2 m . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.6 ' HG2' HD11 ' A' ' 178' ' ' LEU . 7.4 Cg_exo -75.19 -134.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.86 2.374 . . . . 0.0 112.283 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 13.5 p -152.69 -47.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.3 m -77.21 70.16 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 111.513 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.737 HD22 ' HG2' ' A' ' 182' ' ' GLU . 69.9 mt -142.66 155.12 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.236 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 183' ' ' MET . 35.2 p -64.92 152.06 44.09 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -60.53 -31.54 70.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.783 0.325 . . . . 0.0 110.597 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.585 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 50.6 tttm -61.12 -48.2 82.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.51 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.737 ' HG2' HD22 ' A' ' 178' ' ' LEU . 20.4 tp10 -63.45 -37.45 87.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.64 176.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.446 ' HE1' HD11 ' A' ' 212' ' ' ILE . 64.2 mtt -57.82 -50.91 71.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.565 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 202' ' ' LEU . 60.5 mt -64.75 -45.16 95.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.032 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 235' ' ' GLU . 81.6 mt -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.012 0.434 . . . . 0.0 110.794 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -78.14 -38.74 43.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.8 p -78.83 -27.52 44.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.249 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.507 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 2.6 mmt -49.01 -53.86 34.07 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.2 Cg_endo -58.34 -28.79 86.01 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.117 1.878 . . . . 0.0 112.578 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.13 -39.8 65.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 109.78 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.01 92.89 9.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.437 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.15 32.75 21.03 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.83 32.78 12.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.992 0.425 . . . . 0.0 111.588 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.84 18.16 68.19 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.273 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 247' ' ' LYS . 66.3 mttm -74.37 -38.45 63.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.267 0.534 . . . . 0.0 109.883 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 167.54 123.68 0.68 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.796 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.401 ' C ' HG13 ' A' ' 245' ' ' ILE . 50.7 m -140.65 138.27 34.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.618 0.247 . . . . 0.0 110.685 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 201' ' ' VAL . 14.5 p -61.65 148.98 40.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -54.76 -37.38 65.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.402 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -50.29 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.64 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 198' ' ' SER . 8.5 p -69.23 -35.88 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.809 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.657 HD21 HG23 ' A' ' 184' ' ' ILE . 17.3 tp -64.71 -51.13 64.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.338 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 219' ' ' PHE . 27.9 ttpp -58.85 -40.78 85.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -59.07 -46.23 88.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.935 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -71.04 -43.35 68.04 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.237 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.858 HG12 HG21 ' A' ' 213' ' ' VAL . 19.8 t -57.54 -42.26 80.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.977 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.92 -44.31 89.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.778 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.95 -46.01 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.295 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.6 p -74.66 -43.51 54.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.335 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.661 ' O ' HG22 ' A' ' 213' ' ' VAL . 49.2 m-85 -109.82 89.85 8.39 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.14 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 209' ' ' THR . 34.5 Cg_exo -60.16 -15.83 36.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.891 2.394 . . . . 0.0 112.877 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.446 HD11 ' HE1' ' A' ' 183' ' ' MET . 28.5 pt -67.89 -32.89 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.877 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.858 HG21 HG12 ' A' ' 206' ' ' VAL . 4.2 m -76.81 -31.25 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.036 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -66.26 -40.43 94.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.631 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.7 t -71.35 -36.22 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.701 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.96 44.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.938 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -75.35 -50.41 16.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 110.976 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 50.2 t30 -90.07 38.52 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.472 0.654 . . . . 0.0 110.603 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.673 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.5 t80 -64.69 -48.52 74.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.562 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.42 -41.48 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.548 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.08 -45.29 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.0 110.549 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 77.8 mt -62.32 -37.77 86.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.192 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 227' ' ' ILE . 42.8 t80 -59.83 -49.56 77.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.973 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 242' ' ' PRO . 3.1 t-20 -57.02 -42.79 81.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.949 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.4 m -65.43 -37.87 88.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.73 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.66 86.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -62.23 -45.16 99.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.114 0.483 . . . . 0.0 110.022 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -56.42 -40.99 75.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.791 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -73.81 -43.12 59.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.367 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.66 ' HB3' ' HB2' ' A' ' 236' ' ' LEU . 73.8 m -59.02 -41.92 88.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.532 0.206 . . . . 0.0 111.428 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 30.0 m -69.18 -43.17 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.31 -34.8 75.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.899 0.381 . . . . 0.0 110.447 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -64.79 -24.7 67.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.526 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.44 27.66 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 185' ' ' LEU . 5.5 mm-40 -108.49 -26.22 10.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.322 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 230' ' ' CYS . 14.1 tp -141.57 156.37 45.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.452 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 249' ' ' ASN . 2.1 t -133.17 136.14 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.979 0.418 . . . . 0.0 110.351 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.8 OUTLIER -145.67 102.84 4.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 16.6 Cg_endo -61.38 -26.02 80.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.184 2.589 . . . . 0.0 113.0 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -104.82 28.85 6.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 242' ' ' PRO . . . 65.2 -122.58 23.94 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.8 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.47 ' HB3' ' ND2' ' A' ' 224' ' ' ASN . 7.5 Cg_exo -75.48 -57.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.918 2.412 . . . . 0.0 112.463 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 p -91.94 127.86 37.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.51 -144.55 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.23 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.401 HG13 ' C ' ' A' ' 197' ' ' SER . 13.0 tt -110.35 121.86 63.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.341 0.591 . . . . 0.0 110.521 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.462 ' HA ' ' HG2' ' A' ' 238' ' ' GLN . 3.1 mp -85.48 130.0 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.11 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 195' ' ' LYS . 50.6 mtpt -127.51 132.04 50.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.86 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 236' ' ' LEU . 2.7 tt -70.72 123.53 22.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.425 ' HB3' HG23 ' A' ' 237' ' ' VAL . 6.4 p-10 . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.378 0.609 . . . . 0.0 110.937 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 9.0 p . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.851 0.358 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.25 138.82 12.83 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.799 2.333 . . . . 0.0 112.254 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.5 t -75.44 -172.2 1.72 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.4 m 59.61 55.04 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.253 0.549 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 40.4 mt -149.63 158.33 44.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.843 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 182' ' ' GLU . 5.6 t -64.76 157.65 26.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.448 ' HA ' ' SD ' ' A' ' 183' ' ' MET . 3.5 m-30 -57.35 -27.75 62.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 55.9 tttm -65.53 -47.6 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.572 ' H ' HG23 ' A' ' 179' ' ' THR . 65.5 mm-40 -60.87 -38.77 86.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.973 0.416 . . . . 0.0 110.82 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.465 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 58.2 mtt -55.98 -48.31 76.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 180' ' ' TYR . 23.7 mt -70.33 -37.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.749 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 86.2 mt -54.75 -45.68 74.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 17.5 tppt? -70.84 -39.53 72.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.418 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 51.0 m -72.57 -32.75 66.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 0.5 OUTLIER -51.79 -51.89 66.13 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 188' ' ' MET . 23.9 Cg_endo -63.44 -30.12 71.95 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.841 1.694 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 66.0 mt-30 -66.7 -36.15 81.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.13 113.85 26.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 29.3 m120 54.74 37.7 28.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.78 30.98 9.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.487 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.01 24.08 75.91 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.265 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.82 -41.68 25.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.38 0.609 . . . . 0.0 110.144 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.49 136.34 2.17 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.383 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.404 ' C ' HG13 ' A' ' 245' ' ' ILE . 41.8 m -139.88 139.79 36.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.989 0.423 . . . . 0.0 110.795 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.1 p -62.26 155.65 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.264 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HD2' ' HA ' ' A' ' 243' ' ' SER . 54.2 ttt85 -53.35 -41.52 65.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.55 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.82 -44.56 98.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.646 0.26 . . . . 0.0 111.143 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 76.0 t -63.94 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.369 . . . . 0.0 111.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.523 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 24.2 tp -68.34 -46.81 69.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 207' ' ' LYS . 38.1 ttpt -62.06 -43.34 99.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 50.6 pttt -62.43 -32.59 73.47 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.396 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -78.23 -45.5 22.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.145 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.798 HG12 HG21 ' A' ' 213' ' ' VAL . 40.1 t -59.08 -43.37 89.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.484 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HE3' ' HA2' ' A' ' 214' ' ' GLY . 46.6 mtpt -67.0 -41.17 87.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.364 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.76 -42.32 81.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.3 p -77.54 -37.17 51.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.607 ' O ' HG22 ' A' ' 213' ' ' VAL . 63.7 m-85 -113.79 95.35 37.01 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.52 -17.25 40.3 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.904 2.403 . . . . 0.0 112.519 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.6 pt -71.67 -39.15 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.052 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.798 HG21 HG12 ' A' ' 206' ' ' VAL . 6.1 m -74.36 -29.72 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.02 0.438 . . . . 0.0 110.077 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.583 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -63.35 -29.43 74.51 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.745 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.0 m -95.45 48.26 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -148.47 128.9 13.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.787 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.4 t -78.75 -41.82 29.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.142 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.436 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.0 p-10 -88.76 20.07 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.673 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 5.2 t80 -59.34 -51.07 71.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -52.54 -40.79 62.9 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.237 0.335 . . . . 0.0 111.207 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -67.01 -48.71 67.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.177 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 63.2 mt -62.39 -36.32 81.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 110.243 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.523 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 21.9 t80 -59.41 -48.88 79.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.723 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.557 ' HB2' HH22 ' A' ' 199' ' ' ARG . 3.0 t-20 -59.47 -41.72 90.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.449 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.5 t -65.24 -37.27 86.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.876 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.36 90.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -68.25 -39.23 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.417 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 231' ' ' VAL . 40.1 ttmt -55.12 -42.25 72.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -66.63 -38.56 87.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 110.499 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 78.0 m -64.32 -38.78 92.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.013 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 228' ' ' LYS . 18.2 m -65.63 -37.65 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.491 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.75 -46.03 55.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.468 0.651 . . . . 0.0 109.312 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 8.4 m-80 -60.5 -30.53 69.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.42 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 87.27 31.9 15.47 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 233' ' ' ASN . 22.7 mm-40 -97.02 -49.16 5.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.0 109.025 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 9.8 mp -122.83 142.04 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.882 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.2 m -118.19 134.29 62.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.14 0.495 . . . . 0.0 111.169 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -125.76 79.92 67.52 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.753 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -53.75 -46.13 35.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.397 2.731 . . . . 0.0 112.973 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.482 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 63.3 mttm -71.96 -54.65 9.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.95 -162.86 36.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.825 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.88 -41.13 65.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.287 2.658 . . . . 0.0 112.615 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 199' ' ' ARG . 2.7 p -90.96 6.64 43.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.176 0.512 . . . . 0.0 110.628 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . -84.29 164.96 40.64 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.35 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 197' ' ' SER . 15.4 tt -59.26 128.77 20.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.428 ' CG2' HD23 ' A' ' 236' ' ' LEU . 4.6 mp -86.59 119.83 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.8 mtpp -114.46 136.51 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.346 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.77 117.11 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.568 ' HB2' HG13 ' A' ' 237' ' ' VAL . 52.4 t30 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 209' ' ' THR . 27.7 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 178' ' ' LEU . 9.1 Cg_exo -72.17 -136.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.076 2.518 . . . . 0.0 112.285 -178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.69 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 44.7 m -155.35 -46.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.248 -0.283 . . . . 0.0 111.281 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.3 m -76.43 63.06 1.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 175' ' ' PRO . 91.2 mt -132.04 156.27 46.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.0 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -63.65 145.64 55.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.74 -36.92 38.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 24.3 ttpp -63.18 -53.18 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.545 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -57.91 -37.13 73.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.963 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.472 ' HB3' ' HE2' ' A' ' 183' ' ' MET . 48.5 mtp -57.59 -53.19 60.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.424 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 202' ' ' LEU . 57.5 mt -62.59 -53.44 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.932 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 181' ' ' LYS . 10.7 mp -52.29 -32.13 36.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.855 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -74.36 -42.17 59.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.909 0.385 . . . . 0.0 111.217 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.1 p -78.33 -28.01 47.21 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.502 ' HE1' ' O ' ' A' ' 246' ' ' ILE . 60.7 mmm -52.24 -50.77 77.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -60.68 -18.15 53.62 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.034 1.823 . . . . 0.0 112.95 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -77.13 -48.56 17.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.337 0.589 . . . . 0.0 109.957 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 205' ' ' TYR . 68.3 mt -71.79 121.4 18.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.331 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 52.02 36.58 19.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 55.1 30.98 15.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.24 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 68.78 25.73 75.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.238 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -84.43 -39.34 19.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 109.993 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 168.85 132.6 1.45 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.0 m -116.66 126.38 53.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.082 0.441 . . . . 0.0 110.892 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 201' ' ' VAL . 2.7 p -65.05 150.73 47.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.577 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -50.22 -42.74 52.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.599 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.86 -49.43 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.611 HG23 ' HE2' ' A' ' 204' ' ' LYS . 9.6 p -63.63 -35.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.591 0.234 . . . . 0.0 110.869 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 184' ' ' ILE . 22.7 tp -69.97 -49.09 55.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.863 0.363 . . . . 0.0 110.187 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.4 -43.72 92.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.336 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.611 ' HE2' HG23 ' A' ' 201' ' ' VAL . 50.9 pttt -66.46 -37.98 86.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.386 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.408 ' CG ' HD21 ' A' ' 191' ' ' LEU . 10.0 t80 -70.88 -44.74 65.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 109.719 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.791 HG12 HG21 ' A' ' 213' ' ' VAL . 23.0 t -59.55 -44.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.286 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.744 ' HA ' HG23 ' A' ' 213' ' ' VAL . 43.6 mtpt -62.94 -45.2 93.62 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.36 -47.41 49.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.522 -175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 174' ' ' SER . 6.6 m -70.91 -45.29 64.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.121 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.69 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 28.1 m-85 -103.67 103.76 38.32 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 209' ' ' THR . 31.6 Cg_exo -64.75 -15.14 48.66 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.095 2.53 . . . . 0.0 113.127 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.3 mt -67.05 -45.22 87.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.624 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.791 HG21 HG12 ' A' ' 206' ' ' VAL . 23.2 m -72.8 -31.23 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.382 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.512 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.45 -42.02 99.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.551 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.4 m -71.83 -34.58 69.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.715 -0.242 . . . . 0.0 111.252 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -62.59 125.42 23.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 0.0 111.433 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.6 m -76.22 -43.18 43.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.991 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 34.1 t30 -95.01 36.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.534 0.683 . . . . 0.0 110.181 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.709 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 3.4 t80 -62.05 -48.9 78.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.518 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.85 -43.05 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.899 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -62.2 -46.72 87.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.258 . . . . 0.0 110.628 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 59.3 mt -63.75 -40.22 96.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.536 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 28.2 t80 -61.1 -54.42 44.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.57 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -63.99 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 47.9 t -61.83 -40.81 96.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.09 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.666 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.2 mt -67.83 -39.04 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -55.97 -40.25 72.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.32 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' SER . 93.3 mttt -73.0 -40.02 65.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.174 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.672 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 84.8 m -58.29 -45.71 87.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.025 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 34.8 m -64.15 -37.46 79.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -77.15 -37.07 54.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.424 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.5 -30.51 67.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.51 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.35 25.8 20.24 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 46.9 mm-40 -85.17 -49.05 8.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.334 0.588 . . . . 0.0 109.434 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 45.0 mt -127.23 145.09 50.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.843 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 249' ' ' ASN . 6.5 m -114.71 129.15 71.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.044 0.45 . . . . 0.0 110.346 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -116.86 97.13 50.14 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.687 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.6 -41.21 66.51 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 123.043 2.495 . . . . 0.0 112.272 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 240' ' ' LYS . 3.6 mptp? -80.95 -69.8 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 0.0 110.278 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 167.5 -156.65 28.54 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.11 -48.61 20.65 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.066 2.511 . . . . 0.0 112.671 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 7.9 t -89.49 55.11 3.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.263 0.554 . . . . 0.0 109.833 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -152.87 162.33 29.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.653 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.3 tt -57.04 125.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.526 0.679 . . . . 0.0 111.971 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 236' ' ' LEU . 4.8 mp -87.9 123.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.309 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.534 ' HB2' HG23 ' A' ' 237' ' ' VAL . 58.1 mtpt -112.28 137.12 50.86 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.98 113.51 9.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.553 ' HB2' HG13 ' A' ' 237' ' ' VAL . 46.5 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 120.864 0.364 . . . . 0.0 110.269 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.609 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 18.9 m . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 186' ' ' LYS . 43.5 Cg_endo -70.25 -143.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.031 2.488 . . . . 0.0 113.172 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 50.8 m -153.08 161.87 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.09 -0.381 . . . . 0.0 110.722 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.6 m 62.14 49.99 4.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.55 0.69 . . . . 0.0 111.214 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 51.6 mt -129.35 163.09 26.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.349 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 182' ' ' GLU . 1.9 m -63.0 150.5 42.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -54.57 -37.28 65.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.67 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 39.1 ttpt -60.42 -46.45 89.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.033 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 55.6 mm-40 -61.45 -33.67 74.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.422 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 60.6 mtt -58.15 -49.52 76.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 58.8 mt -68.94 -43.35 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 87.6 mt -53.33 -39.52 64.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 47.6 tptt -73.74 -42.06 61.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 m -69.21 -30.04 68.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.33 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.65 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 5.1 mmt -51.63 -57.7 13.58 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 32.1 Cg_exo -59.1 -28.33 87.5 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.12 1.88 . . . . 0.0 112.127 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -71.06 -39.6 72.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.15 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.446 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 51.89 35.34 15.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.057 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 54.78 34.92 22.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.588 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.73 19.22 69.12 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.759 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -75.96 -41.72 50.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.3 0.55 . . . . 0.0 110.251 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 247' ' ' LYS . . . 167.82 145.9 4.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 m -143.69 133.42 23.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.879 0.34 . . . . 0.0 110.793 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.2 t -61.19 144.82 53.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.204 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.572 HH12 ' HB2' ' A' ' 224' ' ' ASN . 46.3 ttm-85 -53.89 -38.71 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 110.419 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.14 -49.67 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.0 -34.44 45.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.714 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 28.8 tp -66.17 -49.91 65.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 219' ' ' PHE . 38.6 ttpt -59.67 -36.47 76.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -57.34 -45.87 83.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.15 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.27 -44.47 65.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.478 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.635 HG21 ' HE1' ' A' ' 223' ' ' PHE . 46.3 t -56.49 -45.86 82.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.626 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 7.7 mtpm? -66.43 -43.44 85.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 175.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.52 -41.56 96.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.496 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.494 ' CB ' ' HB2' ' A' ' 174' ' ' SER . 18.7 p -79.67 -42.89 23.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 213' ' ' VAL . 16.4 m-85 -106.88 102.58 43.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.92 -31.94 84.74 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.546 2.164 . . . . 0.0 111.509 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.12 -37.04 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.774 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.699 HG22 ' CE1' ' A' ' 219' ' ' PHE . 4.1 p -82.25 -36.32 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -82.03 41.1 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.507 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.9 t -160.23 51.89 0.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.323 0.583 . . . . 0.0 109.448 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.94 29.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.592 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.3 m -74.9 -53.07 9.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.465 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 18.1 t-20 -84.82 55.23 3.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 0.0 109.391 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 213' ' ' VAL . 3.4 t80 -88.98 -60.13 2.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.312 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -59.94 -36.98 78.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.5 -48.56 81.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.824 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 20.1 mt -68.27 -39.67 82.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.476 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.635 ' HE1' HG21 ' A' ' 206' ' ' VAL . 58.6 t80 -54.85 -49.72 70.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.709 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.572 ' HB2' HH12 ' A' ' 199' ' ' ARG . 20.4 t30 -62.78 -42.31 99.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.716 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 57.8 m -68.38 -30.67 69.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.94 99.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -67.04 -38.76 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 231' ' ' VAL . 25.1 tptp -57.29 -39.94 76.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.38 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.39 -40.34 74.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.67 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.7 m -61.54 -38.66 88.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.266 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 228' ' ' LYS . 22.4 m -65.36 -34.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.88 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 228' ' ' LYS . 9.4 mt-10 -73.14 -44.82 59.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 109.224 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -63.51 -22.43 66.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.684 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.75 29.1 55.74 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.164 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -96.18 -52.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 110.279 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 230' ' ' CYS . 40.6 mt -110.58 134.7 52.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 247' ' ' LYS . 4.1 m -110.98 135.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.15 0.5 . . . . 0.0 110.699 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -125.87 82.87 63.69 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.166 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.65 -41.71 23.83 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.903 2.402 . . . . 0.0 113.078 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.59 -62.55 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.793 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 169.41 -134.21 3.11 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.711 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 18.8 Cg_endo -64.08 -59.71 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.905 2.403 . . . . 0.0 113.202 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.6 m -80.62 -63.2 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 42.82 -123.86 3.91 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.571 -0.741 . . . . 0.0 114.169 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.5 tt -160.74 114.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 227' ' ' ILE . 4.1 mp -75.2 114.95 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.71 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.611 ' HB2' HG23 ' A' ' 237' ' ' VAL . 56.0 mtpt -112.39 131.87 55.32 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.104 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.4 tp -70.06 106.83 3.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 237' ' ' VAL . 44.7 t30 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.826 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.3 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 13.0 Cg_exo -71.01 -148.8 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.847 2.364 . . . . 0.0 112.36 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -109.66 -38.28 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.733 0.301 . . . . 0.0 111.279 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.9 t -134.13 131.04 38.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 0.0 110.879 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' HG3' ' A' ' 182' ' ' GLU . 33.6 mt -161.61 169.47 21.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.805 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 p -66.37 143.24 57.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -56.42 -32.95 65.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.579 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 73.5 tttt -62.82 -47.5 83.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.042 173.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.791 ' HG3' HD13 ' A' ' 178' ' ' LEU . 20.5 tp10 -66.66 -36.73 83.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.865 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 60.9 mtt -50.73 -50.24 55.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.734 HG23 HD21 ' A' ' 202' ' ' LEU . 79.7 mt -64.83 -54.54 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.208 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' A' ' 235' ' ' GLU . 7.9 mp -56.37 -24.97 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.69 -36.12 23.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.292 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 12.9 p -78.39 -26.7 46.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 73.9 mmm -55.89 -50.17 88.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 13.4 Cg_endo -60.07 -38.36 78.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 112.806 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 187' ' ' SER . 11.5 pt20 -75.83 -39.24 57.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.72 114.53 4.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.717 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 53.32 35.58 20.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.311 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 38.5 t0 56.78 34.08 24.08 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.517 0.675 . . . . 0.0 110.954 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 188' ' ' MET . . . 73.56 27.92 66.53 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.637 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.86 -41.4 26.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.472 . . . . 0.0 110.61 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 143.06 157.41 7.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.4 p -151.94 136.24 16.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.955 0.377 . . . . 0.0 110.572 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 2.1 p -68.1 153.43 43.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.48 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 25.4 ttp180 -51.74 -42.17 62.11 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.43 -41.44 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.4 -48.08 84.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.18 0.514 . . . . 0.0 110.675 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.734 HD21 HG23 ' A' ' 184' ' ' ILE . 20.0 tp -61.81 -41.8 98.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.699 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HG3' ' HE2' ' A' ' 219' ' ' PHE . 39.7 ttmt -57.25 -44.85 84.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.964 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -39.29 86.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.424 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -50.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 213' ' ' VAL . 77.5 t -58.56 -41.81 82.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.716 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.57 ' HA ' HG12 ' A' ' 213' ' ' VAL . 27.2 mtpp -64.38 -45.3 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.27 -46.79 26.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.021 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 33.4 p -67.15 -48.95 66.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.244 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 174' ' ' SER . 38.6 m-85 -94.35 106.9 25.82 Favored Pre-proline 0 N--CA 1.453 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 209' ' ' THR . 51.2 Cg_exo -59.69 -36.32 92.3 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.901 2.401 . . . . 0.0 112.548 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.38 -38.1 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 206' ' ' VAL . 54.8 t -66.35 -47.98 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.413 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.4 92.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.276 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.5 t -79.97 -26.6 39.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.508 0.194 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.59 136.13 57.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.957 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -78.73 -62.44 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.749 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.475 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.6 p-10 -87.04 35.58 0.7 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.459 ' CD1' HG13 ' A' ' 213' ' ' VAL . 4.7 t80 -63.13 -50.93 68.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.548 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.29 -44.36 53.91 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -62.69 -46.64 87.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.416 . . . . 0.0 110.799 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 53.8 mt -65.2 -35.2 80.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.323 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 227' ' ' ILE . 18.6 t80 -58.09 -51.04 71.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.623 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -60.83 -38.68 86.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.179 0.514 . . . . 0.0 110.864 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.3 t -65.08 -38.45 90.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.385 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.93 94.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.641 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.4 mt -62.11 -46.58 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.122 0.487 . . . . 0.0 110.141 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 231' ' ' VAL . 49.1 tttp -61.12 -37.94 84.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.849 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.73 -34.56 78.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.083 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.579 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 94.3 m -71.18 -41.96 69.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.565 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 28.2 m -67.96 -39.6 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.617 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.54 -36.45 81.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.391 0.615 . . . . 0.0 109.775 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 3.9 m-80 -68.7 -25.97 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.327 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.55 76.73 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.151 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.915 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.5 mm-40 -72.85 -32.85 65.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.606 0.717 . . . . 0.0 110.194 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 7.2 tt -131.49 140.06 49.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.191 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 249' ' ' ASN . 7.6 m -116.05 137.88 48.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.031 0.443 . . . . 0.0 110.888 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 242' ' ' PRO . 8.7 mm-40 -127.88 79.07 74.29 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.62 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.26 -39.03 2.31 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.841 2.361 . . . . 0.0 112.264 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.626 ' HD2' HG22 ' A' ' 245' ' ' ILE . 63.6 mttp -90.28 24.72 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.176 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 74.36 173.05 29.01 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.387 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HA ' ' NE2' ' A' ' 238' ' ' GLN . 52.0 Cg_exo -55.23 -40.6 84.87 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.015 2.477 . . . . 0.0 113.218 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -81.68 -2.26 49.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.768 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -82.56 -136.22 2.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.883 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.626 HG22 ' HD2' ' A' ' 240' ' ' LYS . 16.1 tt -105.38 121.79 57.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.23 0.538 . . . . 0.0 111.558 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 236' ' ' LEU . 3.3 mp -79.77 116.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.469 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 237' ' ' VAL . 26.1 mtmt -116.29 138.65 51.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 53.2 tp -81.58 113.95 19.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.548 ' HB2' HG13 ' A' ' 237' ' ' VAL . 54.4 t30 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 176' ' ' SER . 60.5 Cg_endo -75.84 -144.25 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.946 2.43 . . . . 0.0 112.625 -176.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 7.9 t -140.28 -39.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 178' ' ' LEU . 8.1 m -114.4 123.78 50.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.66 0.267 . . . . 0.0 110.75 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 177' ' ' SER . 17.0 mt -166.23 -179.41 5.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.741 0.816 . . . . 0.0 109.121 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -82.35 148.01 28.52 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.59 -42.85 62.22 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.876 0.369 . . . . 0.0 110.933 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.579 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -62.49 -41.16 98.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.031 178.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -67.35 -34.63 77.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.502 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.51 ' HE1' HD11 ' A' ' 212' ' ' ILE . 63.3 mtt -58.65 -49.71 76.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.63 HG23 HD21 ' A' ' 202' ' ' LEU . 52.7 mt -63.59 -39.97 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.977 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.5 mt -55.98 -36.94 68.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.506 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 1.9 tppp? -86.28 -32.75 20.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.3 m -70.73 -36.62 73.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.639 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.532 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 4.1 mmt -52.68 -52.11 67.32 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 35.3 Cg_exo -54.31 -33.66 76.94 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.287 1.991 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -67.91 -43.68 78.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.291 0.567 . . . . 0.0 110.394 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 78.8 mt -76.01 107.17 8.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.642 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.79 34.32 23.2 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 59.29 35.15 23.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.955 0.407 . . . . 0.0 110.806 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.72 32.51 70.69 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.395 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -85.8 -41.63 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.231 0.516 . . . . 0.0 110.681 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 247' ' ' LYS . . . 156.27 150.31 5.6 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.848 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 74.7 m -153.64 142.68 21.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.715 0.293 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 9.1 p -62.7 149.51 43.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.631 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.467 ' HA ' ' CD1' ' A' ' 246' ' ' ILE . 54.8 ttp85 -52.41 -43.03 64.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.049 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.3 mt -64.57 -40.35 88.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.22 -46.22 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.975 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.63 HD21 HG23 ' A' ' 184' ' ' ILE . 10.8 tp -62.56 -48.66 78.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.338 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -58.75 -41.72 87.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.914 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -58.5 -41.23 84.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.527 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -72.09 -43.05 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.955 HG12 HG21 ' A' ' 213' ' ' VAL . 99.2 t -60.39 -44.14 95.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.941 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 60.6 mtpt -67.57 -38.99 84.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.419 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.59 -50.27 70.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.809 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.1 p -79.59 -44.93 20.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.096 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.609 ' O ' HG22 ' A' ' 213' ' ' VAL . 21.4 m-85 -103.62 97.68 11.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.628 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 209' ' ' THR . 32.8 Cg_exo -62.79 -15.23 45.58 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.887 2.391 . . . . 0.0 112.942 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.51 HD11 ' HE1' ' A' ' 183' ' ' MET . 14.6 pt -71.81 -35.59 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 0.0 111.285 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.955 HG21 HG12 ' A' ' 206' ' ' VAL . 11.6 m -74.28 -32.71 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.427 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.99 -38.86 97.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.734 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -72.59 -33.79 66.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.819 0.342 . . . . 0.0 111.234 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -66.58 130.52 43.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.98 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.2 m -80.19 -43.87 20.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.159 0.504 . . . . 0.0 110.652 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.509 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 15.2 p-10 -86.66 21.29 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.661 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.0 t80 -61.56 -52.85 62.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -51.24 -40.54 59.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.41 . . . . 0.0 111.42 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -65.3 -52.77 51.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.874 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 57.5 mt -61.22 -37.18 82.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 110.517 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 227' ' ' ILE . 58.4 t80 -54.09 -54.66 36.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.927 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -72.04 -32.15 66.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.9 t -64.08 -41.33 97.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.48 92.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.42 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.597 HD13 HG12 ' A' ' 246' ' ' ILE . 2.3 mt -66.24 -36.26 76.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.689 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -58.49 -34.48 70.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.398 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.46 -38.27 49.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.354 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 181' ' ' LYS . 73.4 m -59.29 -41.64 89.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.782 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -64.0 -42.75 96.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.8 -35.53 67.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.99 0.424 . . . . 0.0 110.203 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 235' ' ' GLU . 9.2 m-80 -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.365 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.16 29.22 41.97 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.848 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.608 ' HG3' ' HB3' ' A' ' 233' ' ' ASN . 29.6 mt-10 -95.71 -47.85 6.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 57.3 mt -118.51 144.83 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.972 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 247' ' ' LYS . 10.5 m -115.2 134.8 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 120.984 0.421 . . . . 0.0 110.105 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.11 81.34 28.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.231 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.439 ' HG2' ' HD3' ' A' ' 247' ' ' LYS . 32.3 Cg_exo -59.19 -39.31 79.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.668 2.245 . . . . 0.0 111.804 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -93.68 29.53 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.691 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 63.17 -164.12 29.24 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.174 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.77 -41.35 8.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.936 2.424 . . . . 0.0 112.706 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.2 p -88.2 58.9 4.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.49 . . . . 0.0 111.263 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -161.66 -134.55 1.66 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.653 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.3 tt -98.17 133.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 111.392 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 227' ' ' ILE . 4.9 mp -97.15 129.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.541 ' HB2' HG23 ' A' ' 237' ' ' VAL . 52.8 mtpt -126.41 138.15 53.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 49.9 tp -71.41 124.76 25.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.425 -176.169 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 120.45 0.167 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 176' ' ' SER . 46.5 Cg_endo -69.34 -140.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.463 2.775 . . . . 0.0 113.55 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.632 ' HA ' ' CE2' ' A' ' 210' ' ' TYR . 73.3 m -155.54 177.82 10.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.059 -0.401 . . . . 0.0 110.508 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.6 m 60.77 47.53 7.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 111.076 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.472 HD12 ' OH ' ' A' ' 210' ' ' TYR . 93.7 mt -135.78 159.92 40.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 183' ' ' MET . 2.4 m -66.02 150.98 47.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.737 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -51.91 -42.95 63.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.603 0.239 . . . . 0.0 111.457 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.81 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 23.4 ttpt -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.54 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 52.6 mt-10 -65.32 -32.95 74.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.245 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.524 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 61.2 mtt -57.91 -45.89 85.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 109.583 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 69.6 mt -68.25 -41.16 83.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.235 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.766 HD11 ' HE3' ' A' ' 181' ' ' LYS . 79.8 mt -53.24 -37.65 62.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.61 -33.84 27.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -73.24 -35.62 66.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.829 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.532 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 1.6 mmt -53.36 -54.41 45.56 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.0 Cg_endo -58.82 -29.23 89.39 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.013 1.809 . . . . 0.0 112.205 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.54 -42.07 71.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.647 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.483 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 98.6 mt -74.78 115.05 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.189 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 51.44 42.39 29.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.992 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 56.59 30.82 18.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.9 28.17 67.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.847 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -91.92 -36.24 13.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.851 -0.205 . . . . 0.0 110.987 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 150.23 147.48 4.55 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.963 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 72.6 m -154.6 144.71 21.88 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 64.4 p -62.43 154.4 28.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HA ' HD11 ' A' ' 246' ' ' ILE . 38.4 ttp85 -57.38 -32.25 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.982 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 55.8 mt -68.6 -41.15 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.08 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 42.6 t -64.35 -43.72 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 43.1 tp -62.85 -39.07 93.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.254 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -56.66 -43.24 80.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 10.4 pttp -63.45 -34.28 77.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.566 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.38 -47.45 27.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.206 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 223' ' ' PHE . 48.6 t -56.53 -48.06 80.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -62.6 -44.17 96.98 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.04 -42.42 69.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.81 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.5 p -73.89 -41.39 62.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.906 0.384 . . . . 0.0 111.099 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 176' ' ' SER . 19.8 m-85 -110.75 98.87 39.61 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.139 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.71 -32.88 85.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.736 2.291 . . . . 0.0 111.975 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.3 pt -64.74 -39.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.18 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 210' ' ' TYR . 5.4 p -77.35 -28.97 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 110.687 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.94 95.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.948 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.0 p -97.82 33.95 1.99 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.894 0.378 . . . . 0.0 111.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.92 142.98 31.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.601 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.1 m -65.8 -60.53 2.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.888 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 221' ' ' TYR . 79.2 m-20 -92.99 48.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 213' ' ' VAL . 9.5 t80 -53.6 -63.17 1.23 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.243 -175.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -64.94 -33.58 76.38 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.37 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.661 ' HB3' ' HB3' ' A' ' 218' ' ' ASN . 93.1 t80 -61.4 -54.66 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.789 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 75.2 mt -66.95 -35.55 80.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.559 ' CE1' HG21 ' A' ' 206' ' ' VAL . 17.1 t80 -62.91 -48.19 80.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.012 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.45 -34.18 77.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.561 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.2 t -62.34 -39.45 93.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.092 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.28 96.4 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.6 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 223' ' ' PHE . 6.9 mm -59.95 -46.31 94.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.319 0.58 . . . . 0.0 111.034 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.72 -36.2 78.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.356 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -73.31 -42.35 62.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.892 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 236' ' ' LEU . 16.7 p -60.43 -39.24 86.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.224 -0.297 . . . . 0.0 111.211 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.44 -42.28 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.28 -36.21 74.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.986 0.422 . . . . 0.0 110.792 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -68.35 -27.54 66.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.989 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.65 29.37 29.7 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.805 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.81 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 11.9 mm-40 -84.79 -48.28 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.531 HD12 ' SG ' ' A' ' 230' ' ' CYS . 19.0 mt -125.55 154.82 41.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.806 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 247' ' ' LYS . 8.5 m -115.09 132.46 64.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.566 ' NE2' HG12 ' A' ' 246' ' ' ILE . 47.1 mt-30 -121.57 93.58 48.68 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.985 0.422 . . . . 0.0 110.859 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 27.8 Cg_endo -64.21 -38.17 37.18 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.918 2.412 . . . . 0.0 112.712 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -100.82 32.51 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.079 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 70.5 -175.3 37.16 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.301 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.24 -42.96 45.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.201 2.601 . . . . 0.0 112.708 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 m -84.18 42.67 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -145.76 -148.04 4.72 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.474 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 198' ' ' SER . 18.1 tt -82.38 123.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.507 0.67 . . . . 0.0 111.258 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.566 HG12 ' NE2' ' A' ' 238' ' ' GLN . 9.4 mt -94.2 116.52 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.812 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.697 ' HB2' HG23 ' A' ' 237' ' ' VAL . 53.5 mtpt -109.52 133.69 52.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.594 0.235 . . . . 0.0 110.483 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 63.4 tp -68.59 114.57 7.1 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.595 ' HB2' HG13 ' A' ' 237' ' ' VAL . 32.3 t30 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.426 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.99 125.51 26.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p -69.62 145.72 52.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.39 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.6 m -85.7 131.92 45.91 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.894 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.636 ' HG2' HD11 ' A' ' 178' ' ' LEU . 67.4 Cg_endo -75.04 -144.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.939 2.426 . . . . 0.0 112.384 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 27.1 m -151.71 156.2 39.84 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.1 m 60.74 36.57 19.33 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.49 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.636 HD11 ' HG2' ' A' ' 175' ' ' PRO . 87.9 mt -91.24 172.89 8.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.581 173.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 182' ' ' GLU . 63.6 p -71.2 154.37 41.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.504 ' CE2' ' HD1' ' A' ' 219' ' ' PHE . 3.0 m-85 -58.42 -32.41 68.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.702 0.286 . . . . 0.0 110.33 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 27.9 ttpp -62.47 -53.63 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.805 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 70.1 mm-40 -61.77 -34.35 75.71 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.517 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 212' ' ' ILE . 62.0 mtt -57.77 -47.37 82.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.581 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 202' ' ' LEU . 52.8 mt -69.09 -42.51 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.466 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 235' ' ' GLU . 88.3 mt -59.55 -25.6 64.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.438 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.537 ' HG2' ' HD2' ' A' ' 175' ' ' PRO . 55.5 tptt -83.22 -41.21 18.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.916 0.389 . . . . 0.0 110.698 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.2 p -76.42 -34.86 58.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.146 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 0.0 OUTLIER -52.05 -54.86 36.34 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -176.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 188' ' ' MET . 19.4 Cg_endo -58.85 -22.95 64.88 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.247 1.964 . . . . 0.0 112.473 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -75.54 -44.79 41.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.81 112.39 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.302 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 53.81 38.86 29.52 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 53.32 33.48 15.75 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.012 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 73.73 14.89 79.6 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.282 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -72.56 -38.71 67.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 149.36 146.51 4.34 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.055 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 43.4 p -150.5 145.57 26.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.683 0.277 . . . . 0.0 110.797 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 201' ' ' VAL . 29.0 t -57.95 152.13 16.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.083 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.453 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 50.8 ttp180 -56.13 -38.86 71.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.12 -46.21 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.742 0.305 . . . . 0.0 110.747 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 198' ' ' SER . 42.7 t -60.55 -47.04 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 184' ' ' ILE . 9.0 tp -64.08 -51.16 65.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.967 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -56.28 -48.26 76.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.033 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -37.19 74.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.224 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -75.75 -45.69 35.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.059 0.457 . . . . 0.0 110.409 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.912 HG12 HG21 ' A' ' 213' ' ' VAL . 68.6 t -60.73 -47.77 91.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.563 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.753 ' HA ' HG23 ' A' ' 213' ' ' VAL . 27.4 mtpp -64.76 -33.84 76.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.71 -47.72 37.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.686 0.279 . . . . 0.0 111.408 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 28.5 p -78.34 -30.72 48.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 111.231 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 213' ' ' VAL . 83.0 m-85 -109.53 91.75 10.74 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.08 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 209' ' ' THR . 54.3 Cg_exo -55.24 -26.61 52.63 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.094 2.53 . . . . 0.0 113.704 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 183' ' ' MET . 43.9 pt -69.19 -37.72 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.694 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.912 HG21 HG12 ' A' ' 206' ' ' VAL . 3.6 m -79.52 -23.16 12.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.369 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.537 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -69.27 -45.02 62.85 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -69.79 -38.94 76.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 0.0 110.796 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.09 120.92 16.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.6 m -80.67 -34.79 34.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.961 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -67.87 -20.82 65.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.863 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 10.0 t80 -48.0 -48.23 32.77 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.51 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -54.6 -35.94 63.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.778 -171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.02 -46.93 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 110.312 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.42 -32.2 72.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.607 ' O ' HG13 ' A' ' 227' ' ' ILE . 50.0 t80 -57.51 -50.41 73.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.384 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -63.66 -37.46 87.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.571 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.1 t -66.88 -38.33 86.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.831 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.23 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.711 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -63.98 -42.43 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 231' ' ' VAL . 39.1 ttmt -57.37 -39.04 75.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 229' ' ' LYS . 32.0 tptt -73.3 -34.95 66.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.213 0.53 . . . . 0.0 110.324 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.4 m -66.4 -39.58 89.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.167 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.0 m -64.62 -39.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.69 -30.88 64.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.077 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.481 ' O ' ' HD3' ' A' ' 252' ' ' LYS . 7.0 m-80 -77.61 -16.92 58.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.41 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 252' ' ' LYS . . . 76.54 19.39 78.09 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.432 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.683 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.3 mm-40 -79.85 -51.01 9.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 55.4 mt -120.24 153.16 36.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.413 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 247' ' ' LYS . 5.8 m -127.69 132.78 68.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.04 0.448 . . . . 0.0 110.672 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.2 OUTLIER -125.67 92.76 45.86 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.809 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -65.65 -35.98 35.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.066 2.511 . . . . 0.0 113.166 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.523 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 15.0 mptt -71.39 -51.79 22.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.335 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 140.85 -134.34 6.35 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.03 -53.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.549 2.166 . . . . 0.0 111.259 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.2 m -99.05 125.47 44.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.363 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . 172.45 -114.9 0.54 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.961 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.7 tt -153.23 122.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.164 0.507 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 227' ' ' ILE . 4.2 mp -85.46 117.77 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.802 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.73 ' HB2' HG23 ' A' ' 237' ' ' VAL . 45.3 mtpt -103.95 136.15 44.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.636 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 2.8 tm? -76.02 96.87 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -74.12 -70.32 0.4 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.7 tttp 44.35 45.83 7.52 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.177 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -110.03 -32.25 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.49 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 233' ' ' ASN . 13.9 ptmm? -79.77 31.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.452 . . . . 0.0 111.371 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.69 106.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.624 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -164.12 32.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.145 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 54.36 48.03 21.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.154 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.11 52.02 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.835 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.496 179.146 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.13 135.72 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.3 m -108.3 143.45 37.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.123 -174.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -117.42 135.79 23.31 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.94 33.38 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.272 2.648 . . . . 0.0 113.641 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.0 t 68.45 -64.95 0.29 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.377 0.671 . . . . 0.0 112.048 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.4 t -162.82 142.58 9.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 30.4 mt -157.89 -179.81 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 183' ' ' MET . 3.2 m -70.83 149.3 46.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.42 ' CZ ' HG12 ' A' ' 213' ' ' VAL . 3.0 m-85 -49.74 -40.78 42.05 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.679 0.276 . . . . 0.0 111.221 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.484 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 26.0 ttpp -64.06 -45.59 88.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 79.9 mt-10 -65.95 -33.95 77.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.352 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 179' ' ' THR . 63.3 mtt -52.36 -53.18 48.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.056 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 202' ' ' LEU . 55.8 mt -66.35 -43.86 91.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 98.1 mt -54.96 -40.17 69.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -81.46 -28.95 33.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 110.547 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.9 t -71.55 -32.74 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.673 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.447 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 1.5 mmt -52.71 -54.29 44.84 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.5 Cg_endo -58.99 -25.61 78.32 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.873 1.716 . . . . 0.0 112.644 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -73.34 -49.11 29.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.21 132.96 35.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.241 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 53.23 33.49 15.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.572 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 54.02 31.8 14.31 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.773 0.429 . . . . 0.0 112.148 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 65.02 29.64 75.92 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 113.088 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -94.65 -42.01 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.064 0.459 . . . . 0.0 110.55 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 156.08 132.41 1.52 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.1 m -126.07 141.51 51.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.744 0.272 . . . . 0.0 110.618 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.8 p -67.8 147.12 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.18 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.474 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 72.8 ttt180 -51.02 -39.25 55.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.894 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 74.0 mt -65.34 -43.79 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.443 0.163 . . . . 0.0 111.141 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.74 -46.87 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.145 0.498 . . . . 0.0 110.843 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 184' ' ' ILE . 27.3 tp -65.44 -45.9 82.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.003 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.56 -45.02 85.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.402 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 205' ' ' TYR . 0.1 OUTLIER -54.98 -44.71 74.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.773 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.554 ' N ' ' HG2' ' A' ' 204' ' ' LYS . 44.0 t80 -72.73 -46.81 51.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 1.031 HG12 HG21 ' A' ' 213' ' ' VAL . 53.1 t -57.92 -44.32 86.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 213' ' ' VAL . 49.5 mtpt -63.92 -41.49 97.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.98 -50.61 47.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.925 0.393 . . . . 0.0 111.238 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 23.2 p -72.17 -43.88 63.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.966 -175.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.586 ' O ' HG22 ' A' ' 213' ' ' VAL . 28.1 m-85 -104.98 102.4 35.57 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.74 0.305 . . . . 0.0 110.225 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.1 Cg_exo -64.74 -14.45 44.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.873 2.382 . . . . 0.0 112.399 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.7 -46.01 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.053 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.031 HG21 HG12 ' A' ' 206' ' ' VAL . 5.5 m -77.14 -30.79 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.91 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.27 97.86 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.72 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.0 m -74.12 -33.73 63.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.114 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.29 126.05 25.96 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 111.413 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.4 p -75.97 -45.78 33.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.273 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 59.3 t30 -92.65 39.61 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.694 0.759 . . . . 0.0 110.016 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.62 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 8.3 t80 -65.13 -48.76 72.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.758 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -50.53 -42.53 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.448 -172.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -63.26 -47.84 80.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.725 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 55.6 mt -62.55 -40.5 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.2 0.524 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 227' ' ' ILE . 39.8 t80 -56.62 -52.52 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.364 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.82 -31.41 72.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 69.2 m -65.55 -39.94 92.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.854 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 181' ' ' LYS . . . -61.12 -45.6 94.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.214 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -66.25 -38.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -57.81 -32.4 67.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.206 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -75.65 -47.73 25.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 109.785 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 97.9 m -55.48 -42.66 74.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.36 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -63.49 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.625 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.6 -37.1 60.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.936 0.398 . . . . 0.0 110.434 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.514 ' OD1' ' HE2' ' A' ' 254' ' ' LYS . 51.5 m-20 -74.42 -9.08 58.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.55 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 70.68 33.08 66.93 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.1 -51.14 4.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 66.0 mt -117.18 138.1 51.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.896 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' A' ' 249' ' ' ASN . 4.8 m -109.25 126.54 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.343 0.592 . . . . 0.0 110.659 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 239' ' ' PRO . 58.9 mt-30 -119.34 99.75 50.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.492 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 9.9 Cg_endo -57.26 -50.48 10.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.204 2.603 . . . . 0.0 113.091 -174.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.33 -56.61 4.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.24 -150.48 18.82 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.489 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.5 -45.85 34.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.971 2.448 . . . . 0.0 112.247 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.9 t -92.07 121.72 33.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.97 -143.04 9.66 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.242 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 21.2 tt -108.03 134.72 49.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.077 0.465 . . . . 0.0 111.019 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 236' ' ' LEU . 4.7 mp -98.61 108.25 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.916 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.624 ' HB2' HG23 ' A' ' 237' ' ' VAL . 39.5 mtmt -100.67 135.06 42.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.27 113.53 9.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.646 ' HB2' HG13 ' A' ' 237' ' ' VAL . 38.4 t30 -67.68 115.82 7.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.371 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -86.83 89.59 8.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.039 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 251' ' ' LYS . 37.6 tptt -175.19 -44.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.258 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.454 ' HG3' HD23 ' A' ' 255' ' ' LEU . 16.1 tppt? 59.41 57.75 3.23 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.728 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.75 143.28 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.923 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.514 ' HE2' ' OD1' ' A' ' 233' ' ' ASN . 14.6 ttpp 64.46 76.43 0.35 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.136 0.493 . . . . 0.0 110.341 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.454 HD23 ' HG3' ' A' ' 252' ' ' LYS . 90.4 mt -59.35 137.05 58.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 51.8 p -169.29 -117.55 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.354 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.4 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.522 175.508 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.089 0.471 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.417 ' HB1' ' OH ' ' A' ' 205' ' ' TYR . . . -80.26 62.81 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.579 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.1 m -77.86 59.32 2.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.065 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 p -67.5 129.45 93.56 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.409 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 178' ' ' LEU . 72.3 Cg_endo -77.6 -140.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.82 2.346 . . . . 0.0 112.535 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.636 ' HA ' ' CD2' ' A' ' 210' ' ' TYR . 21.7 t -155.65 -163.44 1.51 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.5 p 49.9 37.43 13.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.293 0.637 . . . . 0.0 111.255 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 175' ' ' PRO . 88.5 mt -114.37 149.68 35.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.652 ' HB ' ' OE1' ' A' ' 182' ' ' GLU . 12.3 m -64.52 154.89 34.65 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -45.78 -52.03 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.591 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 pttm -67.81 -37.58 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.924 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.652 ' OE1' ' HB ' ' A' ' 179' ' ' THR . 18.3 mp0 -57.65 -38.27 74.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 179' ' ' THR . 46.5 mtm -58.04 -49.16 77.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.8 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 188' ' ' MET . 37.0 mt -63.45 -45.18 98.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.095 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 95.4 mt -52.58 -43.31 65.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.375 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 3.2 tppp? -78.91 -35.98 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.6 m -68.49 -36.1 78.45 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.655 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 84.9 mmm -52.53 -55.64 30.3 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 39.2 Cg_exo -56.99 -28.82 80.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.194 1.929 . . . . 0.0 112.478 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 49.3 mm-40 -74.48 -40.85 61.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.682 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 77.0 mt -85.51 114.86 22.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.712 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 32.0 m120 68.71 -59.25 0.47 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.833 0.708 . . . . 0.0 111.541 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 189' ' ' PRO . 4.0 t70 175.86 -36.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.783 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 140.21 -19.04 2.87 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.701 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.45 -43.05 67.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.712 -0.744 . . . . 0.0 112.171 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 172.75 137.35 2.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.809 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.0 m -141.6 136.26 30.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 53.5 p -68.15 153.1 44.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.691 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -63.37 -29.77 71.01 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.4 -47.74 89.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.76 -48.36 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.893 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 25.2 tp -62.27 -48.63 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.847 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.653 ' HA ' HG22 ' A' ' 206' ' ' VAL . 38.1 ttpt -66.77 -37.32 84.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -61.26 -35.28 76.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.513 0.673 . . . . 0.0 110.432 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.417 ' OH ' ' HB1' ' A' ' 172' ' ' ALA . 66.4 t80 -77.53 -51.34 10.87 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.467 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 203' ' ' LYS . 33.4 m -58.68 -42.52 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.018 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.578 ' HA ' HG23 ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.22 -40.26 95.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.69 -41.43 31.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 25.7 p -83.05 -38.5 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.297 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 17.0 m-85 -101.56 101.01 15.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.6 Cg_exo -65.89 -10.74 28.01 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.051 2.501 . . . . 0.0 112.703 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 213' ' ' VAL . 22.4 pt -69.06 -34.65 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 212' ' ' ILE . 35.0 m -102.36 -24.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.12 62.46 1.72 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.678 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.8 t -171.33 -48.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.682 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.06 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.1 p -77.12 -35.5 56.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.32 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -6.05 36.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.953 0.406 . . . . 0.0 110.751 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -55.0 -36.99 66.02 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.391 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.43 -46.37 69.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -67.63 -47.51 69.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.944 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.12 -40.42 95.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 111.047 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 14.6 t80 -61.31 -50.34 73.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.077 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -58.97 -36.93 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.86 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.2 m -62.52 -40.04 95.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.864 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.17 96.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.852 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -64.54 -43.54 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.233 0.539 . . . . 0.0 110.098 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 231' ' ' VAL . 38.5 ttpt -61.94 -31.69 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.707 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -71.96 -34.29 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.637 0.732 . . . . 0.0 109.671 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 233' ' ' ASN . 71.8 m -72.52 -33.11 66.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.419 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 228' ' ' LYS . 26.6 m -63.5 -38.51 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.227 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.54 -33.49 64.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.965 0.412 . . . . 0.0 110.159 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 230' ' ' CYS . 7.8 m-80 -62.97 -33.96 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.91 18.72 53.67 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.339 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 235' ' ' GLU . 23.1 mm-40 -95.38 -39.89 9.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 2.8 mm? -119.23 140.45 50.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.417 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.7 m -118.45 136.04 56.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.043 0.449 . . . . 0.0 110.733 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.67 93.85 48.57 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.38 -38.6 25.59 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.11 2.54 . . . . 0.0 112.828 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.413 ' HG2' HG22 ' A' ' 245' ' ' ILE . 33.2 mmtp -68.57 -42.33 78.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.181 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 150.6 -127.64 2.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.68 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.415 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 31.7 Cg_endo -63.83 -29.5 68.0 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.735 2.29 . . . . 0.0 111.9 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.6 m -143.16 -123.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.054 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.51 -63.79 3.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.285 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.413 HG22 ' HG2' ' A' ' 240' ' ' LYS . 19.5 tt -168.58 130.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.512 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.438 HG12 HD13 ' A' ' 227' ' ' ILE . 5.2 mp -92.81 127.1 45.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.237 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.75 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.5 mtpp -118.65 132.14 56.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.558 0.218 . . . . 0.0 110.575 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.3 tp -75.48 105.96 6.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 237' ' ' VAL . 58.1 t30 -68.97 117.86 11.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.42 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.729 ' HB3' HG23 ' A' ' 253' ' ' VAL . 4.5 mptp? -63.7 -42.42 97.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.93 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 68.2 -48.79 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.241 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 253' ' ' VAL . 24.7 mtpp -103.98 35.25 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.934 0.397 . . . . 0.0 111.522 -176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -165.27 142.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.813 175.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -156.42 131.43 9.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.895 0.378 . . . . 0.0 111.354 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.6 mp -75.97 133.78 40.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.748 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.4 t -160.72 47.05 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.291 0.567 . . . . 0.0 110.355 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.108 179.71 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 171' ' ' LYS . 27.5 mtpp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.12 91.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.759 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.4 m -156.84 -56.4 0.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 3.2 m -108.09 121.95 42.18 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.6 ' HG2' HD11 ' A' ' 178' ' ' LEU . 7.4 Cg_exo -75.19 -134.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.86 2.374 . . . . 0.0 112.283 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 13.5 p -152.69 -47.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.3 m -77.21 70.16 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 111.513 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.737 HD22 ' HG2' ' A' ' 182' ' ' GLU . 69.9 mt -142.66 155.12 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.236 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 183' ' ' MET . 35.2 p -64.92 152.06 44.09 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -60.53 -31.54 70.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.783 0.325 . . . . 0.0 110.597 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.585 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 50.6 tttm -61.12 -48.2 82.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.51 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.737 ' HG2' HD22 ' A' ' 178' ' ' LEU . 20.4 tp10 -63.45 -37.45 87.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.64 176.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.446 ' HE1' HD11 ' A' ' 212' ' ' ILE . 64.2 mtt -57.82 -50.91 71.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.565 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 202' ' ' LEU . 60.5 mt -64.75 -45.16 95.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.032 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 235' ' ' GLU . 81.6 mt -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.012 0.434 . . . . 0.0 110.794 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -78.14 -38.74 43.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.8 p -78.83 -27.52 44.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.249 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.507 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 2.6 mmt -49.01 -53.86 34.07 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.2 Cg_endo -58.34 -28.79 86.01 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.117 1.878 . . . . 0.0 112.578 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.13 -39.8 65.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 109.78 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.01 92.89 9.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.437 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.15 32.75 21.03 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.83 32.78 12.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.992 0.425 . . . . 0.0 111.588 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.84 18.16 68.19 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.273 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 247' ' ' LYS . 66.3 mttm -74.37 -38.45 63.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.267 0.534 . . . . 0.0 109.883 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 167.54 123.68 0.68 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.796 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.401 ' C ' HG13 ' A' ' 245' ' ' ILE . 50.7 m -140.65 138.27 34.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.618 0.247 . . . . 0.0 110.685 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 201' ' ' VAL . 14.5 p -61.65 148.98 40.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -54.76 -37.38 65.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.402 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -50.29 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.64 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 198' ' ' SER . 8.5 p -69.23 -35.88 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.809 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.657 HD21 HG23 ' A' ' 184' ' ' ILE . 17.3 tp -64.71 -51.13 64.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.338 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 219' ' ' PHE . 27.9 ttpp -58.85 -40.78 85.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -59.07 -46.23 88.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.935 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -71.04 -43.35 68.04 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.237 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.858 HG12 HG21 ' A' ' 213' ' ' VAL . 19.8 t -57.54 -42.26 80.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.977 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.92 -44.31 89.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.778 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.95 -46.01 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.295 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.6 p -74.66 -43.51 54.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.335 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.661 ' O ' HG22 ' A' ' 213' ' ' VAL . 49.2 m-85 -109.82 89.85 8.39 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.14 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 209' ' ' THR . 34.5 Cg_exo -60.16 -15.83 36.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.891 2.394 . . . . 0.0 112.877 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.446 HD11 ' HE1' ' A' ' 183' ' ' MET . 28.5 pt -67.89 -32.89 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.877 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.858 HG21 HG12 ' A' ' 206' ' ' VAL . 4.2 m -76.81 -31.25 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.036 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -66.26 -40.43 94.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.631 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.7 t -71.35 -36.22 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.701 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.96 44.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.938 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -75.35 -50.41 16.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 110.976 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 50.2 t30 -90.07 38.52 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.472 0.654 . . . . 0.0 110.603 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.673 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.5 t80 -64.69 -48.52 74.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.562 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.42 -41.48 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.548 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.08 -45.29 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.0 110.549 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 77.8 mt -62.32 -37.77 86.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.192 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 227' ' ' ILE . 42.8 t80 -59.83 -49.56 77.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.973 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 242' ' ' PRO . 3.1 t-20 -57.02 -42.79 81.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.949 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.4 m -65.43 -37.87 88.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.73 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.66 86.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -62.23 -45.16 99.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.114 0.483 . . . . 0.0 110.022 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -56.42 -40.99 75.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.791 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -73.81 -43.12 59.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.367 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.66 ' HB3' ' HB2' ' A' ' 236' ' ' LEU . 73.8 m -59.02 -41.92 88.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.532 0.206 . . . . 0.0 111.428 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 30.0 m -69.18 -43.17 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.31 -34.8 75.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.899 0.381 . . . . 0.0 110.447 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -64.79 -24.7 67.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.526 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.44 27.66 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 185' ' ' LEU . 5.5 mm-40 -108.49 -26.22 10.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.322 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 230' ' ' CYS . 14.1 tp -141.57 156.37 45.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.452 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 249' ' ' ASN . 2.1 t -133.17 136.14 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.979 0.418 . . . . 0.0 110.351 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.8 OUTLIER -145.67 102.84 4.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 16.6 Cg_endo -61.38 -26.02 80.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.184 2.589 . . . . 0.0 113.0 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -104.82 28.85 6.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 242' ' ' PRO . . . 65.2 -122.58 23.94 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.8 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.47 ' HB3' ' ND2' ' A' ' 224' ' ' ASN . 7.5 Cg_exo -75.48 -57.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.918 2.412 . . . . 0.0 112.463 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 p -91.94 127.86 37.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.51 -144.55 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.23 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.401 HG13 ' C ' ' A' ' 197' ' ' SER . 13.0 tt -110.35 121.86 63.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.341 0.591 . . . . 0.0 110.521 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.462 ' HA ' ' HG2' ' A' ' 238' ' ' GLN . 3.1 mp -85.48 130.0 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.11 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 195' ' ' LYS . 50.6 mtpt -127.51 132.04 50.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.86 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 236' ' ' LEU . 2.7 tt -70.72 123.53 22.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.425 ' HB3' HG23 ' A' ' 237' ' ' VAL . 6.4 p-10 -67.71 135.27 52.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.378 0.609 . . . . 0.0 110.937 -173.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -110.87 47.1 1.01 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.954 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' A' ' 252' ' ' LYS . 64.0 pttt -70.93 -28.22 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.412 0.625 . . . . 0.0 109.391 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 251' ' ' LYS . 65.3 pttt -168.17 148.42 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.291 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.6 m -73.5 60.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.339 0.59 . . . . 0.0 110.615 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 143.47 57.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.461 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.4 mp -74.32 135.68 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.177 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.5 t -147.0 -48.48 0.18 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--O 1.247 0.963 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.033 175.634 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 60.15 44.37 12.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -78.26 130.93 36.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 9.0 p -84.82 116.53 65.72 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.884 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.25 138.82 12.83 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.799 2.333 . . . . 0.0 112.254 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.5 t -75.44 -172.2 1.72 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.4 m 59.61 55.04 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.253 0.549 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 40.4 mt -149.63 158.33 44.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.843 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 182' ' ' GLU . 5.6 t -64.76 157.65 26.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.448 ' HA ' ' SD ' ' A' ' 183' ' ' MET . 3.5 m-30 -57.35 -27.75 62.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 55.9 tttm -65.53 -47.6 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.572 ' H ' HG23 ' A' ' 179' ' ' THR . 65.5 mm-40 -60.87 -38.77 86.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.973 0.416 . . . . 0.0 110.82 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.465 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 58.2 mtt -55.98 -48.31 76.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 180' ' ' TYR . 23.7 mt -70.33 -37.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.749 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 86.2 mt -54.75 -45.68 74.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 17.5 tppt? -70.84 -39.53 72.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.418 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 51.0 m -72.57 -32.75 66.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 0.5 OUTLIER -51.79 -51.89 66.13 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 188' ' ' MET . 23.9 Cg_endo -63.44 -30.12 71.95 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.841 1.694 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 66.0 mt-30 -66.7 -36.15 81.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.13 113.85 26.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 29.3 m120 54.74 37.7 28.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.78 30.98 9.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.487 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.01 24.08 75.91 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.265 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.82 -41.68 25.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.38 0.609 . . . . 0.0 110.144 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.49 136.34 2.17 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.383 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.404 ' C ' HG13 ' A' ' 245' ' ' ILE . 41.8 m -139.88 139.79 36.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.989 0.423 . . . . 0.0 110.795 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.1 p -62.26 155.65 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.264 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HD2' ' HA ' ' A' ' 243' ' ' SER . 54.2 ttt85 -53.35 -41.52 65.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.55 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.82 -44.56 98.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.646 0.26 . . . . 0.0 111.143 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 76.0 t -63.94 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.369 . . . . 0.0 111.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 24.2 tp -68.34 -46.81 69.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 207' ' ' LYS . 38.1 ttpt -62.06 -43.34 99.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 50.6 pttt -62.43 -32.59 73.47 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.396 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -78.23 -45.5 22.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.145 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.798 HG12 HG21 ' A' ' 213' ' ' VAL . 40.1 t -59.08 -43.37 89.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.484 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HE3' ' HA2' ' A' ' 214' ' ' GLY . 46.6 mtpt -67.0 -41.17 87.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.364 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.76 -42.32 81.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.3 p -77.54 -37.17 51.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.607 ' O ' HG22 ' A' ' 213' ' ' VAL . 63.7 m-85 -113.79 95.35 37.01 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.52 -17.25 40.3 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.904 2.403 . . . . 0.0 112.519 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.6 pt -71.67 -39.15 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.052 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.798 HG21 HG12 ' A' ' 206' ' ' VAL . 6.1 m -74.36 -29.72 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.02 0.438 . . . . 0.0 110.077 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.583 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -63.35 -29.43 74.51 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.745 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.0 m -95.45 48.26 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -148.47 128.9 13.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.787 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.4 t -78.75 -41.82 29.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.142 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.436 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.0 p-10 -88.76 20.07 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.673 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 5.2 t80 -59.34 -51.07 71.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -52.54 -40.79 62.9 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.237 0.335 . . . . 0.0 111.207 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -67.01 -48.71 67.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.177 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 63.2 mt -62.39 -36.32 81.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 110.243 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.523 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 21.9 t80 -59.41 -48.88 79.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.723 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.557 ' HB2' HH22 ' A' ' 199' ' ' ARG . 3.0 t-20 -59.47 -41.72 90.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.449 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.5 t -65.24 -37.27 86.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.876 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.36 90.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -68.25 -39.23 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.417 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 231' ' ' VAL . 40.1 ttmt -55.12 -42.25 72.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -66.63 -38.56 87.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 110.499 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 78.0 m -64.32 -38.78 92.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.013 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 228' ' ' LYS . 18.2 m -65.63 -37.65 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.491 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.75 -46.03 55.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.468 0.651 . . . . 0.0 109.312 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 8.4 m-80 -60.5 -30.53 69.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.42 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 87.27 31.9 15.47 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 233' ' ' ASN . 22.7 mm-40 -97.02 -49.16 5.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.0 109.025 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 9.8 mp -122.83 142.04 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.882 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.2 m -118.19 134.29 62.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.14 0.495 . . . . 0.0 111.169 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -125.76 79.92 67.52 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.753 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -53.75 -46.13 35.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.397 2.731 . . . . 0.0 112.973 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.482 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 63.3 mttm -71.96 -54.65 9.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.95 -162.86 36.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.825 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.88 -41.13 65.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.287 2.658 . . . . 0.0 112.615 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 199' ' ' ARG . 2.7 p -90.96 6.64 43.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.176 0.512 . . . . 0.0 110.628 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . -84.29 164.96 40.64 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.35 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 197' ' ' SER . 15.4 tt -59.26 128.77 20.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.428 ' CG2' HD23 ' A' ' 236' ' ' LEU . 4.6 mp -86.59 119.83 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.8 mtpp -114.46 136.51 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.346 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.77 117.11 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.568 ' HB2' HG13 ' A' ' 237' ' ' VAL . 52.4 t30 -74.94 80.31 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -76.61 36.5 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.181 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 249' ' ' ASN . 14.7 mmmm -103.24 -42.62 5.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -90.39 141.77 28.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.019 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 15.7 m -56.44 123.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.299 0.571 . . . . 0.0 111.902 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -72.2 143.89 48.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 83.0 mt -80.57 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 41.5 m 58.45 54.26 5.68 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.113 0.482 . . . . 0.0 110.757 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.869 -179.518 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.715 0.293 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -81.97 43.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.978 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -86.61 132.98 33.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 209' ' ' THR . 27.7 m -94.21 124.3 56.26 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 178' ' ' LEU . 9.1 Cg_exo -72.17 -136.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.076 2.518 . . . . 0.0 112.285 -178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.69 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 44.7 m -155.35 -46.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.248 -0.283 . . . . 0.0 111.281 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.3 m -76.43 63.06 1.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 175' ' ' PRO . 91.2 mt -132.04 156.27 46.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.0 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -63.65 145.64 55.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.74 -36.92 38.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 24.3 ttpp -63.18 -53.18 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.545 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -57.91 -37.13 73.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.963 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.472 ' HB3' ' HE2' ' A' ' 183' ' ' MET . 48.5 mtp -57.59 -53.19 60.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.424 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 202' ' ' LEU . 57.5 mt -62.59 -53.44 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.932 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 181' ' ' LYS . 10.7 mp -52.29 -32.13 36.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.855 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -74.36 -42.17 59.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.909 0.385 . . . . 0.0 111.217 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.1 p -78.33 -28.01 47.21 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.502 ' HE1' ' O ' ' A' ' 246' ' ' ILE . 60.7 mmm -52.24 -50.77 77.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -60.68 -18.15 53.62 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.034 1.823 . . . . 0.0 112.95 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -77.13 -48.56 17.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.337 0.589 . . . . 0.0 109.957 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 205' ' ' TYR . 68.3 mt -71.79 121.4 18.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.331 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 52.02 36.58 19.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 55.1 30.98 15.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.24 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 68.78 25.73 75.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.238 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -84.43 -39.34 19.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 109.993 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 168.85 132.6 1.45 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.0 m -116.66 126.38 53.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.082 0.441 . . . . 0.0 110.892 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 201' ' ' VAL . 2.7 p -65.05 150.73 47.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.577 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -50.22 -42.74 52.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.599 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.86 -49.43 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.611 HG23 ' HE2' ' A' ' 204' ' ' LYS . 9.6 p -63.63 -35.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.591 0.234 . . . . 0.0 110.869 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 184' ' ' ILE . 22.7 tp -69.97 -49.09 55.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.863 0.363 . . . . 0.0 110.187 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.4 -43.72 92.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.336 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.611 ' HE2' HG23 ' A' ' 201' ' ' VAL . 50.9 pttt -66.46 -37.98 86.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.386 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.408 ' CG ' HD21 ' A' ' 191' ' ' LEU . 10.0 t80 -70.88 -44.74 65.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 109.719 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.791 HG12 HG21 ' A' ' 213' ' ' VAL . 23.0 t -59.55 -44.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.286 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.744 ' HA ' HG23 ' A' ' 213' ' ' VAL . 43.6 mtpt -62.94 -45.2 93.62 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.36 -47.41 49.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.522 -175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 174' ' ' SER . 6.6 m -70.91 -45.29 64.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.121 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.69 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 28.1 m-85 -103.67 103.76 38.32 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 209' ' ' THR . 31.6 Cg_exo -64.75 -15.14 48.66 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.095 2.53 . . . . 0.0 113.127 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.3 mt -67.05 -45.22 87.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.624 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.791 HG21 HG12 ' A' ' 206' ' ' VAL . 23.2 m -72.8 -31.23 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.382 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.512 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.45 -42.02 99.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.551 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.4 m -71.83 -34.58 69.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.715 -0.242 . . . . 0.0 111.252 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -62.59 125.42 23.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 0.0 111.433 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.6 m -76.22 -43.18 43.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.991 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 34.1 t30 -95.01 36.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.534 0.683 . . . . 0.0 110.181 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.709 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 3.4 t80 -62.05 -48.9 78.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.518 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.85 -43.05 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.899 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -62.2 -46.72 87.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.258 . . . . 0.0 110.628 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 59.3 mt -63.75 -40.22 96.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.536 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 28.2 t80 -61.1 -54.42 44.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.57 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -63.99 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 47.9 t -61.83 -40.81 96.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.09 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.666 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.2 mt -67.83 -39.04 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -55.97 -40.25 72.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.32 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' SER . 93.3 mttt -73.0 -40.02 65.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.174 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.672 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 84.8 m -58.29 -45.71 87.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.025 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 34.8 m -64.15 -37.46 79.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -77.15 -37.07 54.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.424 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.5 -30.51 67.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.51 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.35 25.8 20.24 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 46.9 mm-40 -85.17 -49.05 8.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.334 0.588 . . . . 0.0 109.434 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 45.0 mt -127.23 145.09 50.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.843 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 249' ' ' ASN . 6.5 m -114.71 129.15 71.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.044 0.45 . . . . 0.0 110.346 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -116.86 97.13 50.14 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.687 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.6 -41.21 66.51 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 123.043 2.495 . . . . 0.0 112.272 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 240' ' ' LYS . 3.6 mptp? -80.95 -69.8 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 0.0 110.278 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 167.5 -156.65 28.54 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.11 -48.61 20.65 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.066 2.511 . . . . 0.0 112.671 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 7.9 t -89.49 55.11 3.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.263 0.554 . . . . 0.0 109.833 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -152.87 162.33 29.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.653 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.3 tt -57.04 125.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.526 0.679 . . . . 0.0 111.971 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 236' ' ' LEU . 4.8 mp -87.9 123.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.309 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.534 ' HB2' HG23 ' A' ' 237' ' ' VAL . 58.1 mtpt -112.28 137.12 50.86 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.98 113.51 9.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.553 ' HB2' HG13 ' A' ' 237' ' ' VAL . 46.5 t30 -62.61 119.39 9.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.864 0.364 . . . . 0.0 110.269 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -78.06 58.53 2.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.586 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -77.34 61.48 2.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 69.53 54.29 0.4 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.067 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.21 124.78 40.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.074 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.483 ' HE2' ' OG ' ' A' ' 256' ' ' SER . 8.0 ttpm? -77.82 136.9 38.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.61 53.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.695 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.483 ' OG ' ' HE2' ' A' ' 254' ' ' LYS . 1.1 m -64.13 135.52 56.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.971 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.51 0.195 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.651 ' HB1' HG22 ' A' ' 209' ' ' THR . . . -69.45 134.84 49.43 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.4 t -69.23 -47.46 64.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.931 0.396 . . . . 0.0 110.089 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.609 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 18.9 m -73.04 131.3 83.82 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.946 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 186' ' ' LYS . 43.5 Cg_endo -70.25 -143.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.031 2.488 . . . . 0.0 113.172 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 50.8 m -153.08 161.87 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.09 -0.381 . . . . 0.0 110.722 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.6 m 62.14 49.99 4.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.55 0.69 . . . . 0.0 111.214 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 51.6 mt -129.35 163.09 26.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.349 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 182' ' ' GLU . 1.9 m -63.0 150.5 42.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -54.57 -37.28 65.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.67 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 39.1 ttpt -60.42 -46.45 89.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.033 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 55.6 mm-40 -61.45 -33.67 74.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.422 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 60.6 mtt -58.15 -49.52 76.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 58.8 mt -68.94 -43.35 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 87.6 mt -53.33 -39.52 64.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 47.6 tptt -73.74 -42.06 61.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 m -69.21 -30.04 68.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.33 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.65 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 5.1 mmt -51.63 -57.7 13.58 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 32.1 Cg_exo -59.1 -28.33 87.5 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.12 1.88 . . . . 0.0 112.127 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -71.06 -39.6 72.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.15 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.446 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 51.89 35.34 15.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.057 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 54.78 34.92 22.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.588 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.73 19.22 69.12 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.759 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -75.96 -41.72 50.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.3 0.55 . . . . 0.0 110.251 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 247' ' ' LYS . . . 167.82 145.9 4.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 m -143.69 133.42 23.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.879 0.34 . . . . 0.0 110.793 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.2 t -61.19 144.82 53.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.204 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.572 HH12 ' HB2' ' A' ' 224' ' ' ASN . 46.3 ttm-85 -53.89 -38.71 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 110.419 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.14 -49.67 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.0 -34.44 45.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.714 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 28.8 tp -66.17 -49.91 65.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 219' ' ' PHE . 38.6 ttpt -59.67 -36.47 76.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -57.34 -45.87 83.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.15 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.27 -44.47 65.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.478 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.635 HG21 ' HE1' ' A' ' 223' ' ' PHE . 46.3 t -56.49 -45.86 82.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.626 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 7.7 mtpm? -66.43 -43.44 85.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 175.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.52 -41.56 96.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.496 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.651 HG22 ' HB1' ' A' ' 172' ' ' ALA . 18.7 p -79.67 -42.89 23.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 213' ' ' VAL . 16.4 m-85 -106.88 102.58 43.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.92 -31.94 84.74 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.546 2.164 . . . . 0.0 111.509 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.12 -37.04 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.774 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.699 HG22 ' CE1' ' A' ' 219' ' ' PHE . 4.1 p -82.25 -36.32 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -82.03 41.1 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.507 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.9 t -160.23 51.89 0.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.323 0.583 . . . . 0.0 109.448 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.94 29.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.592 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.3 m -74.9 -53.07 9.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.465 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 18.1 t-20 -84.82 55.23 3.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 0.0 109.391 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 213' ' ' VAL . 3.4 t80 -88.98 -60.13 2.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.312 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -59.94 -36.98 78.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.5 -48.56 81.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.824 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 20.1 mt -68.27 -39.67 82.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.476 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.635 ' HE1' HG21 ' A' ' 206' ' ' VAL . 58.6 t80 -54.85 -49.72 70.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.709 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.572 ' HB2' HH12 ' A' ' 199' ' ' ARG . 20.4 t30 -62.78 -42.31 99.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.716 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 57.8 m -68.38 -30.67 69.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.94 99.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -67.04 -38.76 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 231' ' ' VAL . 25.1 tptp -57.29 -39.94 76.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.38 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.39 -40.34 74.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.67 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.7 m -61.54 -38.66 88.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.266 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 228' ' ' LYS . 22.4 m -65.36 -34.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.88 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 228' ' ' LYS . 9.4 mt-10 -73.14 -44.82 59.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 109.224 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -63.51 -22.43 66.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.684 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.75 29.1 55.74 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.164 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -96.18 -52.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 110.279 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 230' ' ' CYS . 40.6 mt -110.58 134.7 52.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 247' ' ' LYS . 4.1 m -110.98 135.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.15 0.5 . . . . 0.0 110.699 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -125.87 82.87 63.69 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.166 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.65 -41.71 23.83 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.903 2.402 . . . . 0.0 113.078 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.59 -62.55 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.793 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 169.41 -134.21 3.11 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.711 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 18.8 Cg_endo -64.08 -59.71 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.905 2.403 . . . . 0.0 113.202 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.6 m -80.62 -63.2 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 42.82 -123.86 3.91 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.571 -0.741 . . . . 0.0 114.169 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.5 tt -160.74 114.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 227' ' ' ILE . 4.1 mp -75.2 114.95 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.71 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.611 ' HB2' HG23 ' A' ' 237' ' ' VAL . 56.0 mtpt -112.39 131.87 55.32 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.104 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.4 tp -70.06 106.83 3.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 237' ' ' VAL . 44.7 t30 -73.09 130.49 40.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.826 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 250' ' ' LYS . 16.2 tptm -132.3 36.91 3.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.169 0.509 . . . . 0.0 109.687 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 251' ' ' LYS . 9.8 mtpm? -80.59 59.35 3.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.192 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.412 ' HD3' ' HB ' ' A' ' 257' ' ' THR . 18.4 ptpt -52.33 133.18 34.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.643 -173.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.19 137.43 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.21 145.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.543 0.527 . . . . 0.0 110.181 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.15 -38.35 90.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -173.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.2 m -77.53 114.79 16.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.877 0.37 . . . . 0.0 111.126 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 252' ' ' LYS . 98.4 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.064 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.23 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.565 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -159.85 -166.83 1.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.95 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.3 m -79.19 132.42 63.14 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 13.0 Cg_exo -71.01 -148.8 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.847 2.364 . . . . 0.0 112.36 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -109.66 -38.28 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.733 0.301 . . . . 0.0 111.279 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.9 t -134.13 131.04 38.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 0.0 110.879 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' HG3' ' A' ' 182' ' ' GLU . 33.6 mt -161.61 169.47 21.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.805 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 p -66.37 143.24 57.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -56.42 -32.95 65.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.579 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 73.5 tttt -62.82 -47.5 83.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.042 173.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.791 ' HG3' HD13 ' A' ' 178' ' ' LEU . 20.5 tp10 -66.66 -36.73 83.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.865 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 60.9 mtt -50.73 -50.24 55.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.734 HG23 HD21 ' A' ' 202' ' ' LEU . 79.7 mt -64.83 -54.54 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.208 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' A' ' 235' ' ' GLU . 7.9 mp -56.37 -24.97 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.69 -36.12 23.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.292 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 12.9 p -78.39 -26.7 46.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 73.9 mmm -55.89 -50.17 88.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 13.4 Cg_endo -60.07 -38.36 78.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 112.806 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 187' ' ' SER . 11.0 pt20 -75.83 -39.24 57.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.72 114.53 4.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.717 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 53.32 35.58 20.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.311 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 38.5 t0 56.78 34.08 24.08 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.517 0.675 . . . . 0.0 110.954 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 188' ' ' MET . . . 73.56 27.92 66.53 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.637 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.86 -41.4 26.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.472 . . . . 0.0 110.61 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 143.06 157.41 7.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.4 p -151.94 136.24 16.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.955 0.377 . . . . 0.0 110.572 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 2.1 p -68.1 153.43 43.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.48 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 25.4 ttp180 -51.74 -42.17 62.11 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.43 -41.44 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.4 -48.08 84.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.18 0.514 . . . . 0.0 110.675 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.734 HD21 HG23 ' A' ' 184' ' ' ILE . 20.0 tp -61.81 -41.8 98.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.699 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HG3' ' HE2' ' A' ' 219' ' ' PHE . 39.7 ttmt -57.25 -44.85 84.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.964 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -39.29 86.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.424 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -50.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 213' ' ' VAL . 77.5 t -58.56 -41.81 82.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.716 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.57 ' HA ' HG12 ' A' ' 213' ' ' VAL . 27.2 mtpp -64.38 -45.3 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.27 -46.79 26.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.021 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 33.4 p -67.15 -48.95 66.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.244 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 174' ' ' SER . 38.6 m-85 -94.35 106.9 25.82 Favored Pre-proline 0 N--CA 1.453 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 209' ' ' THR . 51.2 Cg_exo -59.69 -36.32 92.3 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.901 2.401 . . . . 0.0 112.548 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.38 -38.1 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 206' ' ' VAL . 54.8 t -66.35 -47.98 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.413 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.4 92.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.276 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.5 t -79.97 -26.6 39.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.508 0.194 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.59 136.13 57.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.957 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -78.73 -62.44 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.749 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.475 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.6 p-10 -87.04 35.58 0.7 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.459 ' CD1' HG13 ' A' ' 213' ' ' VAL . 4.7 t80 -63.13 -50.93 68.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.548 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.29 -44.36 53.91 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -62.69 -46.64 87.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.416 . . . . 0.0 110.799 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 53.8 mt -65.2 -35.2 80.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.323 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 227' ' ' ILE . 18.6 t80 -58.09 -51.04 71.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.623 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -60.83 -38.68 86.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.179 0.514 . . . . 0.0 110.864 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.3 t -65.08 -38.45 90.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.385 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.93 94.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.641 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.4 mt -62.11 -46.58 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.122 0.487 . . . . 0.0 110.141 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 231' ' ' VAL . 49.1 tttp -61.12 -37.94 84.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.849 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.73 -34.56 78.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.083 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.579 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 94.3 m -71.18 -41.96 69.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.565 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 28.2 m -67.96 -39.6 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.617 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.54 -36.45 81.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.391 0.615 . . . . 0.0 109.775 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 3.9 m-80 -68.7 -25.97 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.327 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.564 ' HA3' ' HD2' ' A' ' 251' ' ' LYS . . . 89.33 2.55 76.73 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.151 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.915 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.5 mm-40 -72.85 -32.85 65.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.606 0.717 . . . . 0.0 110.194 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 7.2 tt -131.49 140.06 49.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.191 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 249' ' ' ASN . 7.6 m -116.05 137.88 48.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.031 0.443 . . . . 0.0 110.888 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 242' ' ' PRO . 8.7 mm-40 -127.88 79.07 74.29 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.62 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.26 -39.03 2.31 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.841 2.361 . . . . 0.0 112.264 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.626 ' HD2' HG22 ' A' ' 245' ' ' ILE . 63.6 mttp -90.28 24.72 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.176 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 74.36 173.05 29.01 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.387 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HA ' ' NE2' ' A' ' 238' ' ' GLN . 52.0 Cg_exo -55.23 -40.6 84.87 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.015 2.477 . . . . 0.0 113.218 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -81.68 -2.26 49.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.768 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -82.56 -136.22 2.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.883 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.626 HG22 ' HD2' ' A' ' 240' ' ' LYS . 16.1 tt -105.38 121.79 57.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.23 0.538 . . . . 0.0 111.558 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 236' ' ' LEU . 3.3 mp -79.77 116.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.469 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 237' ' ' VAL . 26.1 mtmt -116.29 138.65 51.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 53.2 tp -81.58 113.95 19.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.548 ' HB2' HG13 ' A' ' 237' ' ' VAL . 54.4 t30 -83.82 -38.24 21.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 58.11 66.49 1.1 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.303 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.564 ' HD2' ' HA3' ' A' ' 234' ' ' GLY . 30.0 tttt -72.05 -24.03 61.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.387 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -73.43 52.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.12 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.2 133.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.039 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -169.82 155.6 5.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.432 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.58 ' H ' HD22 ' A' ' 255' ' ' LEU . 1.5 mm? -61.78 132.5 53.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.6 t -172.45 133.69 0.64 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.087 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.57 179.117 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.823 0.344 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.08 165.38 25.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.096 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.4 m -62.82 -45.55 92.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.724 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -94.13 124.12 56.98 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 176' ' ' SER . 60.5 Cg_endo -75.84 -144.25 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.946 2.43 . . . . 0.0 112.625 -176.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 7.9 t -140.28 -39.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 178' ' ' LEU . 8.1 m -114.4 123.78 50.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.66 0.267 . . . . 0.0 110.75 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 177' ' ' SER . 17.0 mt -166.23 -179.41 5.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.741 0.816 . . . . 0.0 109.121 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -82.35 148.01 28.52 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.59 -42.85 62.22 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.876 0.369 . . . . 0.0 110.933 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.579 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -62.49 -41.16 98.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.031 178.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -67.35 -34.63 77.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.502 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.51 ' HE1' HD11 ' A' ' 212' ' ' ILE . 63.3 mtt -58.65 -49.71 76.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.63 HG23 HD21 ' A' ' 202' ' ' LEU . 52.7 mt -63.59 -39.97 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.977 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.5 mt -55.98 -36.94 68.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.506 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 1.9 tppp? -86.28 -32.75 20.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.3 m -70.73 -36.62 73.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.639 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.532 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 4.1 mmt -52.68 -52.11 67.32 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 35.3 Cg_exo -54.31 -33.66 76.94 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.287 1.991 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -67.91 -43.68 78.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.291 0.567 . . . . 0.0 110.394 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 78.8 mt -76.01 107.17 8.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.642 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.79 34.32 23.2 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 59.29 35.15 23.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.955 0.407 . . . . 0.0 110.806 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.72 32.51 70.69 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.395 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -85.8 -41.63 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.231 0.516 . . . . 0.0 110.681 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 247' ' ' LYS . . . 156.27 150.31 5.6 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.848 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 74.7 m -153.64 142.68 21.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.715 0.293 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 9.1 p -62.7 149.51 43.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.631 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.467 ' HA ' ' CD1' ' A' ' 246' ' ' ILE . 54.8 ttp85 -52.41 -43.03 64.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.049 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.3 mt -64.57 -40.35 88.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.22 -46.22 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.975 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.63 HD21 HG23 ' A' ' 184' ' ' ILE . 10.8 tp -62.56 -48.66 78.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.338 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -58.75 -41.72 87.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.914 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -58.5 -41.23 84.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.527 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -72.09 -43.05 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.955 HG12 HG21 ' A' ' 213' ' ' VAL . 99.2 t -60.39 -44.14 95.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.941 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 60.6 mtpt -67.57 -38.99 84.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.419 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.59 -50.27 70.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.809 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.1 p -79.59 -44.93 20.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.096 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.609 ' O ' HG22 ' A' ' 213' ' ' VAL . 21.4 m-85 -103.62 97.68 11.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.628 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 209' ' ' THR . 32.8 Cg_exo -62.79 -15.23 45.58 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.887 2.391 . . . . 0.0 112.942 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.51 HD11 ' HE1' ' A' ' 183' ' ' MET . 14.6 pt -71.81 -35.59 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 0.0 111.285 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.955 HG21 HG12 ' A' ' 206' ' ' VAL . 11.6 m -74.28 -32.71 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.427 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.99 -38.86 97.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.734 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -72.59 -33.79 66.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.819 0.342 . . . . 0.0 111.234 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -66.58 130.52 43.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.98 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.2 m -80.19 -43.87 20.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.159 0.504 . . . . 0.0 110.652 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.509 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 15.2 p-10 -86.66 21.29 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.661 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.0 t80 -61.56 -52.85 62.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -51.24 -40.54 59.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.41 . . . . 0.0 111.42 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -65.3 -52.77 51.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.874 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 57.5 mt -61.22 -37.18 82.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 110.517 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 227' ' ' ILE . 58.4 t80 -54.09 -54.66 36.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.927 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -72.04 -32.15 66.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.9 t -64.08 -41.33 97.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.48 92.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.42 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.597 HD13 HG12 ' A' ' 246' ' ' ILE . 2.3 mt -66.24 -36.26 76.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.689 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -58.49 -34.48 70.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.398 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.46 -38.27 49.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.354 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 181' ' ' LYS . 73.4 m -59.29 -41.64 89.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.782 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -64.0 -42.75 96.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.8 -35.53 67.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.99 0.424 . . . . 0.0 110.203 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 235' ' ' GLU . 9.2 m-80 -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.365 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.16 29.22 41.97 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.848 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.608 ' HG3' ' HB3' ' A' ' 233' ' ' ASN . 29.6 mt-10 -95.71 -47.85 6.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 57.3 mt -118.51 144.83 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.972 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 247' ' ' LYS . 10.5 m -115.2 134.8 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 120.984 0.421 . . . . 0.0 110.105 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.11 81.34 28.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.231 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.439 ' HG2' ' HD3' ' A' ' 247' ' ' LYS . 32.3 Cg_exo -59.19 -39.31 79.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.668 2.245 . . . . 0.0 111.804 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -93.68 29.53 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.691 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 63.17 -164.12 29.24 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.174 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.77 -41.35 8.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.936 2.424 . . . . 0.0 112.706 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.2 p -88.2 58.9 4.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.49 . . . . 0.0 111.263 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -161.66 -134.55 1.66 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.653 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.3 tt -98.17 133.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 111.392 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 227' ' ' ILE . 4.9 mp -97.15 129.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.541 ' HB2' HG23 ' A' ' 237' ' ' VAL . 52.8 mtpt -126.41 138.15 53.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 49.9 tp -71.41 124.76 25.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -60.63 129.59 42.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.425 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.6 ' HG3' HG12 ' A' ' 253' ' ' VAL . 0.1 OUTLIER -167.09 53.64 0.07 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.325 0.583 . . . . 0.0 109.686 -178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -75.04 -39.7 60.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -85.05 117.29 23.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.386 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.6 HG12 ' HG3' ' A' ' 250' ' ' LYS . 20.1 m -128.14 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -169.69 122.15 0.72 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.852 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.79 55.7 3.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.475 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 27.4 t -66.36 -45.3 80.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.018 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.636 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.889 0.376 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.92 -139.2 0.23 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.935 ' HB3' HG22 ' A' ' 209' ' ' THR . 21.7 m -71.66 156.91 38.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 148.79 20.77 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.315 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 176' ' ' SER . 46.5 Cg_endo -69.34 -140.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.463 2.775 . . . . 0.0 113.55 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.632 ' HA ' ' CE2' ' A' ' 210' ' ' TYR . 73.3 m -155.54 177.82 10.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.059 -0.401 . . . . 0.0 110.508 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.6 m 60.77 47.53 7.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 111.076 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.472 HD12 ' OH ' ' A' ' 210' ' ' TYR . 93.7 mt -135.78 159.92 40.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 183' ' ' MET . 2.4 m -66.02 150.98 47.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.737 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -51.91 -42.95 63.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.603 0.239 . . . . 0.0 111.457 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.81 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 23.4 ttpt -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.54 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 52.6 mt-10 -65.32 -32.95 74.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.245 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.524 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 61.2 mtt -57.91 -45.89 85.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 109.583 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 69.6 mt -68.25 -41.16 83.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.235 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.766 HD11 ' HE3' ' A' ' 181' ' ' LYS . 79.8 mt -53.24 -37.65 62.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.61 -33.84 27.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -73.24 -35.62 66.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.829 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.532 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 1.6 mmt -53.36 -54.41 45.56 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.0 Cg_endo -58.82 -29.23 89.39 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.013 1.809 . . . . 0.0 112.205 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.54 -42.07 71.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.647 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.483 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 98.6 mt -74.78 115.05 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.189 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 51.44 42.39 29.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.992 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 56.59 30.82 18.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.9 28.17 67.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.847 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -91.92 -36.24 13.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.851 -0.205 . . . . 0.0 110.987 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 150.23 147.48 4.55 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.963 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 72.6 m -154.6 144.71 21.88 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 64.4 p -62.43 154.4 28.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HA ' HD11 ' A' ' 246' ' ' ILE . 38.4 ttp85 -57.38 -32.25 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.982 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 55.8 mt -68.6 -41.15 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.08 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 42.6 t -64.35 -43.72 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 43.1 tp -62.85 -39.07 93.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.254 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -56.66 -43.24 80.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 10.4 pttp -63.45 -34.28 77.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.566 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.38 -47.45 27.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.206 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 223' ' ' PHE . 48.6 t -56.53 -48.06 80.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -62.6 -44.17 96.98 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.04 -42.42 69.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.81 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.935 HG22 ' HB3' ' A' ' 173' ' ' SER . 39.5 p -73.89 -41.39 62.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.906 0.384 . . . . 0.0 111.099 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 176' ' ' SER . 19.8 m-85 -110.75 98.87 39.61 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.139 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.71 -32.88 85.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.736 2.291 . . . . 0.0 111.975 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.3 pt -64.74 -39.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.18 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 210' ' ' TYR . 5.4 p -77.35 -28.97 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 110.687 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.94 95.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.948 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.0 p -97.82 33.95 1.99 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.894 0.378 . . . . 0.0 111.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.92 142.98 31.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.601 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.1 m -65.8 -60.53 2.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.888 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 221' ' ' TYR . 79.2 m-20 -92.99 48.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 213' ' ' VAL . 9.5 t80 -53.6 -63.17 1.23 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.243 -175.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -64.94 -33.58 76.38 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.37 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.661 ' HB3' ' HB3' ' A' ' 218' ' ' ASN . 93.1 t80 -61.4 -54.66 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.789 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 75.2 mt -66.95 -35.55 80.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.559 ' CE1' HG21 ' A' ' 206' ' ' VAL . 17.1 t80 -62.91 -48.19 80.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.012 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.45 -34.18 77.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.561 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.2 t -62.34 -39.45 93.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.092 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.28 96.4 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.6 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 223' ' ' PHE . 6.9 mm -59.95 -46.31 94.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.319 0.58 . . . . 0.0 111.034 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.72 -36.2 78.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.356 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -73.31 -42.35 62.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.892 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 236' ' ' LEU . 16.7 p -60.43 -39.24 86.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.224 -0.297 . . . . 0.0 111.211 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.44 -42.28 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.28 -36.21 74.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.986 0.422 . . . . 0.0 110.792 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -68.35 -27.54 66.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.989 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.65 29.37 29.7 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.805 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.81 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 11.9 mm-40 -84.79 -48.28 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.531 HD12 ' SG ' ' A' ' 230' ' ' CYS . 19.0 mt -125.55 154.82 41.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.806 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 247' ' ' LYS . 8.5 m -115.09 132.46 64.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.566 ' NE2' HG12 ' A' ' 246' ' ' ILE . 47.1 mt-30 -121.57 93.58 48.68 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.985 0.422 . . . . 0.0 110.859 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 27.8 Cg_endo -64.21 -38.17 37.18 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.918 2.412 . . . . 0.0 112.712 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -100.82 32.51 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.079 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 70.5 -175.3 37.16 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.301 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.24 -42.96 45.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.201 2.601 . . . . 0.0 112.708 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 m -84.18 42.67 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -145.76 -148.04 4.72 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.474 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 198' ' ' SER . 18.1 tt -82.38 123.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.507 0.67 . . . . 0.0 111.258 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.566 HG12 ' NE2' ' A' ' 238' ' ' GLN . 9.4 mt -94.2 116.52 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.812 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.697 ' HB2' HG23 ' A' ' 237' ' ' VAL . 53.5 mtpt -109.52 133.69 52.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.594 0.235 . . . . 0.0 110.483 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 63.4 tp -68.59 114.57 7.1 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.595 ' HB2' HG13 ' A' ' 237' ' ' VAL . 32.3 t30 -69.55 86.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -87.7 42.01 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.366 0.603 . . . . 0.0 110.278 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -70.52 -23.07 62.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.082 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt 68.77 27.43 5.79 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.24 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 254' ' ' LYS . 3.5 t 55.76 36.41 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.33 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER 64.56 146.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.332 1.053 . . . . 0.0 111.604 -177.123 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.518 ' HB3' ' H ' ' A' ' 256' ' ' SER . 4.5 mm? -78.35 -143.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.475 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 255' ' ' LEU . 22.1 m 63.33 35.21 12.51 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.581 0.705 . . . . 0.0 110.12 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.798 -179.354 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.6 m . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 120.509 0.195 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.636 ' HG2' HD11 ' A' ' 178' ' ' LEU . 67.4 Cg_endo -75.04 -144.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.939 2.426 . . . . 0.0 112.384 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 27.1 m -151.71 156.2 39.84 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.1 m 60.74 36.57 19.33 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.49 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.636 HD11 ' HG2' ' A' ' 175' ' ' PRO . 87.9 mt -91.24 172.89 8.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.581 173.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 182' ' ' GLU . 63.6 p -71.2 154.37 41.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.504 ' CE2' ' HD1' ' A' ' 219' ' ' PHE . 3.0 m-85 -58.42 -32.41 68.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.702 0.286 . . . . 0.0 110.33 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 27.9 ttpp -62.47 -53.63 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.805 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 70.1 mm-40 -61.77 -34.35 75.71 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.517 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 212' ' ' ILE . 62.0 mtt -57.77 -47.37 82.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.581 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 202' ' ' LEU . 52.8 mt -69.09 -42.51 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.466 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 235' ' ' GLU . 88.3 mt -59.55 -25.6 64.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.438 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.537 ' HG2' ' HD2' ' A' ' 175' ' ' PRO . 55.5 tptt -83.22 -41.21 18.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.916 0.389 . . . . 0.0 110.698 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.2 p -76.42 -34.86 58.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.146 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 0.0 OUTLIER -52.05 -54.86 36.34 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -176.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 188' ' ' MET . 19.4 Cg_endo -58.85 -22.95 64.88 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.247 1.964 . . . . 0.0 112.473 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -75.54 -44.79 41.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.81 112.39 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.302 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 53.81 38.86 29.52 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 53.32 33.48 15.75 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.012 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 73.73 14.89 79.6 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.282 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -72.56 -38.71 67.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 149.36 146.51 4.34 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.055 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 43.4 p -150.5 145.57 26.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.683 0.277 . . . . 0.0 110.797 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 201' ' ' VAL . 29.0 t -57.95 152.13 16.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.083 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.453 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 50.8 ttp180 -56.13 -38.86 71.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.12 -46.21 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.742 0.305 . . . . 0.0 110.747 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 198' ' ' SER . 42.7 t -60.55 -47.04 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 184' ' ' ILE . 9.0 tp -64.08 -51.16 65.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.967 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -56.28 -48.26 76.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.033 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -37.19 74.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.224 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -75.75 -45.69 35.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.059 0.457 . . . . 0.0 110.409 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.912 HG12 HG21 ' A' ' 213' ' ' VAL . 68.6 t -60.73 -47.77 91.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.563 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.753 ' HA ' HG23 ' A' ' 213' ' ' VAL . 27.4 mtpp -64.76 -33.84 76.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.71 -47.72 37.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.686 0.279 . . . . 0.0 111.408 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 28.5 p -78.34 -30.72 48.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 111.231 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 213' ' ' VAL . 83.0 m-85 -109.53 91.75 10.74 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.08 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 209' ' ' THR . 54.3 Cg_exo -55.24 -26.61 52.63 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.094 2.53 . . . . 0.0 113.704 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 183' ' ' MET . 43.9 pt -69.19 -37.72 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.694 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.912 HG21 HG12 ' A' ' 206' ' ' VAL . 3.6 m -79.52 -23.16 12.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.369 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.537 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -69.27 -45.02 62.85 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -69.79 -38.94 76.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 0.0 110.796 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.09 120.92 16.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.6 m -80.67 -34.79 34.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.961 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -67.87 -20.82 65.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.863 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 10.0 t80 -48.0 -48.23 32.77 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.51 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -54.6 -35.94 63.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.778 -171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.02 -46.93 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 110.312 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.42 -32.2 72.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.607 ' O ' HG13 ' A' ' 227' ' ' ILE . 50.0 t80 -57.51 -50.41 73.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.384 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.66 -37.46 87.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.571 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.1 t -66.88 -38.33 86.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.831 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.23 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.711 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -63.98 -42.43 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 231' ' ' VAL . 39.1 ttmt -57.37 -39.04 75.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 32.0 tptt -73.3 -34.95 66.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.213 0.53 . . . . 0.0 110.324 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.4 m -66.4 -39.58 89.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.167 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.0 m -64.62 -39.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.69 -30.88 64.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.077 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.464 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 7.0 m-80 -77.61 -16.92 58.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.41 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 76.54 19.39 78.09 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.432 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.683 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.3 mm-40 -79.85 -51.01 9.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 55.4 mt -120.24 153.16 36.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.413 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 247' ' ' LYS . 5.8 m -127.69 132.78 68.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.04 0.448 . . . . 0.0 110.672 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.2 OUTLIER -125.67 92.76 45.86 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.809 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -65.65 -35.98 35.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.066 2.511 . . . . 0.0 113.166 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.523 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 15.0 mptt -71.39 -51.79 22.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.335 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 140.85 -134.34 6.35 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.03 -53.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.549 2.166 . . . . 0.0 111.259 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.2 m -99.05 125.47 44.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.363 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . 172.45 -114.9 0.54 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.961 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.7 tt -153.23 122.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.164 0.507 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 227' ' ' ILE . 4.2 mp -85.46 117.77 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.802 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.73 ' HB2' HG23 ' A' ' 237' ' ' VAL . 45.3 mtpt -103.95 136.15 44.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.636 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 2.8 tm? -76.02 96.87 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.735 0.303 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.94 33.38 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.272 2.648 . . . . 0.0 113.641 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.0 t 68.45 -64.95 0.29 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.377 0.671 . . . . 0.0 112.048 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.4 t -162.82 142.58 9.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 30.4 mt -157.89 -179.81 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 183' ' ' MET . 3.2 m -70.83 149.3 46.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.42 ' CZ ' HG12 ' A' ' 213' ' ' VAL . 3.0 m-85 -49.74 -40.78 42.05 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.679 0.276 . . . . 0.0 111.221 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.484 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 26.0 ttpp -64.06 -45.59 88.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 79.9 mt-10 -65.95 -33.95 77.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.352 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 179' ' ' THR . 63.3 mtt -52.36 -53.18 48.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.056 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 202' ' ' LEU . 55.8 mt -66.35 -43.86 91.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 98.1 mt -54.96 -40.17 69.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -81.46 -28.95 33.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 110.547 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.9 t -71.55 -32.74 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.673 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.447 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 1.5 mmt -52.71 -54.29 44.84 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.5 Cg_endo -58.99 -25.61 78.32 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.873 1.716 . . . . 0.0 112.644 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -73.34 -49.11 29.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.21 132.96 35.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.241 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 53.23 33.49 15.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.572 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 54.02 31.8 14.31 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.773 0.429 . . . . 0.0 112.148 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 65.02 29.64 75.92 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 113.088 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -94.65 -42.01 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.064 0.459 . . . . 0.0 110.55 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 156.08 132.41 1.52 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.1 m -126.07 141.51 51.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.744 0.272 . . . . 0.0 110.618 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.8 p -67.8 147.12 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.18 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.474 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 72.8 ttt180 -51.02 -39.25 55.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.894 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 74.0 mt -65.34 -43.79 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.443 0.163 . . . . 0.0 111.141 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.74 -46.87 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.145 0.498 . . . . 0.0 110.843 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 184' ' ' ILE . 27.3 tp -65.44 -45.9 82.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.003 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.56 -45.02 85.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.402 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 205' ' ' TYR . 0.1 OUTLIER -54.98 -44.71 74.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.773 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.554 ' N ' ' HG2' ' A' ' 204' ' ' LYS . 44.0 t80 -72.73 -46.81 51.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 1.031 HG12 HG21 ' A' ' 213' ' ' VAL . 53.1 t -57.92 -44.32 86.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 213' ' ' VAL . 49.5 mtpt -63.92 -41.49 97.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.98 -50.61 47.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.925 0.393 . . . . 0.0 111.238 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 23.2 p -72.17 -43.88 63.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.966 -175.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.586 ' O ' HG22 ' A' ' 213' ' ' VAL . 28.1 m-85 -104.98 102.4 35.57 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.74 0.305 . . . . 0.0 110.225 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.1 Cg_exo -64.74 -14.45 44.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.873 2.382 . . . . 0.0 112.399 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.7 -46.01 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.053 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.031 HG21 HG12 ' A' ' 206' ' ' VAL . 5.5 m -77.14 -30.79 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.91 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.27 97.86 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.72 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.0 m -74.12 -33.73 63.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.114 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.29 126.05 25.96 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 111.413 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.4 p -75.97 -45.78 33.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.273 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 59.3 t30 -92.65 39.61 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.694 0.759 . . . . 0.0 110.016 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.62 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 8.3 t80 -65.13 -48.76 72.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.758 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -50.53 -42.53 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.448 -172.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -63.26 -47.84 80.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.725 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 55.6 mt -62.55 -40.5 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.2 0.524 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 227' ' ' ILE . 39.8 t80 -56.62 -52.52 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.364 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.82 -31.41 72.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 69.2 m -65.55 -39.94 92.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.854 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 181' ' ' LYS . . . -61.12 -45.6 94.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.214 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -66.25 -38.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -57.81 -32.4 67.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.206 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -75.65 -47.73 25.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 109.785 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 97.9 m -55.48 -42.66 74.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.36 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -63.49 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.625 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.6 -37.1 60.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.936 0.398 . . . . 0.0 110.434 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -74.42 -9.08 58.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 70.68 33.08 66.93 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.1 -51.14 4.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 66.0 mt -117.18 138.1 51.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.896 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' A' ' 249' ' ' ASN . 4.8 m -109.25 126.54 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.343 0.592 . . . . 0.0 110.659 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 239' ' ' PRO . 58.9 mt-30 -119.34 99.75 50.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.492 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 9.9 Cg_endo -57.26 -50.48 10.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.204 2.603 . . . . 0.0 113.091 -174.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.33 -56.61 4.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.24 -150.48 18.82 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.489 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.5 -45.85 34.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.971 2.448 . . . . 0.0 112.247 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.9 t -92.07 121.72 33.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.97 -143.04 9.66 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.242 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 21.2 tt -108.03 134.72 49.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.077 0.465 . . . . 0.0 111.019 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 236' ' ' LEU . 4.7 mp -98.61 108.25 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.916 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.624 ' HB2' HG23 ' A' ' 237' ' ' VAL . 39.5 mtmt -100.67 135.06 42.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.27 113.53 9.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.646 ' HB2' HG13 ' A' ' 237' ' ' VAL . 38.4 t30 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.371 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 178' ' ' LEU . 72.3 Cg_endo -77.6 -140.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.82 2.346 . . . . 0.0 112.535 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.636 ' HA ' ' CD2' ' A' ' 210' ' ' TYR . 21.7 t -155.65 -163.44 1.51 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.5 p 49.9 37.43 13.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.293 0.637 . . . . 0.0 111.255 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 175' ' ' PRO . 88.5 mt -114.37 149.68 35.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.652 ' HB ' ' OE1' ' A' ' 182' ' ' GLU . 12.3 m -64.52 154.89 34.65 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -45.78 -52.03 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.591 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 pttm -67.81 -37.58 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.924 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.652 ' OE1' ' HB ' ' A' ' 179' ' ' THR . 18.3 mp0 -57.65 -38.27 74.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 179' ' ' THR . 46.5 mtm -58.04 -49.16 77.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.8 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 188' ' ' MET . 37.0 mt -63.45 -45.18 98.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.095 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 95.4 mt -52.58 -43.31 65.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.375 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 3.2 tppp? -78.91 -35.98 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.6 m -68.49 -36.1 78.45 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.655 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 84.9 mmm -52.53 -55.64 30.3 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 39.2 Cg_exo -56.99 -28.82 80.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.194 1.929 . . . . 0.0 112.478 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 49.3 mm-40 -74.48 -40.85 61.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.682 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 77.0 mt -85.51 114.86 22.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.712 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 68.71 -59.25 0.47 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.833 0.708 . . . . 0.0 111.541 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 189' ' ' PRO . 4.0 t70 175.86 -36.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.783 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 140.21 -19.04 2.87 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.701 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.45 -43.05 67.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.712 -0.744 . . . . 0.0 112.171 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 172.75 137.35 2.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.809 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.0 m -141.6 136.26 30.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 53.5 p -68.15 153.1 44.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.691 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -63.37 -29.77 71.01 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.4 -47.74 89.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.76 -48.36 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.893 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 25.2 tp -62.27 -48.63 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.847 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.653 ' HA ' HG22 ' A' ' 206' ' ' VAL . 38.1 ttpt -66.77 -37.32 84.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -61.26 -35.28 76.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.513 0.673 . . . . 0.0 110.432 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -77.53 -51.34 10.87 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.467 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 203' ' ' LYS . 33.4 m -58.68 -42.52 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.018 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.578 ' HA ' HG23 ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.22 -40.26 95.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.69 -41.43 31.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 25.7 p -83.05 -38.5 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.297 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 17.0 m-85 -101.56 101.01 15.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.6 Cg_exo -65.89 -10.74 28.01 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.051 2.501 . . . . 0.0 112.703 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 213' ' ' VAL . 22.4 pt -69.06 -34.65 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 212' ' ' ILE . 35.0 m -102.36 -24.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.12 62.46 1.72 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.678 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.8 t -171.33 -48.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.682 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.06 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.1 p -77.12 -35.5 56.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.32 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.26 -6.05 36.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.953 0.406 . . . . 0.0 110.751 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -55.0 -36.99 66.02 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.391 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.43 -46.37 69.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -67.63 -47.51 69.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.944 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.12 -40.42 95.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 111.047 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 14.6 t80 -61.31 -50.34 73.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.077 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -58.97 -36.93 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.86 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.2 m -62.52 -40.04 95.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.864 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.17 96.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.852 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -64.54 -43.54 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.233 0.539 . . . . 0.0 110.098 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 231' ' ' VAL . 38.5 ttpt -61.94 -31.69 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.707 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -71.96 -34.29 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.637 0.732 . . . . 0.0 109.671 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 233' ' ' ASN . 71.8 m -72.52 -33.11 66.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.419 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 228' ' ' LYS . 26.6 m -63.5 -38.51 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.227 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.54 -33.49 64.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.965 0.412 . . . . 0.0 110.159 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 230' ' ' CYS . 7.8 m-80 -62.97 -33.96 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.91 18.72 53.67 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.339 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 235' ' ' GLU . 23.1 mm-40 -95.38 -39.89 9.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 2.8 mm? -119.23 140.45 50.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.417 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.7 m -118.45 136.04 56.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.043 0.449 . . . . 0.0 110.733 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.67 93.85 48.57 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.38 -38.6 25.59 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.11 2.54 . . . . 0.0 112.828 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.413 ' HG2' HG22 ' A' ' 245' ' ' ILE . 33.2 mmtp -68.57 -42.33 78.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.181 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 150.6 -127.64 2.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.68 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.415 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 31.7 Cg_endo -63.83 -29.5 68.0 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.735 2.29 . . . . 0.0 111.9 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.6 m -143.16 -123.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.054 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.51 -63.79 3.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.285 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.413 HG22 ' HG2' ' A' ' 240' ' ' LYS . 19.5 tt -168.58 130.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.512 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.438 HG12 HD13 ' A' ' 227' ' ' ILE . 5.2 mp -92.81 127.1 45.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.237 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.75 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.5 mtpp -118.65 132.14 56.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.558 0.218 . . . . 0.0 110.575 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.3 tp -75.48 105.96 6.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 237' ' ' VAL . 58.1 t30 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.42 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 3.2 m . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.6 ' HG2' HD11 ' A' ' 178' ' ' LEU . 7.4 Cg_exo -75.19 -134.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.86 2.374 . . . . 0.0 112.283 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 13.5 p -152.69 -47.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.3 m -77.21 70.16 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 111.513 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.737 HD22 ' HG2' ' A' ' 182' ' ' GLU . 69.9 mt -142.66 155.12 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.236 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 183' ' ' MET . 35.2 p -64.92 152.06 44.09 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -60.53 -31.54 70.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.783 0.325 . . . . 0.0 110.597 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.585 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 50.6 tttm -61.12 -48.2 82.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.51 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.737 ' HG2' HD22 ' A' ' 178' ' ' LEU . 20.4 tp10 -63.45 -37.45 87.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.64 176.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.446 ' HE1' HD11 ' A' ' 212' ' ' ILE . 64.2 mtt -57.82 -50.91 71.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.565 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 202' ' ' LEU . 60.5 mt -64.75 -45.16 95.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.032 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 235' ' ' GLU . 81.6 mt -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.012 0.434 . . . . 0.0 110.794 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -78.14 -38.74 43.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.8 p -78.83 -27.52 44.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.249 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.507 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 2.6 mmt -49.01 -53.86 34.07 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.2 Cg_endo -58.34 -28.79 86.01 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.117 1.878 . . . . 0.0 112.578 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -73.13 -39.8 65.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 109.78 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.01 92.89 9.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.437 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.15 32.75 21.03 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.83 32.78 12.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.992 0.425 . . . . 0.0 111.588 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.84 18.16 68.19 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.273 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 247' ' ' LYS . 66.3 mttm -74.37 -38.45 63.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.267 0.534 . . . . 0.0 109.883 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 167.54 123.68 0.68 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.796 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.401 ' C ' HG13 ' A' ' 245' ' ' ILE . 50.7 m -140.65 138.27 34.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.618 0.247 . . . . 0.0 110.685 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 201' ' ' VAL . 14.5 p -61.65 148.98 40.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -54.76 -37.38 65.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.402 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -50.29 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.64 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 198' ' ' SER . 8.5 p -69.23 -35.88 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.809 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.657 HD21 HG23 ' A' ' 184' ' ' ILE . 17.3 tp -64.71 -51.13 64.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.338 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 219' ' ' PHE . 27.9 ttpp -58.85 -40.78 85.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -59.07 -46.23 88.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.935 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -71.04 -43.35 68.04 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.237 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.858 HG12 HG21 ' A' ' 213' ' ' VAL . 19.8 t -57.54 -42.26 80.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.977 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.92 -44.31 89.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.778 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.95 -46.01 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.295 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.6 p -74.66 -43.51 54.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.335 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.661 ' O ' HG22 ' A' ' 213' ' ' VAL . 49.2 m-85 -109.82 89.85 8.39 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.14 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 209' ' ' THR . 34.5 Cg_exo -60.16 -15.83 36.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.891 2.394 . . . . 0.0 112.877 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.446 HD11 ' HE1' ' A' ' 183' ' ' MET . 28.5 pt -67.89 -32.89 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.877 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.858 HG21 HG12 ' A' ' 206' ' ' VAL . 4.2 m -76.81 -31.25 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.036 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -66.26 -40.43 94.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.631 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.7 t -71.35 -36.22 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.701 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.96 44.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.938 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -75.35 -50.41 16.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 110.976 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 50.2 t30 -90.07 38.52 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.472 0.654 . . . . 0.0 110.603 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.673 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.5 t80 -64.69 -48.52 74.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.562 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.42 -41.48 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.548 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.08 -45.29 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.0 110.549 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 77.8 mt -62.32 -37.77 86.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.192 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 227' ' ' ILE . 42.8 t80 -59.83 -49.56 77.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.973 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 242' ' ' PRO . 3.1 t-20 -57.02 -42.79 81.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.949 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.4 m -65.43 -37.87 88.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.73 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.66 86.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -62.23 -45.16 99.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.114 0.483 . . . . 0.0 110.022 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -56.42 -40.99 75.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.791 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -73.81 -43.12 59.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.367 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.66 ' HB3' ' HB2' ' A' ' 236' ' ' LEU . 73.8 m -59.02 -41.92 88.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.532 0.206 . . . . 0.0 111.428 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 30.0 m -69.18 -43.17 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.31 -34.8 75.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.899 0.381 . . . . 0.0 110.447 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -64.79 -24.7 67.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.526 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.44 27.66 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 185' ' ' LEU . 5.5 mm-40 -108.49 -26.22 10.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.322 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 230' ' ' CYS . 14.1 tp -141.57 156.37 45.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.452 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 249' ' ' ASN . 2.1 t -133.17 136.14 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.979 0.418 . . . . 0.0 110.351 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.8 OUTLIER -145.67 102.84 4.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 16.6 Cg_endo -61.38 -26.02 80.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.184 2.589 . . . . 0.0 113.0 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -104.82 28.85 6.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 242' ' ' PRO . . . 65.2 -122.58 23.94 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.8 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.47 ' HB3' ' ND2' ' A' ' 224' ' ' ASN . 7.5 Cg_exo -75.48 -57.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.918 2.412 . . . . 0.0 112.463 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 p -91.94 127.86 37.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.51 -144.55 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.23 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.401 HG13 ' C ' ' A' ' 197' ' ' SER . 13.0 tt -110.35 121.86 63.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.341 0.591 . . . . 0.0 110.521 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.462 ' HA ' ' HG2' ' A' ' 238' ' ' GLN . 3.1 mp -85.48 130.0 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.11 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 195' ' ' LYS . 50.6 mtpt -127.51 132.04 50.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.86 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 236' ' ' LEU . 2.7 tt -70.72 123.53 22.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.425 ' HB3' HG23 ' A' ' 237' ' ' VAL . 6.4 p-10 . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.378 0.609 . . . . 0.0 110.937 -173.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 9.0 p . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.851 0.358 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.25 138.82 12.83 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.799 2.333 . . . . 0.0 112.254 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.5 t -75.44 -172.2 1.72 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.4 m 59.61 55.04 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.253 0.549 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 40.4 mt -149.63 158.33 44.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.843 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 182' ' ' GLU . 5.6 t -64.76 157.65 26.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.448 ' HA ' ' SD ' ' A' ' 183' ' ' MET . 3.5 m-30 -57.35 -27.75 62.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 55.9 tttm -65.53 -47.6 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.572 ' H ' HG23 ' A' ' 179' ' ' THR . 65.5 mm-40 -60.87 -38.77 86.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.973 0.416 . . . . 0.0 110.82 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.465 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 58.2 mtt -55.98 -48.31 76.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 180' ' ' TYR . 23.7 mt -70.33 -37.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.749 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 86.2 mt -54.75 -45.68 74.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 17.5 tppt? -70.84 -39.53 72.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.418 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 51.0 m -72.57 -32.75 66.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 0.5 OUTLIER -51.79 -51.89 66.13 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 188' ' ' MET . 23.9 Cg_endo -63.44 -30.12 71.95 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.841 1.694 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 66.0 mt-30 -66.7 -36.15 81.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.13 113.85 26.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 54.74 37.7 28.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.78 30.98 9.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.487 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.01 24.08 75.91 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.265 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.82 -41.68 25.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.38 0.609 . . . . 0.0 110.144 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.49 136.34 2.17 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.383 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.404 ' C ' HG13 ' A' ' 245' ' ' ILE . 41.8 m -139.88 139.79 36.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.989 0.423 . . . . 0.0 110.795 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.1 p -62.26 155.65 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.264 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HD2' ' HA ' ' A' ' 243' ' ' SER . 54.2 ttt85 -53.35 -41.52 65.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.55 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.82 -44.56 98.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.646 0.26 . . . . 0.0 111.143 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 76.0 t -63.94 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.369 . . . . 0.0 111.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.523 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 24.2 tp -68.34 -46.81 69.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 207' ' ' LYS . 38.1 ttpt -62.06 -43.34 99.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 50.6 pttt -62.43 -32.59 73.47 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.396 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -78.23 -45.5 22.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.145 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.798 HG12 HG21 ' A' ' 213' ' ' VAL . 40.1 t -59.08 -43.37 89.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.484 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HE3' ' HA2' ' A' ' 214' ' ' GLY . 46.6 mtpt -67.0 -41.17 87.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.364 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.76 -42.32 81.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.3 p -77.54 -37.17 51.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.607 ' O ' HG22 ' A' ' 213' ' ' VAL . 63.7 m-85 -113.79 95.35 37.01 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.52 -17.25 40.3 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.904 2.403 . . . . 0.0 112.519 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.6 pt -71.67 -39.15 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.052 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.798 HG21 HG12 ' A' ' 206' ' ' VAL . 6.1 m -74.36 -29.72 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.02 0.438 . . . . 0.0 110.077 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.583 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -63.35 -29.43 74.51 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.745 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.0 m -95.45 48.26 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -148.47 128.9 13.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.787 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.4 t -78.75 -41.82 29.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.142 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.436 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.0 p-10 -88.76 20.07 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.673 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 5.2 t80 -59.34 -51.07 71.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -52.54 -40.79 62.9 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.237 0.335 . . . . 0.0 111.207 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -67.01 -48.71 67.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.177 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 63.2 mt -62.39 -36.32 81.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 110.243 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.523 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 21.9 t80 -59.41 -48.88 79.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.723 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.557 ' HB2' HH22 ' A' ' 199' ' ' ARG . 3.0 t-20 -59.47 -41.72 90.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.449 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.5 t -65.24 -37.27 86.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.876 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.36 90.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -68.25 -39.23 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.417 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 231' ' ' VAL . 40.1 ttmt -55.12 -42.25 72.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -66.63 -38.56 87.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 110.499 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 78.0 m -64.32 -38.78 92.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.013 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 228' ' ' LYS . 18.2 m -65.63 -37.65 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.491 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.75 -46.03 55.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.468 0.651 . . . . 0.0 109.312 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 8.4 m-80 -60.5 -30.53 69.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.42 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 87.27 31.9 15.47 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 233' ' ' ASN . 22.7 mm-40 -97.02 -49.16 5.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.0 109.025 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 9.8 mp -122.83 142.04 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.882 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.2 m -118.19 134.29 62.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.14 0.495 . . . . 0.0 111.169 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -125.76 79.92 67.52 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.753 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -53.75 -46.13 35.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.397 2.731 . . . . 0.0 112.973 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.482 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 63.3 mttm -71.96 -54.65 9.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.95 -162.86 36.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.825 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.88 -41.13 65.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.287 2.658 . . . . 0.0 112.615 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 199' ' ' ARG . 2.7 p -90.96 6.64 43.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.176 0.512 . . . . 0.0 110.628 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . -84.29 164.96 40.64 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.35 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 197' ' ' SER . 15.4 tt -59.26 128.77 20.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.428 ' CG2' HD23 ' A' ' 236' ' ' LEU . 4.6 mp -86.59 119.83 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.8 mtpp -114.46 136.51 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.346 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.77 117.11 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.568 ' HB2' HG13 ' A' ' 237' ' ' VAL . 52.4 t30 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 209' ' ' THR . 27.7 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 178' ' ' LEU . 9.1 Cg_exo -72.17 -136.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.076 2.518 . . . . 0.0 112.285 -178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.69 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 44.7 m -155.35 -46.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.248 -0.283 . . . . 0.0 111.281 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.3 m -76.43 63.06 1.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 175' ' ' PRO . 91.2 mt -132.04 156.27 46.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.0 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -63.65 145.64 55.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.74 -36.92 38.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 24.3 ttpp -63.18 -53.18 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.545 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -57.91 -37.13 73.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.963 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.472 ' HB3' ' HE2' ' A' ' 183' ' ' MET . 48.5 mtp -57.59 -53.19 60.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.424 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 202' ' ' LEU . 57.5 mt -62.59 -53.44 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.932 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 181' ' ' LYS . 10.7 mp -52.29 -32.13 36.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.855 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -74.36 -42.17 59.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.909 0.385 . . . . 0.0 111.217 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.1 p -78.33 -28.01 47.21 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.502 ' HE1' ' O ' ' A' ' 246' ' ' ILE . 60.7 mmm -52.24 -50.77 77.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -60.68 -18.15 53.62 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.034 1.823 . . . . 0.0 112.95 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.453 HE21 ' HG2' ' A' ' 189' ' ' PRO . 60.4 mm-40 -77.13 -48.56 17.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.337 0.589 . . . . 0.0 109.957 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 205' ' ' TYR . 68.3 mt -71.79 121.4 18.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.331 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 52.02 36.58 19.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 55.1 30.98 15.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.24 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 68.78 25.73 75.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.238 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -84.43 -39.34 19.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 109.993 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 168.85 132.6 1.45 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.0 m -116.66 126.38 53.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.082 0.441 . . . . 0.0 110.892 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 201' ' ' VAL . 2.7 p -65.05 150.73 47.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.577 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -50.22 -42.74 52.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.599 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.86 -49.43 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.611 HG23 ' HE2' ' A' ' 204' ' ' LYS . 9.6 p -63.63 -35.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.591 0.234 . . . . 0.0 110.869 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 184' ' ' ILE . 22.7 tp -69.97 -49.09 55.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.863 0.363 . . . . 0.0 110.187 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.4 -43.72 92.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.336 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.611 ' HE2' HG23 ' A' ' 201' ' ' VAL . 50.9 pttt -66.46 -37.98 86.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.386 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.408 ' CG ' HD21 ' A' ' 191' ' ' LEU . 10.0 t80 -70.88 -44.74 65.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 109.719 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.791 HG12 HG21 ' A' ' 213' ' ' VAL . 23.0 t -59.55 -44.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.286 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.744 ' HA ' HG23 ' A' ' 213' ' ' VAL . 43.6 mtpt -62.94 -45.2 93.62 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.36 -47.41 49.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.522 -175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 174' ' ' SER . 6.6 m -70.91 -45.29 64.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.121 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.69 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 28.1 m-85 -103.67 103.76 38.32 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 209' ' ' THR . 31.6 Cg_exo -64.75 -15.14 48.66 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.095 2.53 . . . . 0.0 113.127 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.3 mt -67.05 -45.22 87.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.624 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.791 HG21 HG12 ' A' ' 206' ' ' VAL . 23.2 m -72.8 -31.23 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.382 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.512 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.45 -42.02 99.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.551 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.4 m -71.83 -34.58 69.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.715 -0.242 . . . . 0.0 111.252 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -62.59 125.42 23.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 0.0 111.433 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.6 m -76.22 -43.18 43.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.991 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 34.1 t30 -95.01 36.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.534 0.683 . . . . 0.0 110.181 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.709 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 3.4 t80 -62.05 -48.9 78.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.518 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.85 -43.05 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.899 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -62.2 -46.72 87.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.258 . . . . 0.0 110.628 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 59.3 mt -63.75 -40.22 96.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.536 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 28.2 t80 -61.1 -54.42 44.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.57 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -63.99 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 47.9 t -61.83 -40.81 96.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.09 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.666 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.2 mt -67.83 -39.04 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -55.97 -40.25 72.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.32 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' SER . 93.3 mttt -73.0 -40.02 65.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.174 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.672 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 84.8 m -58.29 -45.71 87.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.025 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 34.8 m -64.15 -37.46 79.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -77.15 -37.07 54.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.424 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.5 -30.51 67.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.51 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.35 25.8 20.24 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 46.9 mm-40 -85.17 -49.05 8.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.334 0.588 . . . . 0.0 109.434 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 45.0 mt -127.23 145.09 50.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.843 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 249' ' ' ASN . 6.5 m -114.71 129.15 71.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.044 0.45 . . . . 0.0 110.346 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.86 97.13 50.14 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.687 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.6 -41.21 66.51 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 123.043 2.495 . . . . 0.0 112.272 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 240' ' ' LYS . 3.6 mptp? -80.95 -69.8 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 0.0 110.278 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 167.5 -156.65 28.54 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.11 -48.61 20.65 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.066 2.511 . . . . 0.0 112.671 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 7.9 t -89.49 55.11 3.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.263 0.554 . . . . 0.0 109.833 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -152.87 162.33 29.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.653 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.3 tt -57.04 125.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.526 0.679 . . . . 0.0 111.971 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 236' ' ' LEU . 4.8 mp -87.9 123.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.309 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.534 ' HB2' HG23 ' A' ' 237' ' ' VAL . 58.1 mtpt -112.28 137.12 50.86 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.98 113.51 9.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.553 ' HB2' HG13 ' A' ' 237' ' ' VAL . 46.5 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 120.864 0.364 . . . . 0.0 110.269 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.609 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 18.9 m . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 186' ' ' LYS . 43.5 Cg_endo -70.25 -143.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.031 2.488 . . . . 0.0 113.172 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 50.8 m -153.08 161.87 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.09 -0.381 . . . . 0.0 110.722 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.6 m 62.14 49.99 4.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.55 0.69 . . . . 0.0 111.214 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 51.6 mt -129.35 163.09 26.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.349 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 182' ' ' GLU . 1.9 m -63.0 150.5 42.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -54.57 -37.28 65.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.67 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 39.1 ttpt -60.42 -46.45 89.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.033 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 55.6 mm-40 -61.45 -33.67 74.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.422 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 60.6 mtt -58.15 -49.52 76.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 58.8 mt -68.94 -43.35 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 87.6 mt -53.33 -39.52 64.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 47.6 tptt -73.74 -42.06 61.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 m -69.21 -30.04 68.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.33 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.65 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 5.1 mmt -51.63 -57.7 13.58 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 32.1 Cg_exo -59.1 -28.33 87.5 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.12 1.88 . . . . 0.0 112.127 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -71.06 -39.6 72.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.15 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.446 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 51.89 35.34 15.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.057 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 54.78 34.92 22.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.588 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.73 19.22 69.12 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.759 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -75.96 -41.72 50.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.3 0.55 . . . . 0.0 110.251 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 247' ' ' LYS . . . 167.82 145.9 4.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 m -143.69 133.42 23.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.879 0.34 . . . . 0.0 110.793 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.2 t -61.19 144.82 53.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.204 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.572 HH12 ' HB2' ' A' ' 224' ' ' ASN . 46.3 ttm-85 -53.89 -38.71 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 110.419 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.14 -49.67 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.0 -34.44 45.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.714 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 28.8 tp -66.17 -49.91 65.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 219' ' ' PHE . 38.6 ttpt -59.67 -36.47 76.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -57.34 -45.87 83.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.15 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.27 -44.47 65.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.478 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.635 HG21 ' HE1' ' A' ' 223' ' ' PHE . 46.3 t -56.49 -45.86 82.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.626 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 7.7 mtpm? -66.43 -43.44 85.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 175.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.52 -41.56 96.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.496 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.494 ' CB ' ' HB2' ' A' ' 174' ' ' SER . 18.7 p -79.67 -42.89 23.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 213' ' ' VAL . 16.4 m-85 -106.88 102.58 43.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.92 -31.94 84.74 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.546 2.164 . . . . 0.0 111.509 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.12 -37.04 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.774 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.699 HG22 ' CE1' ' A' ' 219' ' ' PHE . 4.1 p -82.25 -36.32 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -82.03 41.1 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.507 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.9 t -160.23 51.89 0.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.323 0.583 . . . . 0.0 109.448 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.94 29.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.592 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.3 m -74.9 -53.07 9.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.465 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 18.1 t-20 -84.82 55.23 3.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 0.0 109.391 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 213' ' ' VAL . 3.4 t80 -88.98 -60.13 2.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.312 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -59.94 -36.98 78.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.5 -48.56 81.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.824 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 20.1 mt -68.27 -39.67 82.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.476 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.635 ' HE1' HG21 ' A' ' 206' ' ' VAL . 58.6 t80 -54.85 -49.72 70.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.709 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.572 ' HB2' HH12 ' A' ' 199' ' ' ARG . 20.4 t30 -62.78 -42.31 99.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.716 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 57.8 m -68.38 -30.67 69.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.94 99.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -67.04 -38.76 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 231' ' ' VAL . 25.1 tptp -57.29 -39.94 76.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.38 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.39 -40.34 74.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.67 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.7 m -61.54 -38.66 88.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.266 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 228' ' ' LYS . 22.4 m -65.36 -34.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.88 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 228' ' ' LYS . 9.4 mt-10 -73.14 -44.82 59.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 109.224 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -63.51 -22.43 66.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.684 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.75 29.1 55.74 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.164 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -96.18 -52.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 110.279 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 230' ' ' CYS . 40.6 mt -110.58 134.7 52.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 247' ' ' LYS . 4.1 m -110.98 135.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.15 0.5 . . . . 0.0 110.699 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -125.87 82.87 63.69 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.166 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.65 -41.71 23.83 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.903 2.402 . . . . 0.0 113.078 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.59 -62.55 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.793 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 169.41 -134.21 3.11 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.711 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 18.8 Cg_endo -64.08 -59.71 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.905 2.403 . . . . 0.0 113.202 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.6 m -80.62 -63.2 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 42.82 -123.86 3.91 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.571 -0.741 . . . . 0.0 114.169 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.5 tt -160.74 114.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 227' ' ' ILE . 4.1 mp -75.2 114.95 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.71 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.611 ' HB2' HG23 ' A' ' 237' ' ' VAL . 56.0 mtpt -112.39 131.87 55.32 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.104 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.4 tp -70.06 106.83 3.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 237' ' ' VAL . 44.7 t30 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.826 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.3 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 13.0 Cg_exo -71.01 -148.8 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.847 2.364 . . . . 0.0 112.36 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -109.66 -38.28 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.733 0.301 . . . . 0.0 111.279 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.9 t -134.13 131.04 38.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 0.0 110.879 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' HG3' ' A' ' 182' ' ' GLU . 33.6 mt -161.61 169.47 21.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.805 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 p -66.37 143.24 57.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -56.42 -32.95 65.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.579 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 73.5 tttt -62.82 -47.5 83.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.042 173.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.791 ' HG3' HD13 ' A' ' 178' ' ' LEU . 20.5 tp10 -66.66 -36.73 83.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.865 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 60.9 mtt -50.73 -50.24 55.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.734 HG23 HD21 ' A' ' 202' ' ' LEU . 79.7 mt -64.83 -54.54 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.208 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' A' ' 235' ' ' GLU . 7.9 mp -56.37 -24.97 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.69 -36.12 23.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.292 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 12.9 p -78.39 -26.7 46.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 73.9 mmm -55.89 -50.17 88.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 13.4 Cg_endo -60.07 -38.36 78.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 112.806 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 187' ' ' SER . 11.0 pt20 -75.83 -39.24 57.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.72 114.53 4.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.717 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 53.32 35.58 20.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.311 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 38.5 t0 56.78 34.08 24.08 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.517 0.675 . . . . 0.0 110.954 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 188' ' ' MET . . . 73.56 27.92 66.53 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.637 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.86 -41.4 26.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.472 . . . . 0.0 110.61 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 143.06 157.41 7.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.4 p -151.94 136.24 16.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.955 0.377 . . . . 0.0 110.572 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 2.1 p -68.1 153.43 43.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.48 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 25.4 ttp180 -51.74 -42.17 62.11 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.43 -41.44 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.4 -48.08 84.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.18 0.514 . . . . 0.0 110.675 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.734 HD21 HG23 ' A' ' 184' ' ' ILE . 20.0 tp -61.81 -41.8 98.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.699 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HG3' ' HE2' ' A' ' 219' ' ' PHE . 39.7 ttmt -57.25 -44.85 84.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.964 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -39.29 86.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.424 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -50.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 213' ' ' VAL . 77.5 t -58.56 -41.81 82.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.716 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.57 ' HA ' HG12 ' A' ' 213' ' ' VAL . 27.2 mtpp -64.38 -45.3 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.27 -46.79 26.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.021 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 33.4 p -67.15 -48.95 66.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.244 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 174' ' ' SER . 38.6 m-85 -94.35 106.9 25.82 Favored Pre-proline 0 N--CA 1.453 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 209' ' ' THR . 51.2 Cg_exo -59.69 -36.32 92.3 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.901 2.401 . . . . 0.0 112.548 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.38 -38.1 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 206' ' ' VAL . 54.8 t -66.35 -47.98 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.413 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.4 92.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.276 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.5 t -79.97 -26.6 39.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.508 0.194 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.59 136.13 57.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.957 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -78.73 -62.44 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.749 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.475 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.6 p-10 -87.04 35.58 0.7 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.459 ' CD1' HG13 ' A' ' 213' ' ' VAL . 4.7 t80 -63.13 -50.93 68.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.548 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.29 -44.36 53.91 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -62.69 -46.64 87.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.416 . . . . 0.0 110.799 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 53.8 mt -65.2 -35.2 80.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.323 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 227' ' ' ILE . 18.6 t80 -58.09 -51.04 71.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.623 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -60.83 -38.68 86.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.179 0.514 . . . . 0.0 110.864 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.3 t -65.08 -38.45 90.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.385 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.93 94.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.641 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.4 mt -62.11 -46.58 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.122 0.487 . . . . 0.0 110.141 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 231' ' ' VAL . 49.1 tttp -61.12 -37.94 84.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.849 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.73 -34.56 78.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.083 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.579 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 94.3 m -71.18 -41.96 69.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.565 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 28.2 m -67.96 -39.6 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.617 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.54 -36.45 81.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.391 0.615 . . . . 0.0 109.775 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 3.9 m-80 -68.7 -25.97 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.327 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.55 76.73 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.151 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.915 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.5 mm-40 -72.85 -32.85 65.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.606 0.717 . . . . 0.0 110.194 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 7.2 tt -131.49 140.06 49.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.191 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 249' ' ' ASN . 7.6 m -116.05 137.88 48.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.031 0.443 . . . . 0.0 110.888 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 242' ' ' PRO . 8.7 mm-40 -127.88 79.07 74.29 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.62 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.26 -39.03 2.31 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.841 2.361 . . . . 0.0 112.264 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.626 ' HD2' HG22 ' A' ' 245' ' ' ILE . 63.6 mttp -90.28 24.72 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.176 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 74.36 173.05 29.01 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.387 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HA ' ' NE2' ' A' ' 238' ' ' GLN . 52.0 Cg_exo -55.23 -40.6 84.87 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.015 2.477 . . . . 0.0 113.218 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -81.68 -2.26 49.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.768 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -82.56 -136.22 2.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.883 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.626 HG22 ' HD2' ' A' ' 240' ' ' LYS . 16.1 tt -105.38 121.79 57.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.23 0.538 . . . . 0.0 111.558 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 236' ' ' LEU . 3.3 mp -79.77 116.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.469 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 237' ' ' VAL . 26.1 mtmt -116.29 138.65 51.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 53.2 tp -81.58 113.95 19.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.548 ' HB2' HG13 ' A' ' 237' ' ' VAL . 54.4 t30 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 176' ' ' SER . 60.5 Cg_endo -75.84 -144.25 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.946 2.43 . . . . 0.0 112.625 -176.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 7.9 t -140.28 -39.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 178' ' ' LEU . 8.1 m -114.4 123.78 50.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.66 0.267 . . . . 0.0 110.75 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 177' ' ' SER . 17.0 mt -166.23 -179.41 5.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.741 0.816 . . . . 0.0 109.121 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -82.35 148.01 28.52 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.59 -42.85 62.22 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.876 0.369 . . . . 0.0 110.933 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.579 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -62.49 -41.16 98.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.031 178.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -67.35 -34.63 77.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.502 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.51 ' HE1' HD11 ' A' ' 212' ' ' ILE . 63.3 mtt -58.65 -49.71 76.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.63 HG23 HD21 ' A' ' 202' ' ' LEU . 52.7 mt -63.59 -39.97 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.977 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.5 mt -55.98 -36.94 68.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.506 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 1.9 tppp? -86.28 -32.75 20.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.3 m -70.73 -36.62 73.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.639 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.532 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 4.1 mmt -52.68 -52.11 67.32 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 35.3 Cg_exo -54.31 -33.66 76.94 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.287 1.991 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -67.91 -43.68 78.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.291 0.567 . . . . 0.0 110.394 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 78.8 mt -76.01 107.17 8.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.642 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.79 34.32 23.2 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 59.29 35.15 23.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.955 0.407 . . . . 0.0 110.806 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.72 32.51 70.69 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.395 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -85.8 -41.63 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.231 0.516 . . . . 0.0 110.681 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 247' ' ' LYS . . . 156.27 150.31 5.6 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.848 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 74.7 m -153.64 142.68 21.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.715 0.293 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 9.1 p -62.7 149.51 43.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.631 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.467 ' HA ' ' CD1' ' A' ' 246' ' ' ILE . 54.8 ttp85 -52.41 -43.03 64.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.049 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.3 mt -64.57 -40.35 88.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.22 -46.22 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.975 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.63 HD21 HG23 ' A' ' 184' ' ' ILE . 10.8 tp -62.56 -48.66 78.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.338 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -58.75 -41.72 87.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.914 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -58.5 -41.23 84.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.527 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -72.09 -43.05 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.955 HG12 HG21 ' A' ' 213' ' ' VAL . 99.2 t -60.39 -44.14 95.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.941 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 60.6 mtpt -67.57 -38.99 84.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.419 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.59 -50.27 70.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.809 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.1 p -79.59 -44.93 20.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.096 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.609 ' O ' HG22 ' A' ' 213' ' ' VAL . 21.4 m-85 -103.62 97.68 11.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.628 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 209' ' ' THR . 32.8 Cg_exo -62.79 -15.23 45.58 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.887 2.391 . . . . 0.0 112.942 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.51 HD11 ' HE1' ' A' ' 183' ' ' MET . 14.6 pt -71.81 -35.59 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 0.0 111.285 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.955 HG21 HG12 ' A' ' 206' ' ' VAL . 11.6 m -74.28 -32.71 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.427 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.99 -38.86 97.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.734 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -72.59 -33.79 66.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.819 0.342 . . . . 0.0 111.234 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -66.58 130.52 43.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.98 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.2 m -80.19 -43.87 20.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.159 0.504 . . . . 0.0 110.652 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.509 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 15.2 p-10 -86.66 21.29 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.661 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.0 t80 -61.56 -52.85 62.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -51.24 -40.54 59.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.41 . . . . 0.0 111.42 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -65.3 -52.77 51.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.874 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 57.5 mt -61.22 -37.18 82.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 110.517 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 227' ' ' ILE . 58.4 t80 -54.09 -54.66 36.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.927 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -72.04 -32.15 66.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.9 t -64.08 -41.33 97.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.48 92.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.42 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.597 HD13 HG12 ' A' ' 246' ' ' ILE . 2.3 mt -66.24 -36.26 76.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.689 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -58.49 -34.48 70.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.398 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.46 -38.27 49.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.354 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 181' ' ' LYS . 73.4 m -59.29 -41.64 89.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.782 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -64.0 -42.75 96.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.8 -35.53 67.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.99 0.424 . . . . 0.0 110.203 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 235' ' ' GLU . 9.2 m-80 -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.365 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.16 29.22 41.97 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.848 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.608 ' HG3' ' HB3' ' A' ' 233' ' ' ASN . 29.6 mt-10 -95.71 -47.85 6.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 57.3 mt -118.51 144.83 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.972 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 247' ' ' LYS . 10.5 m -115.2 134.8 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 120.984 0.421 . . . . 0.0 110.105 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.11 81.34 28.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.231 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.439 ' HG2' ' HD3' ' A' ' 247' ' ' LYS . 32.3 Cg_exo -59.19 -39.31 79.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.668 2.245 . . . . 0.0 111.804 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -93.68 29.53 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.691 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 63.17 -164.12 29.24 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.174 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.77 -41.35 8.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.936 2.424 . . . . 0.0 112.706 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.2 p -88.2 58.9 4.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.49 . . . . 0.0 111.263 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -161.66 -134.55 1.66 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.653 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.3 tt -98.17 133.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 111.392 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 227' ' ' ILE . 4.9 mp -97.15 129.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.541 ' HB2' HG23 ' A' ' 237' ' ' VAL . 52.8 mtpt -126.41 138.15 53.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 49.9 tp -71.41 124.76 25.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.425 -176.169 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 120.45 0.167 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 176' ' ' SER . 46.5 Cg_endo -69.34 -140.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.463 2.775 . . . . 0.0 113.55 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.632 ' HA ' ' CE2' ' A' ' 210' ' ' TYR . 73.3 m -155.54 177.82 10.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.059 -0.401 . . . . 0.0 110.508 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.6 m 60.77 47.53 7.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 111.076 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.472 HD12 ' OH ' ' A' ' 210' ' ' TYR . 93.7 mt -135.78 159.92 40.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 183' ' ' MET . 2.4 m -66.02 150.98 47.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.737 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -51.91 -42.95 63.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.603 0.239 . . . . 0.0 111.457 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.81 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 23.4 ttpt -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.54 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 52.6 mt-10 -65.32 -32.95 74.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.245 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.524 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 61.2 mtt -57.91 -45.89 85.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 109.583 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 69.6 mt -68.25 -41.16 83.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.235 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.766 HD11 ' HE3' ' A' ' 181' ' ' LYS . 79.8 mt -53.24 -37.65 62.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.61 -33.84 27.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -73.24 -35.62 66.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.829 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.532 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 1.6 mmt -53.36 -54.41 45.56 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.0 Cg_endo -58.82 -29.23 89.39 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.013 1.809 . . . . 0.0 112.205 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.54 -42.07 71.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.647 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.483 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 98.6 mt -74.78 115.05 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.189 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 51.44 42.39 29.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.992 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 56.59 30.82 18.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.9 28.17 67.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.847 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -91.92 -36.24 13.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.851 -0.205 . . . . 0.0 110.987 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 150.23 147.48 4.55 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.963 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 72.6 m -154.6 144.71 21.88 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 64.4 p -62.43 154.4 28.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HA ' HD11 ' A' ' 246' ' ' ILE . 38.4 ttp85 -57.38 -32.25 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.982 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 55.8 mt -68.6 -41.15 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.08 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 42.6 t -64.35 -43.72 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 43.1 tp -62.85 -39.07 93.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.254 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -56.66 -43.24 80.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 10.4 pttp -63.45 -34.28 77.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.566 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.38 -47.45 27.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.206 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 223' ' ' PHE . 48.6 t -56.53 -48.06 80.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -62.6 -44.17 96.98 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.04 -42.42 69.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.81 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.5 p -73.89 -41.39 62.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.906 0.384 . . . . 0.0 111.099 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 176' ' ' SER . 19.8 m-85 -110.75 98.87 39.61 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.139 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.71 -32.88 85.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.736 2.291 . . . . 0.0 111.975 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.3 pt -64.74 -39.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.18 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 210' ' ' TYR . 5.4 p -77.35 -28.97 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 110.687 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.94 95.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.948 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.0 p -97.82 33.95 1.99 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.894 0.378 . . . . 0.0 111.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.92 142.98 31.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.601 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.1 m -65.8 -60.53 2.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.888 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 221' ' ' TYR . 79.2 m-20 -92.99 48.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 213' ' ' VAL . 9.5 t80 -53.6 -63.17 1.23 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.243 -175.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -64.94 -33.58 76.38 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.37 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.661 ' HB3' ' HB3' ' A' ' 218' ' ' ASN . 93.1 t80 -61.4 -54.66 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.789 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 75.2 mt -66.95 -35.55 80.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.559 ' CE1' HG21 ' A' ' 206' ' ' VAL . 17.1 t80 -62.91 -48.19 80.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.012 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.45 -34.18 77.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.561 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.2 t -62.34 -39.45 93.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.092 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.28 96.4 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.6 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 223' ' ' PHE . 6.9 mm -59.95 -46.31 94.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.319 0.58 . . . . 0.0 111.034 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.72 -36.2 78.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.356 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -73.31 -42.35 62.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.892 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 236' ' ' LEU . 16.7 p -60.43 -39.24 86.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.224 -0.297 . . . . 0.0 111.211 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.44 -42.28 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.28 -36.21 74.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.986 0.422 . . . . 0.0 110.792 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -68.35 -27.54 66.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.989 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.65 29.37 29.7 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.805 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.81 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 11.9 mm-40 -84.79 -48.28 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.531 HD12 ' SG ' ' A' ' 230' ' ' CYS . 19.0 mt -125.55 154.82 41.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.806 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 247' ' ' LYS . 8.5 m -115.09 132.46 64.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.566 ' NE2' HG12 ' A' ' 246' ' ' ILE . 47.1 mt-30 -121.57 93.58 48.68 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.985 0.422 . . . . 0.0 110.859 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 27.8 Cg_endo -64.21 -38.17 37.18 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.918 2.412 . . . . 0.0 112.712 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -100.82 32.51 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.079 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 70.5 -175.3 37.16 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.301 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.24 -42.96 45.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.201 2.601 . . . . 0.0 112.708 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 m -84.18 42.67 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -145.76 -148.04 4.72 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.474 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 198' ' ' SER . 18.1 tt -82.38 123.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.507 0.67 . . . . 0.0 111.258 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.566 HG12 ' NE2' ' A' ' 238' ' ' GLN . 9.4 mt -94.2 116.52 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.812 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.697 ' HB2' HG23 ' A' ' 237' ' ' VAL . 53.5 mtpt -109.52 133.69 52.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.594 0.235 . . . . 0.0 110.483 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 63.4 tp -68.59 114.57 7.1 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.595 ' HB2' HG13 ' A' ' 237' ' ' VAL . 32.3 t30 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.426 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.99 125.51 26.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p -69.62 145.72 52.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.39 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.6 m -85.7 131.92 45.91 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.894 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.636 ' HG2' HD11 ' A' ' 178' ' ' LEU . 67.4 Cg_endo -75.04 -144.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.939 2.426 . . . . 0.0 112.384 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 27.1 m -151.71 156.2 39.84 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.1 m 60.74 36.57 19.33 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.49 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.636 HD11 ' HG2' ' A' ' 175' ' ' PRO . 87.9 mt -91.24 172.89 8.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.581 173.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 182' ' ' GLU . 63.6 p -71.2 154.37 41.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.504 ' CE2' ' HD1' ' A' ' 219' ' ' PHE . 3.0 m-85 -58.42 -32.41 68.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.702 0.286 . . . . 0.0 110.33 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 27.9 ttpp -62.47 -53.63 52.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.805 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 70.1 mm-40 -61.77 -34.35 75.71 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.517 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 212' ' ' ILE . 62.0 mtt -57.77 -47.37 82.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.581 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 202' ' ' LEU . 52.8 mt -69.09 -42.51 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.466 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.683 HD21 ' HB3' ' A' ' 235' ' ' GLU . 88.3 mt -59.55 -25.6 64.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.438 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.537 ' HG2' ' HD2' ' A' ' 175' ' ' PRO . 55.5 tptt -83.22 -41.21 18.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.916 0.389 . . . . 0.0 110.698 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.2 p -76.42 -34.86 58.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.146 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 0.0 OUTLIER -52.05 -54.86 36.34 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -176.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 188' ' ' MET . 19.4 Cg_endo -58.85 -22.95 64.88 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.247 1.964 . . . . 0.0 112.473 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -75.54 -44.79 41.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 37.4 mt -75.81 112.39 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.302 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 53.81 38.86 29.52 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 53.32 33.48 15.75 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.012 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 73.73 14.89 79.6 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.282 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -72.56 -38.71 67.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.466 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 149.36 146.51 4.34 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.055 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 43.4 p -150.5 145.57 26.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.683 0.277 . . . . 0.0 110.797 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 201' ' ' VAL . 29.0 t -57.95 152.13 16.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.083 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.453 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 50.8 ttp180 -56.13 -38.86 71.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.9 mm -62.12 -46.21 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.742 0.305 . . . . 0.0 110.747 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 198' ' ' SER . 42.7 t -60.55 -47.04 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.671 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 184' ' ' ILE . 9.0 tp -64.08 -51.16 65.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.967 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -56.28 -48.26 76.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.033 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -37.19 74.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.224 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -75.75 -45.69 35.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.059 0.457 . . . . 0.0 110.409 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.912 HG12 HG21 ' A' ' 213' ' ' VAL . 68.6 t -60.73 -47.77 91.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.563 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.753 ' HA ' HG23 ' A' ' 213' ' ' VAL . 27.4 mtpp -64.76 -33.84 76.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.71 -47.72 37.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.686 0.279 . . . . 0.0 111.408 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 28.5 p -78.34 -30.72 48.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 111.231 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.599 ' O ' HG22 ' A' ' 213' ' ' VAL . 83.0 m-85 -109.53 91.75 10.74 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.08 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 209' ' ' THR . 54.3 Cg_exo -55.24 -26.61 52.63 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.094 2.53 . . . . 0.0 113.704 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 183' ' ' MET . 43.9 pt -69.19 -37.72 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.694 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.912 HG21 HG12 ' A' ' 206' ' ' VAL . 3.6 m -79.52 -23.16 12.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.369 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.537 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -69.27 -45.02 62.85 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.9 m -69.79 -38.94 76.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.708 0.29 . . . . 0.0 110.796 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.09 120.92 16.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.6 m -80.67 -34.79 34.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.961 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -67.87 -20.82 65.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.863 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 10.0 t80 -48.0 -48.23 32.77 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.51 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -54.6 -35.94 63.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.778 -171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -70.02 -46.93 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 110.312 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.42 -32.2 72.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.365 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.607 ' O ' HG13 ' A' ' 227' ' ' ILE . 50.0 t80 -57.51 -50.41 73.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.384 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.66 -37.46 87.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.571 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 47.1 t -66.88 -38.33 86.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.831 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.23 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.711 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -63.98 -42.43 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 231' ' ' VAL . 39.1 ttmt -57.37 -39.04 75.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 32.0 tptt -73.3 -34.95 66.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.213 0.53 . . . . 0.0 110.324 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.4 m -66.4 -39.58 89.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.167 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.0 m -64.62 -39.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -72.69 -30.88 64.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.077 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.481 ' O ' ' HD3' ' A' ' 252' ' ' LYS . 7.0 m-80 -77.61 -16.92 58.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.41 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 252' ' ' LYS . . . 76.54 19.39 78.09 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.432 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.683 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.3 mm-40 -79.85 -51.01 9.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 55.4 mt -120.24 153.16 36.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.413 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 247' ' ' LYS . 5.8 m -127.69 132.78 68.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.04 0.448 . . . . 0.0 110.672 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.402 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.2 OUTLIER -125.67 92.76 45.86 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.809 -178.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -65.65 -35.98 35.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.066 2.511 . . . . 0.0 113.166 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.523 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 15.0 mptt -71.39 -51.79 22.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.335 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 140.85 -134.34 6.35 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.03 -53.15 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.549 2.166 . . . . 0.0 111.259 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.2 m -99.05 125.47 44.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.363 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . 172.45 -114.9 0.54 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.961 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.7 tt -153.23 122.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.164 0.507 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 227' ' ' ILE . 4.2 mp -85.46 117.77 31.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.802 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.73 ' HB2' HG23 ' A' ' 237' ' ' VAL . 45.3 mtpt -103.95 136.15 44.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.636 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.756 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 2.8 tm? -76.02 96.87 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -70.32 0.4 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.7 tttp 44.35 45.83 7.52 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.177 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -110.03 -32.25 7.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.49 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 233' ' ' ASN . 13.9 ptmm? -79.77 31.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.452 . . . . 0.0 111.371 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.2 p -164.69 106.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.624 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -164.12 32.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.145 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 54.36 48.03 21.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.904 0.383 . . . . 0.0 110.154 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.11 52.02 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.835 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.496 179.146 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.64 0.257 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.13 135.72 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.3 m -108.3 143.45 37.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.123 -174.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.4 p -117.42 135.79 23.31 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.51 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.94 33.38 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.272 2.648 . . . . 0.0 113.641 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.0 t 68.45 -64.95 0.29 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.377 0.671 . . . . 0.0 112.048 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 40.4 t -162.82 142.58 9.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 30.4 mt -157.89 -179.81 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 183' ' ' MET . 3.2 m -70.83 149.3 46.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.42 ' CZ ' HG12 ' A' ' 213' ' ' VAL . 3.0 m-85 -49.74 -40.78 42.05 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.679 0.276 . . . . 0.0 111.221 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.484 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 26.0 ttpp -64.06 -45.59 88.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 79.9 mt-10 -65.95 -33.95 77.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.352 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 179' ' ' THR . 63.3 mtt -52.36 -53.18 48.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.056 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 202' ' ' LEU . 55.8 mt -66.35 -43.86 91.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 98.1 mt -54.96 -40.17 69.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -81.46 -28.95 33.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.065 0.46 . . . . 0.0 110.547 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 43.9 t -71.55 -32.74 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.673 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.447 ' N ' ' HD2' ' A' ' 189' ' ' PRO . 1.5 mmt -52.71 -54.29 44.84 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.5 Cg_endo -58.99 -25.61 78.32 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.873 1.716 . . . . 0.0 112.644 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -73.34 -49.11 29.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.303 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.21 132.96 35.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.241 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 53.23 33.49 15.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.572 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 54.02 31.8 14.31 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.773 0.429 . . . . 0.0 112.148 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 65.02 29.64 75.92 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 113.088 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -94.65 -42.01 9.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.064 0.459 . . . . 0.0 110.55 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 156.08 132.41 1.52 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.1 m -126.07 141.51 51.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.744 0.272 . . . . 0.0 110.618 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.8 p -67.8 147.12 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.18 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.474 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 72.8 ttt180 -51.02 -39.25 55.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.894 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 74.0 mt -65.34 -43.79 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.443 0.163 . . . . 0.0 111.141 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.74 -46.87 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.145 0.498 . . . . 0.0 110.843 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 184' ' ' ILE . 27.3 tp -65.44 -45.9 82.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.003 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.56 -45.02 85.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.402 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 205' ' ' TYR . 0.1 OUTLIER -54.98 -44.71 74.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.773 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.554 ' N ' ' HG2' ' A' ' 204' ' ' LYS . 44.0 t80 -72.73 -46.81 51.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 1.031 HG12 HG21 ' A' ' 213' ' ' VAL . 53.1 t -57.92 -44.32 86.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.713 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.645 ' HA ' HG23 ' A' ' 213' ' ' VAL . 49.5 mtpt -63.92 -41.49 97.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.98 -50.61 47.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.925 0.393 . . . . 0.0 111.238 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 23.2 p -72.17 -43.88 63.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.966 -175.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.586 ' O ' HG22 ' A' ' 213' ' ' VAL . 28.1 m-85 -104.98 102.4 35.57 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-O 120.74 0.305 . . . . 0.0 110.225 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.1 Cg_exo -64.74 -14.45 44.9 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.873 2.382 . . . . 0.0 112.399 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.7 -46.01 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.053 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.031 HG21 HG12 ' A' ' 206' ' ' VAL . 5.5 m -77.14 -30.79 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.91 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.27 97.86 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.72 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.0 m -74.12 -33.73 63.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.658 -0.271 . . . . 0.0 111.114 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.29 126.05 25.96 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.958 0.409 . . . . 0.0 111.413 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.4 p -75.97 -45.78 33.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.273 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 59.3 t30 -92.65 39.61 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.694 0.759 . . . . 0.0 110.016 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.62 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 8.3 t80 -65.13 -48.76 72.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.758 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -50.53 -42.53 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.448 -172.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -63.26 -47.84 80.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.725 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 55.6 mt -62.55 -40.5 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.2 0.524 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 227' ' ' ILE . 39.8 t80 -56.62 -52.52 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.364 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.82 -31.41 72.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 69.2 m -65.55 -39.94 92.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.854 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 181' ' ' LYS . . . -61.12 -45.6 94.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.214 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -66.25 -38.73 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -57.81 -32.4 67.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.206 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -75.65 -47.73 25.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 109.785 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 97.9 m -55.48 -42.66 74.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.36 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -63.49 -40.8 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.625 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.6 -37.1 60.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.936 0.398 . . . . 0.0 110.434 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.514 ' OD1' ' HE2' ' A' ' 254' ' ' LYS . 51.5 m-20 -74.42 -9.08 58.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.55 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 70.68 33.08 66.93 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.501 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -94.1 -51.14 4.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.503 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 66.0 mt -117.18 138.1 51.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.896 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' A' ' 249' ' ' ASN . 4.8 m -109.25 126.54 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.343 0.592 . . . . 0.0 110.659 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 239' ' ' PRO . 58.9 mt-30 -119.34 99.75 50.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.492 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 9.9 Cg_endo -57.26 -50.48 10.99 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.204 2.603 . . . . 0.0 113.091 -174.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.33 -56.61 4.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.24 -150.48 18.82 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.489 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.5 -45.85 34.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.971 2.448 . . . . 0.0 112.247 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.9 t -92.07 121.72 33.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.97 -143.04 9.66 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.242 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 21.2 tt -108.03 134.72 49.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.077 0.465 . . . . 0.0 111.019 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 236' ' ' LEU . 4.7 mp -98.61 108.25 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.916 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.624 ' HB2' HG23 ' A' ' 237' ' ' VAL . 39.5 mtmt -100.67 135.06 42.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.27 113.53 9.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.646 ' HB2' HG13 ' A' ' 237' ' ' VAL . 38.4 t30 -67.68 115.82 7.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.371 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -86.83 89.59 8.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.039 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 251' ' ' LYS . 37.6 tptt -175.19 -44.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.258 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.454 ' HG3' HD23 ' A' ' 255' ' ' LEU . 16.1 tppt? 59.41 57.75 3.23 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.728 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.75 143.28 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.923 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.514 ' HE2' ' OD1' ' A' ' 233' ' ' ASN . 14.6 ttpp 64.46 76.43 0.35 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.136 0.493 . . . . 0.0 110.341 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.454 HD23 ' HG3' ' A' ' 252' ' ' LYS . 90.4 mt -59.35 137.05 58.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 51.8 p -169.29 -117.55 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.354 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.4 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.522 175.508 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.089 0.471 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.417 ' HB1' ' OH ' ' A' ' 205' ' ' TYR . . . -80.26 62.81 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.579 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.1 m -77.86 59.32 2.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.065 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 p -67.5 129.45 93.56 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.409 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.481 ' HG2' HD11 ' A' ' 178' ' ' LEU . 72.3 Cg_endo -77.6 -140.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.82 2.346 . . . . 0.0 112.535 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.636 ' HA ' ' CD2' ' A' ' 210' ' ' TYR . 21.7 t -155.65 -163.44 1.51 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.5 p 49.9 37.43 13.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.293 0.637 . . . . 0.0 111.255 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 175' ' ' PRO . 88.5 mt -114.37 149.68 35.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.652 ' HB ' ' OE1' ' A' ' 182' ' ' GLU . 12.3 m -64.52 154.89 34.65 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -45.78 -52.03 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.591 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 23.4 pttm -67.81 -37.58 82.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.924 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.652 ' OE1' ' HB ' ' A' ' 179' ' ' THR . 18.3 mp0 -57.65 -38.27 74.78 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 179' ' ' THR . 46.5 mtm -58.04 -49.16 77.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.8 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.515 ' O ' ' HG2' ' A' ' 188' ' ' MET . 37.0 mt -63.45 -45.18 98.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.095 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 95.4 mt -52.58 -43.31 65.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.375 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 3.2 tppp? -78.91 -35.98 42.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.6 m -68.49 -36.1 78.45 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.655 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 84.9 mmm -52.53 -55.64 30.3 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 39.2 Cg_exo -56.99 -28.82 80.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.194 1.929 . . . . 0.0 112.478 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 186' ' ' LYS . 49.3 mm-40 -74.48 -40.85 61.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.682 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 77.0 mt -85.51 114.86 22.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.712 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 68.71 -59.25 0.47 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.833 0.708 . . . . 0.0 111.541 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 189' ' ' PRO . 4.0 t70 175.86 -36.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.783 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 140.21 -19.04 2.87 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.701 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.45 -43.05 67.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.712 -0.744 . . . . 0.0 112.171 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 172.75 137.35 2.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.809 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.0 m -141.6 136.26 30.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 53.5 p -68.15 153.1 44.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.691 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -63.37 -29.77 71.01 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.402 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 69.9 mt -59.4 -47.74 89.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 72.7 t -68.76 -48.36 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.893 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 223' ' ' PHE . 25.2 tp -62.27 -48.63 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.847 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.653 ' HA ' HG22 ' A' ' 206' ' ' VAL . 38.1 ttpt -66.77 -37.32 84.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -61.26 -35.28 76.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.513 0.673 . . . . 0.0 110.432 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.417 ' OH ' ' HB1' ' A' ' 172' ' ' ALA . 66.4 t80 -77.53 -51.34 10.87 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.467 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.653 HG22 ' HA ' ' A' ' 203' ' ' LYS . 33.4 m -58.68 -42.52 85.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.018 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.578 ' HA ' HG23 ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.22 -40.26 95.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.69 -41.43 31.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.529 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 25.7 p -83.05 -38.5 22.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.297 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 17.0 m-85 -101.56 101.01 15.59 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 209' ' ' THR . 24.6 Cg_exo -65.89 -10.74 28.01 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.051 2.501 . . . . 0.0 112.703 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 213' ' ' VAL . 22.4 pt -69.06 -34.65 64.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 212' ' ' ILE . 35.0 m -102.36 -24.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.787 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.12 62.46 1.72 Allowed Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.678 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.8 t -171.33 -48.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.682 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.9 129.06 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 111.257 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.1 p -77.12 -35.5 56.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.32 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.26 -6.05 36.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.953 0.406 . . . . 0.0 110.751 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -55.0 -36.99 66.02 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.391 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.43 -46.37 69.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -67.63 -47.51 69.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.944 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.12 -40.42 95.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 111.047 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 202' ' ' LEU . 14.6 t80 -61.31 -50.34 73.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.077 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -58.97 -36.93 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.86 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.2 m -62.52 -40.04 95.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.864 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.17 96.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.852 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -64.54 -43.54 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.233 0.539 . . . . 0.0 110.098 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.585 ' O ' HG22 ' A' ' 231' ' ' VAL . 38.5 ttpt -61.94 -31.69 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.707 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -71.96 -34.29 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.637 0.732 . . . . 0.0 109.671 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 233' ' ' ASN . 71.8 m -72.52 -33.11 66.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.419 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 228' ' ' LYS . 26.6 m -63.5 -38.51 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.227 -177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.54 -33.49 64.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.965 0.412 . . . . 0.0 110.159 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 230' ' ' CYS . 7.8 m-80 -62.97 -33.96 76.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 88.91 18.72 53.67 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.339 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 235' ' ' GLU . 23.1 mm-40 -95.38 -39.89 9.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 109.949 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 2.8 mm? -119.23 140.45 50.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.417 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.7 m -118.45 136.04 56.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.043 0.449 . . . . 0.0 110.733 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.67 93.85 48.57 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.38 -38.6 25.59 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.11 2.54 . . . . 0.0 112.828 -175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.413 ' HG2' HG22 ' A' ' 245' ' ' ILE . 33.2 mmtp -68.57 -42.33 78.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.181 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 150.6 -127.64 2.43 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.68 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.415 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 31.7 Cg_endo -63.83 -29.5 68.0 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.735 2.29 . . . . 0.0 111.9 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 56.6 m -143.16 -123.01 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.054 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.51 -63.79 3.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.285 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.413 HG22 ' HG2' ' A' ' 240' ' ' LYS . 19.5 tt -168.58 130.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.512 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.438 HG12 HD13 ' A' ' 227' ' ' ILE . 5.2 mp -92.81 127.1 45.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.237 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.75 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.5 mtpp -118.65 132.14 56.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.558 0.218 . . . . 0.0 110.575 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.3 tp -75.48 105.96 6.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 237' ' ' VAL . 58.1 t30 -68.97 117.86 11.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.42 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.729 ' HB3' HG23 ' A' ' 253' ' ' VAL . 4.5 mptp? -63.7 -42.42 97.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.93 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 68.2 -48.79 0.54 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.883 -1.508 . . . . 0.0 113.241 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 253' ' ' VAL . 24.7 mtpp -103.98 35.25 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.934 0.397 . . . . 0.0 111.522 -176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.729 HG23 ' HB3' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -165.27 142.97 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.813 175.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -156.42 131.43 9.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.895 0.378 . . . . 0.0 111.354 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.6 mp -75.97 133.78 40.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.748 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.4 t -160.72 47.05 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.291 0.567 . . . . 0.0 110.355 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.108 179.71 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 171' ' ' LYS . 27.5 mtpp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.12 91.29 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.759 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.4 m -156.84 -56.4 0.08 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 3.2 m -108.09 121.95 42.18 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.6 ' HG2' HD11 ' A' ' 178' ' ' LEU . 7.4 Cg_exo -75.19 -134.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.86 2.374 . . . . 0.0 112.283 -176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 13.5 p -152.69 -47.94 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.3 m -77.21 70.16 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.082 0.468 . . . . 0.0 111.513 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.737 HD22 ' HG2' ' A' ' 182' ' ' GLU . 69.9 mt -142.66 155.12 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.236 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.42 ' O ' ' HG3' ' A' ' 183' ' ' MET . 35.2 p -64.92 152.06 44.09 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -60.53 -31.54 70.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.783 0.325 . . . . 0.0 110.597 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.585 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 50.6 tttm -61.12 -48.2 82.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.51 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.737 ' HG2' HD22 ' A' ' 178' ' ' LEU . 20.4 tp10 -63.45 -37.45 87.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.64 176.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.446 ' HE1' HD11 ' A' ' 212' ' ' ILE . 64.2 mtt -57.82 -50.91 71.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.565 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 202' ' ' LEU . 60.5 mt -64.75 -45.16 95.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.032 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 235' ' ' GLU . 81.6 mt -64.46 -25.87 68.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.012 0.434 . . . . 0.0 110.794 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -78.14 -38.74 43.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.8 p -78.83 -27.52 44.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.249 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.507 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 2.6 mmt -49.01 -53.86 34.07 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 188' ' ' MET . 16.2 Cg_endo -58.34 -28.79 86.01 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.117 1.878 . . . . 0.0 112.578 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -73.13 -39.8 65.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 109.78 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.01 92.89 9.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.437 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.15 32.75 21.03 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.83 32.78 12.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.992 0.425 . . . . 0.0 111.588 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.84 18.16 68.19 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.273 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 247' ' ' LYS . 66.3 mttm -74.37 -38.45 63.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.267 0.534 . . . . 0.0 109.883 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 167.54 123.68 0.68 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.796 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.401 ' C ' HG13 ' A' ' 245' ' ' ILE . 50.7 m -140.65 138.27 34.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.618 0.247 . . . . 0.0 110.685 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 201' ' ' VAL . 14.5 p -61.65 148.98 40.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -54.76 -37.38 65.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.402 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.25 -50.29 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.64 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 198' ' ' SER . 8.5 p -69.23 -35.88 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.809 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.657 HD21 HG23 ' A' ' 184' ' ' ILE . 17.3 tp -64.71 -51.13 64.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.338 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 219' ' ' PHE . 27.9 ttpp -58.85 -40.78 85.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.491 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -59.07 -46.23 88.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.935 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -71.04 -43.35 68.04 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.237 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.858 HG12 HG21 ' A' ' 213' ' ' VAL . 19.8 t -57.54 -42.26 80.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.977 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 9.9 mtpm? -64.92 -44.31 89.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.778 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.95 -46.01 72.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.295 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.6 p -74.66 -43.51 54.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.335 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.661 ' O ' HG22 ' A' ' 213' ' ' VAL . 49.2 m-85 -109.82 89.85 8.39 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.14 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 209' ' ' THR . 34.5 Cg_exo -60.16 -15.83 36.55 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.891 2.394 . . . . 0.0 112.877 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.446 HD11 ' HE1' ' A' ' 183' ' ' MET . 28.5 pt -67.89 -32.89 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.877 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.858 HG21 HG12 ' A' ' 206' ' ' VAL . 4.2 m -76.81 -31.25 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.036 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -66.26 -40.43 94.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.631 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.7 t -71.35 -36.22 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.701 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.36 129.96 44.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.938 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -75.35 -50.41 16.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 110.976 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 50.2 t30 -90.07 38.52 0.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.472 0.654 . . . . 0.0 110.603 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.673 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.5 t80 -64.69 -48.52 74.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.562 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.42 -41.48 63.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.548 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -64.08 -45.29 89.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.834 0.35 . . . . 0.0 110.549 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 77.8 mt -62.32 -37.77 86.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.192 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.572 ' O ' HG13 ' A' ' 227' ' ' ILE . 42.8 t80 -59.83 -49.56 77.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.973 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 242' ' ' PRO . 3.1 t-20 -57.02 -42.79 81.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.949 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.4 m -65.43 -37.87 88.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.73 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.84 -46.66 86.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.884 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.6 mt -62.23 -45.16 99.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.114 0.483 . . . . 0.0 110.022 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -56.42 -40.99 75.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.791 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -73.81 -43.12 59.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.367 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.66 ' HB3' ' HB2' ' A' ' 236' ' ' LEU . 73.8 m -59.02 -41.92 88.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.532 0.206 . . . . 0.0 111.428 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 30.0 m -69.18 -43.17 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.31 -34.8 75.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.899 0.381 . . . . 0.0 110.447 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -64.79 -24.7 67.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.526 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 83.44 31.44 27.66 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 185' ' ' LEU . 5.5 mm-40 -108.49 -26.22 10.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.322 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 230' ' ' CYS . 14.1 tp -141.57 156.37 45.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.452 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 249' ' ' ASN . 2.1 t -133.17 136.14 55.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.979 0.418 . . . . 0.0 110.351 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 246' ' ' ILE . 0.8 OUTLIER -145.67 102.84 4.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 16.6 Cg_endo -61.38 -26.02 80.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.184 2.589 . . . . 0.0 113.0 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -104.82 28.85 6.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 242' ' ' PRO . . . 65.2 -122.58 23.94 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.8 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.47 ' HB3' ' ND2' ' A' ' 224' ' ' ASN . 7.5 Cg_exo -75.48 -57.81 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.918 2.412 . . . . 0.0 112.463 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 p -91.94 127.86 37.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.51 -144.55 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.23 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.401 HG13 ' C ' ' A' ' 197' ' ' SER . 13.0 tt -110.35 121.86 63.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.341 0.591 . . . . 0.0 110.521 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.462 ' HA ' ' HG2' ' A' ' 238' ' ' GLN . 3.1 mp -85.48 130.0 37.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.11 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 195' ' ' LYS . 50.6 mtpt -127.51 132.04 50.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.86 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 236' ' ' LEU . 2.7 tt -70.72 123.53 22.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.425 ' HB3' HG23 ' A' ' 237' ' ' VAL . 6.4 p-10 -67.71 135.27 52.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.378 0.609 . . . . 0.0 110.937 -173.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -110.87 47.1 1.01 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.954 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' A' ' 252' ' ' LYS . 64.0 pttt -70.93 -28.22 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.412 0.625 . . . . 0.0 109.391 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 251' ' ' LYS . 65.3 pttt -168.17 148.42 4.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.291 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 5.6 m -73.5 60.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.339 0.59 . . . . 0.0 110.615 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 143.47 57.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.461 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.4 mp -74.32 135.68 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.177 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.5 t -147.0 -48.48 0.18 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--O 1.247 0.963 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.033 175.634 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 60.15 44.37 12.96 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -78.26 130.93 36.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.493 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 9.0 p -84.82 116.53 65.72 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.884 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.25 138.82 12.83 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.799 2.333 . . . . 0.0 112.254 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.5 t -75.44 -172.2 1.72 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.4 m 59.61 55.04 4.22 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.253 0.549 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 40.4 mt -149.63 158.33 44.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.843 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 182' ' ' GLU . 5.6 t -64.76 157.65 26.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.448 ' HA ' ' SD ' ' A' ' 183' ' ' MET . 3.5 m-30 -57.35 -27.75 62.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.732 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.683 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 55.9 tttm -65.53 -47.6 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.572 ' H ' HG23 ' A' ' 179' ' ' THR . 65.5 mm-40 -60.87 -38.77 86.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.973 0.416 . . . . 0.0 110.82 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.465 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 58.2 mtt -55.98 -48.31 76.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 180' ' ' TYR . 23.7 mt -70.33 -37.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.749 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 86.2 mt -54.75 -45.68 74.2 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 17.5 tppt? -70.84 -39.53 72.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.783 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.418 ' HA ' ' NE2' ' A' ' 190' ' ' GLN . 51.0 m -72.57 -32.75 66.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 0.5 OUTLIER -51.79 -51.89 66.13 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 188' ' ' MET . 23.9 Cg_endo -63.44 -30.12 71.95 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.841 1.694 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 187' ' ' SER . 66.0 mt-30 -66.7 -36.15 81.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.067 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.13 113.85 26.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 54.74 37.7 28.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.78 30.98 9.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.781 0.324 . . . . 0.0 111.487 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.01 24.08 75.91 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.265 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.82 -41.68 25.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.38 0.609 . . . . 0.0 110.144 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.49 136.34 2.17 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.383 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.404 ' C ' HG13 ' A' ' 245' ' ' ILE . 41.8 m -139.88 139.79 36.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.989 0.423 . . . . 0.0 110.795 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.1 p -62.26 155.65 24.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.264 -178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HD2' ' HA ' ' A' ' 243' ' ' SER . 54.2 ttt85 -53.35 -41.52 65.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.55 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.82 -44.56 98.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.646 0.26 . . . . 0.0 111.143 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 76.0 t -63.94 -42.85 97.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.369 . . . . 0.0 111.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' HG ' ' HZ ' ' A' ' 223' ' ' PHE . 24.2 tp -68.34 -46.81 69.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 207' ' ' LYS . 38.1 ttpt -62.06 -43.34 99.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 50.6 pttt -62.43 -32.59 73.47 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.959 0.409 . . . . 0.0 110.396 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -78.23 -45.5 22.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.145 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.798 HG12 HG21 ' A' ' 213' ' ' VAL . 40.1 t -59.08 -43.37 89.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.484 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HE3' ' HA2' ' A' ' 214' ' ' GLY . 46.6 mtpt -67.0 -41.17 87.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.364 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.76 -42.32 81.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.449 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.3 p -77.54 -37.17 51.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.607 ' O ' HG22 ' A' ' 213' ' ' VAL . 63.7 m-85 -113.79 95.35 37.01 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.52 -17.25 40.3 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.904 2.403 . . . . 0.0 112.519 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 15.6 pt -71.67 -39.15 68.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.052 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.798 HG21 HG12 ' A' ' 206' ' ' VAL . 6.1 m -74.36 -29.72 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.02 0.438 . . . . 0.0 110.077 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.583 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -63.35 -29.43 74.51 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.745 175.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.0 m -95.45 48.26 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -148.47 128.9 13.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.787 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 33.4 t -78.75 -41.82 29.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.142 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.436 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.0 p-10 -88.76 20.07 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.673 ' HB2' ' HB3' ' A' ' 216' ' ' ALA . 5.2 t80 -59.34 -51.07 71.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.34 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -52.54 -40.79 62.9 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.237 0.335 . . . . 0.0 111.207 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -67.01 -48.71 67.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.177 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 63.2 mt -62.39 -36.32 81.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 110.243 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.523 ' HZ ' ' HG ' ' A' ' 202' ' ' LEU . 21.9 t80 -59.41 -48.88 79.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.723 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.557 ' HB2' HH22 ' A' ' 199' ' ' ARG . 3.0 t-20 -59.47 -41.72 90.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.449 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.5 t -65.24 -37.27 86.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.876 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.36 90.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -68.25 -39.23 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.417 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.606 ' O ' HG22 ' A' ' 231' ' ' VAL . 40.1 ttmt -55.12 -42.25 72.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -66.63 -38.56 87.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 110.499 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . . . . . . . . . 78.0 m -64.32 -38.78 92.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.013 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 228' ' ' LYS . 18.2 m -65.63 -37.65 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.491 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.75 -46.03 55.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.468 0.651 . . . . 0.0 109.312 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 8.4 m-80 -60.5 -30.53 69.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.42 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 87.27 31.9 15.47 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.121 -0.561 . . . . 0.0 111.949 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 233' ' ' ASN . 22.7 mm-40 -97.02 -49.16 5.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.0 109.025 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 9.8 mp -122.83 142.04 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.882 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 247' ' ' LYS . 6.2 m -118.19 134.29 62.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.14 0.495 . . . . 0.0 111.169 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -125.76 79.92 67.52 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.753 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -53.75 -46.13 35.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.397 2.731 . . . . 0.0 112.973 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.482 ' HB2' ' HA3' ' A' ' 244' ' ' GLY . 63.3 mttm -71.96 -54.65 9.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.803 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 164.95 -162.86 36.02 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.825 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.88 -41.13 65.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.287 2.658 . . . . 0.0 112.615 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 199' ' ' ARG . 2.7 p -90.96 6.64 43.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.176 0.512 . . . . 0.0 110.628 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 240' ' ' LYS . . . -84.29 164.96 40.64 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.35 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 197' ' ' SER . 15.4 tt -59.26 128.77 20.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.428 ' CG2' HD23 ' A' ' 236' ' ' LEU . 4.6 mp -86.59 119.83 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 237' ' ' VAL . 27.8 mtpp -114.46 136.51 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.346 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.77 117.11 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.568 ' HB2' HG13 ' A' ' 237' ' ' VAL . 52.4 t30 -74.94 80.31 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -76.61 36.5 0.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.181 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 249' ' ' ASN . 14.7 mmmm -103.24 -42.62 5.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 172.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -90.39 141.77 28.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.019 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 15.7 m -56.44 123.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.299 0.571 . . . . 0.0 111.902 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -72.2 143.89 48.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 83.0 mt -80.57 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 41.5 m 58.45 54.26 5.68 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.113 0.482 . . . . 0.0 110.757 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.869 -179.518 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.715 0.293 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -81.97 43.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.978 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -86.61 132.98 33.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 209' ' ' THR . 27.7 m -94.21 124.3 56.26 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 178' ' ' LEU . 9.1 Cg_exo -72.17 -136.35 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.076 2.518 . . . . 0.0 112.285 -178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.69 ' HA ' ' HD2' ' A' ' 210' ' ' TYR . 44.7 m -155.35 -46.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.248 -0.283 . . . . 0.0 111.281 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.3 m -76.43 63.06 1.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 175' ' ' PRO . 91.2 mt -132.04 156.27 46.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.0 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -63.65 145.64 55.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -50.74 -36.92 38.91 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 24.3 ttpp -63.18 -53.18 57.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.545 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -57.91 -37.13 73.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.963 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.472 ' HB3' ' HE2' ' A' ' 183' ' ' MET . 48.5 mtp -57.59 -53.19 60.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.424 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 202' ' ' LEU . 57.5 mt -62.59 -53.44 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.932 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 181' ' ' LYS . 10.7 mp -52.29 -32.13 36.11 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.855 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -74.36 -42.17 59.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.909 0.385 . . . . 0.0 111.217 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 6.1 p -78.33 -28.01 47.21 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.502 ' HE1' ' O ' ' A' ' 246' ' ' ILE . 60.7 mmm -52.24 -50.77 77.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -60.68 -18.15 53.62 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.034 1.823 . . . . 0.0 112.95 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.453 HE21 ' HG2' ' A' ' 189' ' ' PRO . 60.4 mm-40 -77.13 -48.56 17.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.337 0.589 . . . . 0.0 109.957 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.408 HD21 ' CG ' ' A' ' 205' ' ' TYR . 68.3 mt -71.79 121.4 18.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.331 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 52.02 36.58 19.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 55.1 30.98 15.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.24 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 68.78 25.73 75.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.238 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -84.43 -39.34 19.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 109.993 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 168.85 132.6 1.45 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.0 m -116.66 126.38 53.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 117.082 0.441 . . . . 0.0 110.892 -175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 201' ' ' VAL . 2.7 p -65.05 150.73 47.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.577 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -50.22 -42.74 52.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.599 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.86 -49.43 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.611 HG23 ' HE2' ' A' ' 204' ' ' LYS . 9.6 p -63.63 -35.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.591 0.234 . . . . 0.0 110.869 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 184' ' ' ILE . 22.7 tp -69.97 -49.09 55.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.863 0.363 . . . . 0.0 110.187 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.4 -43.72 92.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.336 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.611 ' HE2' HG23 ' A' ' 201' ' ' VAL . 50.9 pttt -66.46 -37.98 86.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.386 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.408 ' CG ' HD21 ' A' ' 191' ' ' LEU . 10.0 t80 -70.88 -44.74 65.69 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 109.719 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.791 HG12 HG21 ' A' ' 213' ' ' VAL . 23.0 t -59.55 -44.18 92.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.286 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.744 ' HA ' HG23 ' A' ' 213' ' ' VAL . 43.6 mtpt -62.94 -45.2 93.62 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.36 -47.41 49.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.522 -175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 174' ' ' SER . 6.6 m -70.91 -45.29 64.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.121 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.69 ' HD2' ' HA ' ' A' ' 176' ' ' SER . 28.1 m-85 -103.67 103.76 38.32 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 209' ' ' THR . 31.6 Cg_exo -64.75 -15.14 48.66 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.095 2.53 . . . . 0.0 113.127 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.3 mt -67.05 -45.22 87.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.624 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.791 HG21 HG12 ' A' ' 206' ' ' VAL . 23.2 m -72.8 -31.23 35.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.382 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.512 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.45 -42.02 99.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.551 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.4 m -71.83 -34.58 69.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.715 -0.242 . . . . 0.0 111.252 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -62.59 125.42 23.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.041 0.448 . . . . 0.0 111.433 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.6 m -76.22 -43.18 43.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.991 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 34.1 t30 -95.01 36.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.534 0.683 . . . . 0.0 110.181 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.709 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 3.4 t80 -62.05 -48.9 78.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.518 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.85 -43.05 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.899 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -62.2 -46.72 87.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.258 . . . . 0.0 110.628 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 59.3 mt -63.75 -40.22 96.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.509 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.536 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 28.2 t80 -61.1 -54.42 44.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.57 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -63.99 -33.76 76.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 47.9 t -61.83 -40.81 96.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.27 -46.09 91.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.666 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 223' ' ' PHE . 1.2 mt -67.83 -39.04 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.712 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -55.97 -40.25 72.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.32 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' SER . 93.3 mttt -73.0 -40.02 65.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.174 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.672 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 84.8 m -58.29 -45.71 87.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.025 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 34.8 m -64.15 -37.46 79.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -77.15 -37.07 54.7 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.424 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.5 -30.51 67.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.51 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 92.35 25.8 20.24 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 46.9 mm-40 -85.17 -49.05 8.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.334 0.588 . . . . 0.0 109.434 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 45.0 mt -127.23 145.09 50.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.843 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 249' ' ' ASN . 6.5 m -114.71 129.15 71.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.044 0.45 . . . . 0.0 110.346 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -116.86 97.13 50.14 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.687 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.6 -41.21 66.51 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 123.043 2.495 . . . . 0.0 112.272 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 240' ' ' LYS . 3.6 mptp? -80.95 -69.8 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.245 0.545 . . . . 0.0 110.278 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 167.5 -156.65 28.54 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.11 -48.61 20.65 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.066 2.511 . . . . 0.0 112.671 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 7.9 t -89.49 55.11 3.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.263 0.554 . . . . 0.0 109.833 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -152.87 162.33 29.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.653 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.3 tt -57.04 125.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.526 0.679 . . . . 0.0 111.971 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 236' ' ' LEU . 4.8 mp -87.9 123.06 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.309 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.534 ' HB2' HG23 ' A' ' 237' ' ' VAL . 58.1 mtpt -112.28 137.12 50.86 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.0 tt -71.98 113.51 9.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.553 ' HB2' HG13 ' A' ' 237' ' ' VAL . 46.5 t30 -62.61 119.39 9.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.864 0.364 . . . . 0.0 110.269 -175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -78.06 58.53 2.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.586 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -77.34 61.48 2.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.918 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 69.53 54.29 0.4 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.067 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.21 124.78 40.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.074 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.483 ' HE2' ' OG ' ' A' ' 256' ' ' SER . 8.0 ttpm? -77.82 136.9 38.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.61 53.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.695 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.483 ' OG ' ' HE2' ' A' ' 254' ' ' LYS . 1.1 m -64.13 135.52 56.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.889 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.971 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.51 0.195 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.651 ' HB1' HG22 ' A' ' 209' ' ' THR . . . -69.45 134.84 49.43 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.4 t -69.23 -47.46 64.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.931 0.396 . . . . 0.0 110.089 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.609 ' HA ' ' HG2' ' A' ' 186' ' ' LYS . 18.9 m -73.04 131.3 83.82 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.946 175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 186' ' ' LYS . 43.5 Cg_endo -70.25 -143.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.031 2.488 . . . . 0.0 113.172 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 50.8 m -153.08 161.87 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.09 -0.381 . . . . 0.0 110.722 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.6 m 62.14 49.99 4.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.55 0.69 . . . . 0.0 111.214 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 182' ' ' GLU . 51.6 mt -129.35 163.09 26.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.349 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.5 ' HB ' ' HG2' ' A' ' 182' ' ' GLU . 1.9 m -63.0 150.5 42.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.834 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -54.57 -37.28 65.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.67 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 39.1 ttpt -60.42 -46.45 89.98 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.033 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 55.6 mm-40 -61.45 -33.67 74.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.422 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 60.6 mtt -58.15 -49.52 76.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 58.8 mt -68.94 -43.35 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 87.6 mt -53.33 -39.52 64.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 174' ' ' SER . 47.6 tptt -73.74 -42.06 61.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 m -69.21 -30.04 68.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.33 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.65 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 5.1 mmt -51.63 -57.7 13.58 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 32.1 Cg_exo -59.1 -28.33 87.5 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.12 1.88 . . . . 0.0 112.127 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -71.06 -39.6 72.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.537 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.15 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.446 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 51.89 35.34 15.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.057 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 54.78 34.92 22.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.588 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 66.73 19.22 69.12 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.759 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -75.96 -41.72 50.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.3 0.55 . . . . 0.0 110.251 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 247' ' ' LYS . . . 167.82 145.9 4.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 m -143.69 133.42 23.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.879 0.34 . . . . 0.0 110.793 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 30.2 t -61.19 144.82 53.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.204 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.572 HH12 ' HB2' ' A' ' 224' ' ' ASN . 46.3 ttm-85 -53.89 -38.71 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 110.419 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.14 -49.67 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.0 -34.44 45.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.714 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 28.8 tp -66.17 -49.91 65.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 219' ' ' PHE . 38.6 ttpt -59.67 -36.47 76.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -57.34 -45.87 83.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.15 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.27 -44.47 65.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.478 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.635 HG21 ' HE1' ' A' ' 223' ' ' PHE . 46.3 t -56.49 -45.86 82.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.626 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 7.7 mtpm? -66.43 -43.44 85.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.712 175.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.52 -41.56 96.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.496 -173.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.651 HG22 ' HB1' ' A' ' 172' ' ' ALA . 18.7 p -79.67 -42.89 23.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.202 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.585 ' O ' HG12 ' A' ' 213' ' ' VAL . 16.4 m-85 -106.88 102.58 43.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.92 -31.94 84.74 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.546 2.164 . . . . 0.0 111.509 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.2 pt -63.12 -37.04 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.774 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.699 HG22 ' CE1' ' A' ' 219' ' ' PHE . 4.1 p -82.25 -36.32 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -82.03 41.1 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.507 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.9 t -160.23 51.89 0.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.323 0.583 . . . . 0.0 109.448 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.94 29.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.592 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.3 m -74.9 -53.07 9.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.465 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 18.1 t-20 -84.82 55.23 3.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.645 0.736 . . . . 0.0 109.391 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 213' ' ' VAL . 3.4 t80 -88.98 -60.13 2.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.312 -176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -59.94 -36.98 78.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.682 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.5 -48.56 81.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.824 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 20.1 mt -68.27 -39.67 82.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.671 0.272 . . . . 0.0 110.476 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.635 ' HE1' HG21 ' A' ' 206' ' ' VAL . 58.6 t80 -54.85 -49.72 70.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.709 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.572 ' HB2' HH12 ' A' ' 199' ' ' ARG . 20.4 t30 -62.78 -42.31 99.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.716 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 57.8 m -68.38 -30.67 69.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.94 99.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.0 mt -67.04 -38.76 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 231' ' ' VAL . 25.1 tptp -57.29 -39.94 76.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.38 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.39 -40.34 74.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.67 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 87.7 m -61.54 -38.66 88.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.266 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 228' ' ' LYS . 22.4 m -65.36 -34.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.88 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 228' ' ' LYS . 9.4 mt-10 -73.14 -44.82 59.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 109.224 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -63.51 -22.43 66.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.684 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 77.75 29.1 55.74 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.164 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -96.18 -52.79 3.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 110.279 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 230' ' ' CYS . 40.6 mt -110.58 134.7 52.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 247' ' ' LYS . 4.1 m -110.98 135.3 50.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.15 0.5 . . . . 0.0 110.699 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -125.87 82.87 63.69 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.166 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.65 -41.71 23.83 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.903 2.402 . . . . 0.0 113.078 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.59 -62.55 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.793 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 242' ' ' PRO . . . 169.41 -134.21 3.11 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.711 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 241' ' ' GLY . 18.8 Cg_endo -64.08 -59.71 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.905 2.403 . . . . 0.0 113.202 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.6 m -80.62 -63.2 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 42.82 -123.86 3.91 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.571 -0.741 . . . . 0.0 114.169 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 11.5 tt -160.74 114.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 227' ' ' ILE . 4.1 mp -75.2 114.95 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.71 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.611 ' HB2' HG23 ' A' ' 237' ' ' VAL . 56.0 mtpt -112.39 131.87 55.32 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.104 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.4 tp -70.06 106.83 3.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.592 ' HB2' HG13 ' A' ' 237' ' ' VAL . 44.7 t30 -73.09 130.49 40.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.826 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 250' ' ' LYS . 16.2 tptm -132.3 36.91 3.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.169 0.509 . . . . 0.0 109.687 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 251' ' ' LYS . 9.8 mtpm? -80.59 59.35 3.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.192 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.412 ' HD3' ' HB ' ' A' ' 257' ' ' THR . 18.4 ptpt -52.33 133.18 34.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.643 -173.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.19 137.43 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.21 145.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.543 0.527 . . . . 0.0 110.181 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.15 -38.35 90.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.537 -173.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.2 m -77.53 114.79 16.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.877 0.37 . . . . 0.0 111.126 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 252' ' ' LYS . 98.4 m . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.064 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.23 54.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.565 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -159.85 -166.83 1.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.95 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.635 ' HB2' ' HB ' ' A' ' 209' ' ' THR . 13.3 m -79.19 132.42 63.14 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 13.0 Cg_exo -71.01 -148.8 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.847 2.364 . . . . 0.0 112.36 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.1 m -109.66 -38.28 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.733 0.301 . . . . 0.0 111.279 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.9 t -134.13 131.04 38.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.031 0.443 . . . . 0.0 110.879 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' HG3' ' A' ' 182' ' ' GLU . 33.6 mt -161.61 169.47 21.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.805 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 p -66.37 143.24 57.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -56.42 -32.95 65.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.579 ' HG3' ' SG ' ' A' ' 230' ' ' CYS . 73.5 tttt -62.82 -47.5 83.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.042 173.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.791 ' HG3' HD13 ' A' ' 178' ' ' LEU . 20.5 tp10 -66.66 -36.73 83.23 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.865 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 60.9 mtt -50.73 -50.24 55.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.263 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.734 HG23 HD21 ' A' ' 202' ' ' LEU . 79.7 mt -64.83 -54.54 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.208 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' A' ' 235' ' ' GLU . 7.9 mp -56.37 -24.97 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.69 -36.12 23.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.292 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 190' ' ' GLN . 12.9 p -78.39 -26.7 46.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 184' ' ' ILE . 73.9 mmm -55.89 -50.17 88.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 188' ' ' MET . 13.4 Cg_endo -60.07 -38.36 78.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.99 1.794 . . . . 0.0 112.806 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 187' ' ' SER . 11.0 pt20 -75.83 -39.24 57.08 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.72 114.53 4.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.858 0.361 . . . . 0.0 111.717 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 53.32 35.58 20.63 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.311 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 38.5 t0 56.78 34.08 24.08 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.517 0.675 . . . . 0.0 110.954 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 188' ' ' MET . . . 73.56 27.92 66.53 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.637 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.86 -41.4 26.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.472 . . . . 0.0 110.61 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 143.06 157.41 7.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.4 p -151.94 136.24 16.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.955 0.377 . . . . 0.0 110.572 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 2.1 p -68.1 153.43 43.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.48 ' HG3' ' HE2' ' A' ' 223' ' ' PHE . 25.4 ttp180 -51.74 -42.17 62.11 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.43 -41.44 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.035 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.4 -48.08 84.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.18 0.514 . . . . 0.0 110.675 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.734 HD21 HG23 ' A' ' 184' ' ' ILE . 20.0 tp -61.81 -41.8 98.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.699 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HG3' ' HE2' ' A' ' 219' ' ' PHE . 39.7 ttmt -57.25 -44.85 84.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.964 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -39.29 86.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.424 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -50.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.548 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 213' ' ' VAL . 77.5 t -58.56 -41.81 82.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.716 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.57 ' HA ' HG12 ' A' ' 213' ' ' VAL . 27.2 mtpp -64.38 -45.3 88.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.27 -46.79 26.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.021 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 174' ' ' SER . 33.4 p -67.15 -48.95 66.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.244 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 174' ' ' SER . 38.6 m-85 -94.35 106.9 25.82 Favored Pre-proline 0 N--CA 1.453 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 209' ' ' THR . 51.2 Cg_exo -59.69 -36.32 92.3 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.901 2.401 . . . . 0.0 112.548 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.38 -38.1 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 206' ' ' VAL . 54.8 t -66.35 -47.98 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.413 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.4 92.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.276 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.5 t -79.97 -26.6 39.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.508 0.194 . . . . 0.0 111.352 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.59 136.13 57.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.957 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -78.73 -62.44 1.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.749 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.475 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 17.6 p-10 -87.04 35.58 0.7 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.156 0.503 . . . . 0.0 111.362 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.459 ' CD1' HG13 ' A' ' 213' ' ' VAL . 4.7 t80 -63.13 -50.93 68.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.548 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.29 -44.36 53.91 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -62.69 -46.64 87.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.416 . . . . 0.0 110.799 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 53.8 mt -65.2 -35.2 80.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.323 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 227' ' ' ILE . 18.6 t80 -58.09 -51.04 71.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.623 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -60.83 -38.68 86.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.179 0.514 . . . . 0.0 110.864 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.3 t -65.08 -38.45 90.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.385 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.93 94.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.641 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 223' ' ' PHE . 2.4 mt -62.11 -46.58 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.122 0.487 . . . . 0.0 110.141 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 231' ' ' VAL . 49.1 tttp -61.12 -37.94 84.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.849 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -66.73 -34.56 78.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.511 0.672 . . . . 0.0 110.083 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.579 ' SG ' ' HG3' ' A' ' 181' ' ' LYS . 94.3 m -71.18 -41.96 69.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.565 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 28.2 m -67.96 -39.6 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.617 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.54 -36.45 81.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.391 0.615 . . . . 0.0 109.775 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 235' ' ' GLU . 3.9 m-80 -68.7 -25.97 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.327 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.564 ' HA3' ' HD2' ' A' ' 251' ' ' LYS . . . 89.33 2.55 76.73 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.151 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.915 ' HB3' HD21 ' A' ' 185' ' ' LEU . 5.5 mm-40 -72.85 -32.85 65.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.606 0.717 . . . . 0.0 110.194 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 7.2 tt -131.49 140.06 49.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.191 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 249' ' ' ASN . 7.6 m -116.05 137.88 48.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.031 0.443 . . . . 0.0 110.888 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 242' ' ' PRO . 8.7 mm-40 -127.88 79.07 74.29 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.62 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.26 -39.03 2.31 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.841 2.361 . . . . 0.0 112.264 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.626 ' HD2' HG22 ' A' ' 245' ' ' ILE . 63.6 mttp -90.28 24.72 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.176 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 74.36 173.05 29.01 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.387 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HA ' ' NE2' ' A' ' 238' ' ' GLN . 52.0 Cg_exo -55.23 -40.6 84.87 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.015 2.477 . . . . 0.0 113.218 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 50.1 m -81.68 -2.26 49.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.768 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -82.56 -136.22 2.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.883 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.626 HG22 ' HD2' ' A' ' 240' ' ' LYS . 16.1 tt -105.38 121.79 57.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.23 0.538 . . . . 0.0 111.558 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 236' ' ' LEU . 3.3 mp -79.77 116.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.469 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 237' ' ' VAL . 26.1 mtmt -116.29 138.65 51.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 53.2 tp -81.58 113.95 19.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.548 ' HB2' HG13 ' A' ' 237' ' ' VAL . 54.4 t30 -83.82 -38.24 21.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 58.11 66.49 1.1 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.303 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.564 ' HD2' ' HA3' ' A' ' 234' ' ' GLY . 30.0 tttt -72.05 -24.03 61.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.387 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -73.43 52.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.12 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.2 133.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.039 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -169.82 155.6 5.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.432 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.58 HD22 ' H ' ' A' ' 255' ' ' LEU . 1.5 mm? -61.78 132.5 53.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.6 t -172.45 133.69 0.64 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.087 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.57 179.117 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.823 0.344 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.08 165.38 25.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.096 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.4 m -62.82 -45.55 92.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.724 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -94.13 124.12 56.98 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 176' ' ' SER . 60.5 Cg_endo -75.84 -144.25 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.946 2.43 . . . . 0.0 112.625 -176.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 175' ' ' PRO . 7.9 t -140.28 -39.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.667 0.27 . . . . 0.0 110.755 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 178' ' ' LEU . 8.1 m -114.4 123.78 50.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.66 0.267 . . . . 0.0 110.75 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 177' ' ' SER . 17.0 mt -166.23 -179.41 5.05 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.741 0.816 . . . . 0.0 109.121 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.4 m -82.35 148.01 28.52 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.59 -42.85 62.22 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.876 0.369 . . . . 0.0 110.933 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.579 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -62.49 -41.16 98.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.031 178.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -67.35 -34.63 77.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.502 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.51 ' HE1' HD11 ' A' ' 212' ' ' ILE . 63.3 mtt -58.65 -49.71 76.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.63 HG23 HD21 ' A' ' 202' ' ' LEU . 52.7 mt -63.59 -39.97 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.977 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 181' ' ' LYS . 88.5 mt -55.98 -36.94 68.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.506 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 1.9 tppp? -86.28 -32.75 20.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.3 m -70.73 -36.62 73.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.639 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.532 ' HA ' ' CE ' ' A' ' 188' ' ' MET . 4.1 mmt -52.68 -52.11 67.32 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 186' ' ' LYS . 35.3 Cg_exo -54.31 -33.66 76.94 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.287 1.991 . . . . 0.0 112.794 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -67.91 -43.68 78.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.291 0.567 . . . . 0.0 110.394 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 78.8 mt -76.01 107.17 8.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.642 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 55.79 34.32 23.2 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.512 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 59.29 35.15 23.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.955 0.407 . . . . 0.0 110.806 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.72 32.51 70.69 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.395 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -85.8 -41.63 14.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.231 0.516 . . . . 0.0 110.681 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 247' ' ' LYS . . . 156.27 150.31 5.6 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.802 -0.714 . . . . 0.0 111.848 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 74.7 m -153.64 142.68 21.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.715 0.293 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 9.1 p -62.7 149.51 43.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.631 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.467 ' HA ' ' CD1' ' A' ' 246' ' ' ILE . 54.8 ttp85 -52.41 -43.03 64.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.049 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.3 mt -64.57 -40.35 88.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.22 -46.22 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.975 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.63 HD21 HG23 ' A' ' 184' ' ' ILE . 10.8 tp -62.56 -48.66 78.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.338 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -58.75 -41.72 87.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.914 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -58.5 -41.23 84.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.527 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -72.09 -43.05 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.53 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.955 HG12 HG21 ' A' ' 213' ' ' VAL . 99.2 t -60.39 -44.14 95.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.941 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 60.6 mtpt -67.57 -38.99 84.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.419 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.59 -50.27 70.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.809 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.558 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 18.1 p -79.59 -44.93 20.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.096 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.609 ' O ' HG22 ' A' ' 213' ' ' VAL . 21.4 m-85 -103.62 97.68 11.18 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.755 0.312 . . . . 0.0 110.628 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 209' ' ' THR . 32.8 Cg_exo -62.79 -15.23 45.58 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.887 2.391 . . . . 0.0 112.942 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.51 HD11 ' HE1' ' A' ' 183' ' ' MET . 14.6 pt -71.81 -35.59 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 0.0 111.285 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.955 HG21 HG12 ' A' ' 206' ' ' VAL . 11.6 m -74.28 -32.71 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.809 0.337 . . . . 0.0 110.738 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.427 ' HA2' ' HE3' ' A' ' 207' ' ' LYS . . . -62.99 -38.86 97.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.734 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -72.59 -33.79 66.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.819 0.342 . . . . 0.0 111.234 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 219' ' ' PHE . . . -66.58 130.52 43.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.98 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 14.2 m -80.19 -43.87 20.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.159 0.504 . . . . 0.0 110.652 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.509 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 15.2 p-10 -86.66 21.29 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.661 ' CD1' ' HB ' ' A' ' 213' ' ' VAL . 5.0 t80 -61.56 -52.85 62.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.274 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -51.24 -40.54 59.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.962 0.41 . . . . 0.0 111.42 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -65.3 -52.77 51.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.874 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 57.5 mt -61.22 -37.18 82.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.059 0.457 . . . . 0.0 110.517 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 227' ' ' ILE . 58.4 t80 -54.09 -54.66 36.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.927 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -72.04 -32.15 66.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.9 t -64.08 -41.33 97.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.48 92.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.42 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.597 HD13 HG12 ' A' ' 246' ' ' ILE . 2.3 mt -66.24 -36.26 76.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.689 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -58.49 -34.48 70.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.398 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.46 -38.27 49.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.354 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 181' ' ' LYS . 73.4 m -59.29 -41.64 89.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.782 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 236' ' ' LEU . 27.3 m -64.0 -42.75 96.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.8 -35.53 67.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.99 0.424 . . . . 0.0 110.203 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.608 ' HB3' ' HG3' ' A' ' 235' ' ' GLU . 9.2 m-80 -66.44 -25.84 66.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.365 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.16 29.22 41.97 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.848 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.608 ' HG3' ' HB3' ' A' ' 233' ' ' ASN . 29.6 mt-10 -95.71 -47.85 6.02 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 231' ' ' VAL . 57.3 mt -118.51 144.83 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.972 173.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 247' ' ' LYS . 10.5 m -115.2 134.8 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 120.984 0.421 . . . . 0.0 110.105 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -120.11 81.34 28.3 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.231 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.439 ' HG2' ' HD3' ' A' ' 247' ' ' LYS . 32.3 Cg_exo -59.19 -39.31 79.92 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.668 2.245 . . . . 0.0 111.804 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -93.68 29.53 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.691 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 63.17 -164.12 29.24 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.174 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.77 -41.35 8.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.936 2.424 . . . . 0.0 112.706 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.2 p -88.2 58.9 4.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.49 . . . . 0.0 111.263 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -161.66 -134.55 1.66 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.653 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 19.3 tt -98.17 133.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.088 0.471 . . . . 0.0 111.392 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 227' ' ' ILE . 4.9 mp -97.15 129.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.541 ' HB2' HG23 ' A' ' 237' ' ' VAL . 52.8 mtpt -126.41 138.15 53.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 49.9 tp -71.41 124.76 25.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -60.63 129.59 42.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.425 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.6 ' HG3' HG12 ' A' ' 253' ' ' VAL . 0.1 OUTLIER -167.09 53.64 0.07 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.325 0.583 . . . . 0.0 109.686 -178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -75.04 -39.7 60.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -85.05 117.29 23.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.386 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.6 HG12 ' HG3' ' A' ' 250' ' ' LYS . 20.1 m -128.14 138.67 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -169.69 122.15 0.72 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.852 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.79 55.7 3.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.475 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 27.4 t -66.36 -45.3 80.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.018 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.636 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.889 0.376 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.92 -139.2 0.23 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.935 ' HB3' HG22 ' A' ' 209' ' ' THR . 21.7 m -71.66 156.91 38.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 148.79 20.77 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.315 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 176' ' ' SER . 46.5 Cg_endo -69.34 -140.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.463 2.775 . . . . 0.0 113.55 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.632 ' HA ' ' CE2' ' A' ' 210' ' ' TYR . 73.3 m -155.54 177.82 10.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.059 -0.401 . . . . 0.0 110.508 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.6 m 60.77 47.53 7.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 111.076 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.472 HD12 ' OH ' ' A' ' 210' ' ' TYR . 93.7 mt -135.78 159.92 40.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.679 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 183' ' ' MET . 2.4 m -66.02 150.98 47.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.737 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -51.91 -42.95 63.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.603 0.239 . . . . 0.0 111.457 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.81 ' HD2' ' HG3' ' A' ' 235' ' ' GLU . 23.4 ttpt -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.54 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 178' ' ' LEU . 52.6 mt-10 -65.32 -32.95 74.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.245 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.524 ' HG2' ' CE2' ' A' ' 210' ' ' TYR . 61.2 mtt -57.91 -45.89 85.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.553 0.692 . . . . 0.0 109.583 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.406 HG23 HD21 ' A' ' 202' ' ' LEU . 69.6 mt -68.25 -41.16 83.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.235 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.766 HD11 ' HE3' ' A' ' 181' ' ' LYS . 79.8 mt -53.24 -37.65 62.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.61 -33.84 27.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -73.24 -35.62 66.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.829 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.532 ' HB3' ' HB2' ' A' ' 248' ' ' LEU . 1.6 mmt -53.36 -54.41 45.56 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.0 Cg_endo -58.82 -29.23 89.39 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.013 1.809 . . . . 0.0 112.205 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.54 -42.07 71.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.647 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.483 ' HB3' ' OG ' ' A' ' 197' ' ' SER . 98.6 mt -74.78 115.05 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.189 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 51.44 42.39 29.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.992 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 56.59 30.82 18.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 0.0 111.636 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 72.9 28.17 67.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.847 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -91.92 -36.24 13.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.851 -0.205 . . . . 0.0 110.987 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 246' ' ' ILE . . . 150.23 147.48 4.55 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.963 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 191' ' ' LEU . 72.6 m -154.6 144.71 21.88 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 244' ' ' GLY . 64.4 p -62.43 154.4 28.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.282 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HA ' HD11 ' A' ' 246' ' ' ILE . 38.4 ttp85 -57.38 -32.25 66.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.982 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 55.8 mt -68.6 -41.15 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.08 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 42.6 t -64.35 -43.72 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.406 HD21 HG23 ' A' ' 184' ' ' ILE . 43.1 tp -62.85 -39.07 93.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.254 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -56.66 -43.24 80.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 201' ' ' VAL . 10.4 pttp -63.45 -34.28 77.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.566 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.38 -47.45 27.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.206 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 223' ' ' PHE . 48.6 t -56.53 -48.06 80.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -62.6 -44.17 96.98 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.04 -42.42 69.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.81 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.935 HG22 ' HB3' ' A' ' 173' ' ' SER . 39.5 p -73.89 -41.39 62.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.906 0.384 . . . . 0.0 111.099 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 176' ' ' SER . 19.8 m-85 -110.75 98.87 39.61 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.139 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.71 -32.88 85.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.736 2.291 . . . . 0.0 111.975 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.3 pt -64.74 -39.51 85.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.18 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 210' ' ' TYR . 5.4 p -77.35 -28.97 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 110.687 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.94 95.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.948 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.0 p -97.82 33.95 1.99 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.894 0.378 . . . . 0.0 111.811 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.92 142.98 31.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.601 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.1 m -65.8 -60.53 2.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.888 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 221' ' ' TYR . 79.2 m-20 -92.99 48.67 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 213' ' ' VAL . 9.5 t80 -53.6 -63.17 1.23 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.243 -175.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -64.94 -33.58 76.38 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.37 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.661 ' HB3' ' HB3' ' A' ' 218' ' ' ASN . 93.1 t80 -61.4 -54.66 40.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.789 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 218' ' ' ASN . 75.2 mt -66.95 -35.55 80.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.559 ' CE1' HG21 ' A' ' 206' ' ' VAL . 17.1 t80 -62.91 -48.19 80.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.012 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -63.45 -34.18 77.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.561 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.2 t -62.34 -39.45 93.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.092 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.28 96.4 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.6 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 223' ' ' PHE . 6.9 mm -59.95 -46.31 94.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.319 0.58 . . . . 0.0 111.034 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.72 -36.2 78.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.356 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -73.31 -42.35 62.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.892 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 236' ' ' LEU . 16.7 p -60.43 -39.24 86.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.224 -0.297 . . . . 0.0 111.211 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.44 -42.28 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.28 -36.21 74.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.986 0.422 . . . . 0.0 110.792 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -68.35 -27.54 66.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.989 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 84.65 29.37 29.7 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.805 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.81 ' HG3' ' HD2' ' A' ' 181' ' ' LYS . 11.9 mm-40 -84.79 -48.28 9.54 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.531 HD12 ' SG ' ' A' ' 230' ' ' CYS . 19.0 mt -125.55 154.82 41.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.806 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 247' ' ' LYS . 8.5 m -115.09 132.46 64.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.466 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.566 ' NE2' HG12 ' A' ' 246' ' ' ILE . 47.1 mt-30 -121.57 93.58 48.68 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.985 0.422 . . . . 0.0 110.859 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 238' ' ' GLN . 27.8 Cg_endo -64.21 -38.17 37.18 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.918 2.412 . . . . 0.0 112.712 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -100.82 32.51 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.079 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 70.5 -175.3 37.16 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.301 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.24 -42.96 45.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.201 2.601 . . . . 0.0 112.708 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.0 m -84.18 42.67 0.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 198' ' ' SER . . . -145.76 -148.04 4.72 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.474 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 198' ' ' SER . 18.1 tt -82.38 123.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 121.507 0.67 . . . . 0.0 111.258 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.566 HG12 ' NE2' ' A' ' 238' ' ' GLN . 9.4 mt -94.2 116.52 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.812 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.697 ' HB2' HG23 ' A' ' 237' ' ' VAL . 53.5 mtpt -109.52 133.69 52.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.594 0.235 . . . . 0.0 110.483 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 188' ' ' MET . 63.4 tp -68.59 114.57 7.1 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.595 ' HB2' HG13 ' A' ' 237' ' ' VAL . 32.3 t30 -69.55 86.82 0.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -87.7 42.01 1.02 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.366 0.603 . . . . 0.0 110.278 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -70.52 -23.07 62.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.082 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt 68.77 27.43 5.79 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.24 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 254' ' ' LYS . 3.5 t 55.76 36.41 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.33 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER 64.56 146.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.332 1.053 . . . . 0.0 111.604 -177.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.518 ' HB3' ' H ' ' A' ' 256' ' ' SER . 4.5 mm? -78.35 -143.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.475 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 255' ' ' LEU . 22.1 m 63.33 35.21 12.51 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.581 0.705 . . . . 0.0 110.12 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.798 -179.354 . . . . . . . . 0 0 . 1 stop_ save_